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Ribonucleotides (rNMPs) are the most abundant non-standard nucleotides in 
genomic DNA. Presence of rNMPs embedded in DNA alters the DNA structure, function 
and their properties, which ultimately may lead to genomic instability in the form of 
mutagenesis, replication stress and DNA breaks. Despite abundant evidence of the negative 
impact of rNMPs in DNA, not much is known about location and identity of rNMPs 
incorporated in genomic DNA. Here, our aims are to study the genome-wide distribution 
of rNMPs, and to characterize DNA repair mechanisms responsible for removal of rNMPs 
and modified rNMPs. To better understand the profile of rNMPs in DNA, we modified our 
current method, ribose-seq, to generate a robust and effective technique to capture rNMPs 
incorporated in DNA. Using our modified ribose-seq, in addition to mapping rNMPs in 
ribonuclease (RNase) H2 null cells at a much higher efficiency, we also determined the 
rNMP incorporation pattern from wild type DNA of budding yeast S. cerevisiae and S. 
paradoxus, and fission yeast S. pombe. Additionally, we explored the role of RNase H2 in 
cleaving modified rNMPs, such as abasic rNMPs. To study if RNase H2 can cleave at 
abasic rNMPs in DNA, we investigated whether eukaryotic RNase H2 is capable of 
recognizing abasic rNMPs.  Also, we investigated the role of base excision repair (BER) 
enzymes in cleaving rNMPs and abasic rNMPs. We identity the role of 
apurinic/apyrimidinic endonuclease 1 (APE1) in cleaving abasic rNMPs, thus revealing a 
novel function of the BER pathway.  
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CHAPTER 1. INTRODUCTION 
1.1 DNA and RNA structure 
Nucleic acids are the building blocks of life. Nucleic acids differ in their structure of the 
sugar in their nucleotides. They are composed of nucleotides that consists of a 5-carbon 
sugar, a phosphate group, and a nitrogenous base. The 5-carbon sugar can be either 
deoxyribose or ribose, thus giving rise to deoxyribonucleoside 5’-monophosphates 
(dNMPs) or ribonucleoside 5’-monophosphates (rNMPs). dNMPs do not have a 2’-
hydroxyl (OH) whereas rNMPs contains a 2’-OH group, thereby making it less stable 
(Figure 1.1). The base, adenine (A), cytosine (C) and guanine (G) are found in RNA and 
DNA, while thymine (T) occurs in DNA and uracil (U) occurs in RNA. Presence of a 2’-
hydroxyl (OH) on ribose sugar of RNA makes it susceptible to strand breaks [2]. 
 
Figure 1.1 Deoxyribonucleotide vs Ribonucleotide. (a) Deoxyribonucleotide (dNMP) 
lacks a 2’-hydroxyl (OH) and has adenine (A), guanine (G), thymine (T) or cytosine (C) as 
one of its bases  (b) Structure of ribonucleotide containing a 2’-OH, and having uracil (U) 
as one of the four bases, in place of thymine in dNMP.  
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1.2 Genome stability  
DNA and RNA are two fundamental molecules of life. DNA is the genetic material that 
stores biological information. It is responsible for all of the basic cellular functions. DNA 
is transcribed into RNA. RNA has many regulatory functions in the cells; moreover, RNA 
is translated into proteins, and proteins help in maintaining major cellular functions. It is 
crucial to maintain the integrity and stability of the genome, as our DNA is constantly 
threatened by various exogenous agents like chemicals and UV radiation, and by 
endogenous agents such as DNA replication errors, dysfunctional DNA repair pathways, 
and oxidative stresses [3]. These agents can modify the chemical structure of DNA causing 
DNA lesions such as alkylation, oxidation, single and double-strand breaks (DSBs), or 
other types of modified or abnormal nucleotides [4, 5]. Among the different types of DNA 
lesions, rNMPs are the most commonly found non-standard nucleotides in DNA [6]. 
Genome stability is maintained by specialized DNA repair pathways that can remove the 
lesions and help reduce their effects. For example, DNA damage induced by UV result in 
bulky DNA adducts that are recognized by nucleotide excision repair (NER) [7], while 
specific non-bulky lesions in DNA are corrected by base excision repair (BER) [8]. 
Similarly, mismatch repair (MMR) helps in repairing faulty insertion, deletion and 
misincorporation of bases in DNA [9]. Improper repair of DNA lesions can lead to 
deleterious mutations, cell death, and diseases such as cancer [10, 11].  
1.3 Presence of ribonucleotides in DNA 
Studies have shown that the cellular concentrations of ribonucleoside 5’-triphosphate 
(rNTPs) are much higher than deoxyribonucleoside 5’-phosphate (dNTPs). In 
 3 
Saccharomyces cerevisiae and human cells, the physiological concentrations of rNTPs are 
36- to 190- fold molar excess than their corresponding dNTPs [12, 13].  As shown in 
Figure 1.1, rNMPs have an extra 2’OH as compared to dNMPs. If rNMPs are 
(mis)incorporated in DNA, the highly reactive 2’OH can attack the sugar-phosphate 
backbone causing internal threat to DNA, thus making it unstable [2]. Some DNA 
polymerases use a steric gate residue to discriminate against the 2’-OH in rNMPs to 
selectively insert dNMPs in DNA [14].  However, this process is not very efficient as DNA 
polymerases of bacteria, yeast and human can occasionally insert rNMPs in the DNA. E. 
coli DNA polymerases I, II, V, and the polymerase component of bacterial non-
homologous end joining ligases can incorporate rNMPs [15-17]. rNMP incorporation by 
yeast replicative polymerases, , , and  in DNA happens with an insertion ratio 
(rNMP/dNMP) of 1/625, 1/5,000 and 1/1,250, respectively [12]. On measuring the 
physiological in vitro nucleoside triphosphate concentrations, these polymerases can 
introduce more than 13,000 rNMPs in yeast genome during each round of replication [12]. 
In-vitro studies showed that human Pol  can misincorporate 1 rNMP for every 2,000 
dNMPs suggesting that human Pol  may introduce more than a million rNMPs into 
nuclear genome per replication cycle [18]. Human Pol  and Pol  also were shown to insert 
rNMPs into DNA [18-20].  
Additional sources of rNMP incorporation include incomplete Okazaki fragment 
maturation during replication, and oxidative damage. RNA primer initiates the formation 
of Okazaki fragments during lagging strand synthesis [21]. This RNA fragment is later 
removed in the process of Okazaki fragment maturation, but incomplete removal may lead 
to rNMPs to be incorporated in DNA [22]. Oxidation of the deoxyribose sugar into ribose 
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can also lead to formation of rNMPs. It has been shown, in vitro and in vivo, that reactive 
oxygen species (ROS) can cause multiple modifications to dNMPs, including oxidation of 
the deoxyribose sugar forming ribose, to result in formation of rNMPs and other modified 
nucleotides [23]. Treatment of DNA under Fenton reaction conditions can result in 
conversion of dNMPs to rNMPs [24].  
Considering the abundance of rNMPs, there is a good likelihood of having modified 
rNMPs, such as abasic rNMPs also present in DNA. Abasic sites are formed by 
spontaneous hydrolysis of the N-glycosidic bond in DNA or following removal of a 
damaged base [8]. As mentioned earlier, rNMPs were shown to form during oxidative 
DNA damage both in vitro and in vivo [24]. Therefore, it is possible that abasic and 
oxidized dNMPs can be converted to abasic rNMPs. Spontaneous depurination is estimated 
to occur 1,000 times slower in RNA than DNA [25]. The rate of depurination in DNA 
under physiological conditions is estimated to be 1 out of 100,000 purines every cell cycle, 
which gives us a rate of 10,000 abasic sites per day in human cells [26]. Due to the 
abundance of rNMPs in the genome, with more than 600,000 in yeast and more than 100 
million in human DNA [27], hence the possibility of abasic rNMPs present in DNA is very 
realistic.  
1.4 Effects of ribonucleotides  
Unrepaired rNMPs can have deleterious effects in DNA. Due to the highly reactive 2’-OH 
group in the sugar, presence of rNMPs in DNA sensitizes the backbone to DNA breaks [2]. 
rNMPs incorporated in DNA can become template for the next round of replication, where 
DNA polymerases ,  or  can bypass these template containing rNMPs [18, 28]. Short 
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tracts of rNMPs in DNA can serve as templates for DNA synthesis and can propagate 
mutation upon replication in E. coli, budding yeast, and human embryonic kidney cells 
[29-31]. The presence of rNMPs in DNA can stall replication fork progression, thereby 
leading to replication stress [20, 32]. Also, misincorporated rNMPs in yeast and human 
DNA, if left unrepaired can impede cell cycle progression and result in checkpoint 
activation [33-35]. Structurally, the presence of rNMPs can alter the helical parameters and 
result in a transition from B-form to A-from [36]. Misincorporated rNMPs can affect the 
elastic properties of duplex DNA and possibly alter the way DNA binding proteins interact 
with DNA [37]. Additionally, presence of rNMPs may disrupt the nucleosome binding to 
DNA in vitro, and also affect the proper assembly of nucleosomes [38, 39].  
Although there is abundance of evidence suggesting the detrimental effect of rNMPs, there 
are a few known positive physiological roles of rNMPs. Presence of rNMPs in DNA helps 
signal the activation of mismatch repair (MMR). Presence of rNMPs during replication 
marks the nascent strands, thus acting as strand discrimination signals in eukaryotes [40, 
41]. Presence of a two-rNMP imprint in the mating type locus of Schizossacharomyces 
pombe drives recombination process that results in mating type switching between minus 
(M) and plus (P) type [42]. In order to process the rNMPs there are multiple repair 
pathways that can cleave and repair the misincorporated nucleotides. 
1.5 Repair mechanisms of rNMPs in DNA 
As rNMPs incorporated in DNA can have adverse effects on the genome stability and 
integrity, there are several repair mechanisms that can target and remove the rNMPs in 
genomic DNA.  
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1.5.1 Ribonucleotide excision repair (RER pathway) 
Ribonucleotides are efficiently removed by the ribonucleotide excision repair (RER) 
pathway. The process is initiated by ribonucleases (RNases) H, which are the primary 
enzymes that can cut rNMPs in DNA and also cleave the RNA strand of RNA/DNA 
hybrids [43]. There are two types of RNase H: type I/1 and type II/2. RNase H1 is active 
on stretches of four or more consecutive rNMPs embedded in DNA [44]. On the other 
hand, RNase H2 can remove a single rNMP and stretches of rNMPs in DNA, as well target 
RNA-DNA hybrids, as shown in Figure 1.2 [44, 45]. In prokaryotes and eukaryotes, 
RNase H I/1 has only one subunit. Prokaryotic RNase HII has one subunit whereas 
eukaryotic RNase H2 has three different subunits, the catalytic subunit (Rnh201 in yeast, 
and RNase H2A in mammals) and two additional subunits (Rnh202 and Rnh203 in yeast, 
and RNase H2B and RNase H2C in mammals) that are needed for catalysis.  
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The process of RER is initiated by RNase H2-mediated recognition of rNMPs. RNase H2 
cleaves the DNA 5’ of the rNMP, resulting in a DNA containing 3’-hydroxy and 5’-
phosphoribonucleotide ends. This is followed by strand displacement synthesis of the 
nicked DNA strand by DNA Pol  or Pol , followed by flap cleavage by flap endonuclease 
(FEN) 1, and ligation of the broken ends by DNA ligase 1 [1]. One of the subunits of RNase 
H2, Rnh202 contains a PCNA-interacting motif (PIP) box which binds to proliferating cell 
nuclear antigen (PCNA), a complex that plays an essential part at the replication fork 
through recruitment of many enzymes, so as to localize RNase H2 to the DNA replication 
Figure 1.2 RNase H2 removal of rNMPs in ribonucleotide repair pathway (RER). (a) 
RNase H type I can recognize four or more stretches of rNMPs, whereas RNase H type II 
can recognize single and multiple stretches of rNMPs in DNA. (b) RER pathway is initiated 
by incision to the 5’ end of rNMP by RNase H2, which is followed by strand displacement 
synthesis by DNA polymerase, nucleolytic flap processing, and ligation. rNMPs are shown 
here in red. Modified from [1].  
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fork [46, 47]. The presence of the PIP motif in RNase H2 may suggest the coupling of RER 
with DNA replication. In human cells, RNase H2 is shown to be recruited to DNA 
replication and repair foci in both a PCNA-dependent and PCNA-independent manner 
[48].   
Having a compromised RER pathway can result in deleterious effects. Deletion of genes 
encoding RNase H2 subunits in S. cerevisiae have shown to cause an increased rate of 
spontaneous recombination [49, 50]. Also, gross chromosomal rearrangements and gene 
conversion events are elevated in RNase H2-deficient yeast strains [49-52]. Null mutations 
in RNase H1 or RNase H2 can be tolerated in yeast, but deletion of either RNase H enzymes 
in mice is embryonic lethal and activate a p53-dependent damage response [44].  Murine 
RNase H2-null embryonic fibroblasts accumulate over one million rNMPs in their genome 
[53]. In humans, mutations in any of the three subunits of RNase H2 are associated with 
neurodegenerative disorder, such as Aicardi-Goutieres Syndrome (AGS), and autoimmune 
disorder such as systemic lupus erythematosus (SLE) [54, 55].   
1.5.2 Other DNA repair mechanisms involved in rNMP removal  
RNase H2 is the major repair enzyme to cleave rNMPs incorporated in DNA, but in the 
absence or failure of RER, rNMPs can be removed by DNA topoisomerase I (TopI) through 
topoisomerase I-mediated rNMP removal [35, 50, 56, 57].  Top1 is critical for resolving 
DNA supercoils that accumulate during replication and transcription, and also functions in 
removing rNMPs in DNA  [58]. Top1 cleaves at rNMPs generating a single-strand DNA 
break containing DNA ends with 5’-OH and 2’-3’-cyclic phosphate ends. These ends 
cannot be processed by ligases but can be reversed by Top1 [57]. When this nicking 
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happens in DNA repeated sequences, a second Top1-dependent incision occurs, which can 
lead to loss of one or more parts of the repeated sequences [59].  
Additionally, there are other DNA repair pathways that can help in removing rNMPs, 
although on specific substrates. The mismatch repair (MMR) system can recognize 
rNMP/dNMP mismatches and small insertions/deletions in E. coli and budding yeast [29]. 
The nucleotide excision repair (NER) mechanism can recognize a vast array of backbone 
distortions in DNA [60]. Rad14 of the NER pathway can target an rNMP in DNA in 
budding yeast (our lab unpublished data). Unlike in yeast, NER in human cells does not 
target rNMPs [61]. A minor fraction of the misincorporated rNMPs can be removed by the 
3’-5’ exonucleolytic function of DNA polymerases. Yeast and human Pol  have a weak 
exonuclease activity on rNMPs [62, 63].  Also, yeast and human Pol  exhibit a very little 
rNMP proofreading ability [18].   
1.5.3 Base excision repair (BER) pathway 
Base excision repair (BER) is a major pathway for removing damaged bases in DNA. It is 
known to remove a wide spectrum of oxidative lesions and abasic dNMPs in genomic DNA 
[64, 65]. BER is initiated by DNA glycosylases. DNA glycosylase flips the damaged base 
out of the double helix and cleaves the N-glycosylic bond of the damaged base, thereby 
leaving an apurinic/apyrimidinic (AP) site, also called as abasic site. These AP sites are 
recognized by AP endonuclease (APE) I, which cleaves the 5’-end of the AP site to yield 
a 3’hydroxyl adjacent to a 5’deoxyribosephosphate (dRP). Following the removal of AP 
site, the break is processed by either a short-patch or a long-patch, by Pol , FEN1 and 
DNA ligase 1. Recent studies have shown that human APE1 can endonucleolytically cleave 
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abasic single-stranded RNA [66, 67]. The role of BER in targeting rNMPs or abasic rNMPs 
in DNA remains to be investigated.  
1.6 rNMP mapping techniques 
To map the location of rNMPs in the genome, four methods have been developed. After 
initial DNA fragmentation, embedded ribose-sequencing (emRibo-seq) uses RNase H2 to 
cleave 5’ of an rNMP in vitro, generating a 3’-OH which can be tagged, thereby sequencing 
the downstream nucleotides of an rNMP.  Three other techniques, hydrolytic end-
sequencing (HydEN-seq), polymerase usage technique (PU-seq) and ribose-seq, our 
method, after the initial DNA fragmentation, use alkaline hydrolysis treatment to cleave 
the 3’end of rNMP, and resulting in 2’3’-cyclic phosphate and 5’-OH ends [68-71]. 
HydEN-seq and PU-seq tags the 5’-OH end fragment, thereby capturing the dNMP 
downstream from the rNMP. Ribose-seq uses Arabidopsis thaliana tRNA ligase (AtRNL) 
to ligate the 2’3’-cyclic phosphate end of an rNMP to the 5’-phosphate of the same 
fragment, thus directly capturing the rNMP and not the upstream or downstream dNMP of 
rNMP sites. Additionally, ribose-seq does not capture unprocessed Okazaki fragments, 
RNA primers, nicks or abasic sites in DNA.  
All four techniques were developed using RNase H2-null strains of yeast, either S. 
cerevisiae or S. pombe, as there is an increase in rNMPs within DNA in RNase H2 defective 
cells. Despite having these methods to map rNMPs, there is a need to obtain a wide 
spectrum of rNMPs incorporation in genomic DNA of cells having not only inactive but 
also active RER system.  
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1.7 Research goals 
To better understand the biological function and consequence of rNMPs in DNA, we need 
to know the identity and location of the rNMPs that are incorporated in genomic DNA. 
Additionally, to investigate if there are DNA repair pathways that can target modified 
rNMPs in DNA, we set up the following research goals.  
1.7.1 Analysis of rNMPs embedded in genomic DNA 
To develop a more robust system for studying the location, sequence context, and hotspots 
of rNMPs embedded in DNA, we set out to optimize the ribose-seq technique. Using this 
modified technique, we can get a better understanding of rNMP incorporation in wild type 
and RNase H2-null strains of S. cerevisiae. Additionally, we can also analyse and compare 
the profile of rNMP spectra of WT and several RNase H2 defective cells of S. cerevisiae, 
S. paradoxus and S. pombe. 
1.7.2 To study the role of RER and/or BER in recognizing and cleaving rNMPs and/or 
abasic rNMPs.  
Although RNase H2 can effectively target and remove rNMPs that are embedded in DNA, 
there is no information whether RNase H2 can cleave modified rNMPs, such as abasic 
rNMPs. Here we study if yeast, mouse and human RNase H2 can target abasic rNMPs. 
Additionally, we investigate if UNG1 and APE1 of the BER pathway can recognize rNMPs 
or abasic rNMPs.  
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CHAPTER 2. RIBOSE-SEQ – GLOBAL MAPPING OF 
RIBONUCLEOTIDES EMBEDDED IN DNA 
The study in Chapter 2 consists of the work published in Nature Methods 12 (2015) 251-
257. In addition to assisting in the overall development of ribose-seq, the assay and analysis 
to determine the role of UNG1 in cleaving rUMP in DNA were my contributions to this 
study.   
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1School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA 30332, USA. 
2Department of Biochemistry and Molecular Genetics, University of Colorado, Anschutz, 
Medical School, Aurora, CO 80045, USA.  




2.1 Abstract  
Abundant ribonucleotide incorporation during DNA replication, repair, and damage has 
profound consequences for genome stability, but the global distribution of ribonucleotide 
incorporation is unknown. We developed a method, Ribose-seq, to capture DNA fragments 
with terminal 2′,3′-cyclic phosphates or 2′-phosphates, which are unique products 
generated by alkaline cleavage of DNA at embedded ribonucleotides. High-throughput 
sequencing of these captured fragments from yeast Saccharomyces cerevisiae DNA 
revealed widespread and biased ribonucleotide distribution, with a strong preference for 
cytidine and guanosine, and identified hotspots of ribonucleotide incorporation in nuclear 
and mitochondrial DNA. Ribonucleotides were primarily incorporated on the leading 
strand of nuclear DNA and were present upstream of G+C-rich tracts in the mitochondrial 
genome. Ribose-seq establishes a powerful tool for systematic profiling of ribonucleotide 
incorporation in genomic DNA. 
2.2 Introduction 
Genomic DNA contains embedded ribonucleotides (rNMPs) that are incorporated during 
DNA replication, repair, and damage (reviewed in [6]). rNMPs were initially found at 
specific DNA loci in mouse and human mitochondrial DNA [72] and the mating type locus 
of fission yeast [73], but have since been detected in a variety of cell types [74]. Many 
DNA polymerases can incorporate rNMPs into DNA, including the human replicative 
DNA polymerase (Pol)  [18] and mitochondrial Pol γ [75], budding yeast nuclear 
replicative Pol , , and  [12], Escherichia coli polymerase V [16], and the polymerase 
component of bacterial non-homologous end joining ligases [17]. rNMP incorporation 
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could also be a consequence of incomplete maturation of Okazaki fragments during lagging 
strand synthesis in DNA replication [22]. Moreover, generation of hydroxyl radicals ′OH 
during oxidative stress can modify DNA deoxyribose sugars to ribose, forming rNMPs in 
DNA both in vitro and in vivo [24]. 
Ribonuclease (RNase) H enzymes cleave rNMPs incorporated into DNA. RNase H type 1 
(H1/HI) recognizes long stretches (≥4 nt) of rNMPs in RNA/DNA hybrids, whereas RNase 
H type 2 (H2/HII) cleaves even singly incorporated rNMPs in DNA [44]. Both RNases H1 
and H2 are present in the nucleus, and only RNase H1 has been found in mitochondria [44, 
75]. RNase H2/HII initiates ribonucleotide excision repair (RER), the major rNMP repair 
mechanism in bacterial DNA and in eukaryotic nuclear DNA [1, 44]. Inactivation of RNase 
H2/HII enabled detection of unexpectedly high amounts of rNMPs in genomic DNA. 
Quantitative measurements of rNMPs in DNA from RNase H2-deficient mouse embryonic 
fibroblasts (MEF) identified >1 million rNMPs per genome, suggesting that rNMPs are the 
most common non-canonical nucleotides in dividing mouse cells [53]. Similar 
measurements conducted for genomic DNA derived from RNase H2-deficient (rnh201) 
budding yeast estimated a few thousand rNMPs incorporated per genome per cell cycle 
[35, 41], and RNase HII-null Bacillus subtilis cells have high levels of incorporated rNMPs 
[76]. Embedded rNMPs in DNA have highly reactive 2′-hydroxyl groups, altering its 
properties, structure, and function [2, 37] and leading to genome instability [35, 77-79]. 
Also, in humans, mutations in any of the three subunits of RNase H2 are associated with 
the neurological syndrome Aicardi-Goutieres (AGS) [54]. 
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Despite abundant evidence for the frequent incorporation of rNMPs in DNA, a detailed 
picture of how rNMPs are incorporated throughout a genome is lacking. Here, we introduce 
Ribose-seq: a technique for mapping rNMPs in genomic DNA. 
2.3 Materials and Methods 
2.3.1 Construction of yeast strains 
Yeast strains used in this study are presented in Table A.1. Isogenic yeast haploid strains 
KK-100, KK-174, KK-107, and KK-120 were derived from E134 (MATα ade5-1 lys2-14A 
trp1-289 his7-2 leu2-3,112 ura3-52) [80]. KK-100 was made from E134 by deletion and 
replacement of RNH201 via transformation with a PCR product containing the hygMX4 
cassette flanked by 50 nucleotides of sequence homologous to regions upstream and 
downstream of the RNH201 ORF. KK-174 was constructed from KK-100 by deletion and 
replacement of RNH1 via transformation with a PCR product containing the kanMX4. KK-
107 was generated by introducing pol2-4 mutation into KK-100 via integration-excision 
using plasmid YIpJB1 [81]. KK-120 was made by introducing pol3-5DV mutation into 
KK-100 via integration-excision using plasmid p170-5DV [82]. 
Isogenic yeast haploid strains KK-30, KK-125, KK-164, and KK-170 were derived from 
FRO-767,768 (hoΔ hmlΔ::ADE1 MATa-inc hmrΔ::ADE1 ade1 leu2-3,112 lys5 trp1::hisG 
ura3-52 ade3::GAL::HO leu2::HOcs mataΔ::hisG) [31]. KK-30 was made from FRO-768 
by reversion of ade3::GAL::HO to intact ADE3 via transformation with a PCR product 
containing ADE3, followed by replacement of RNH201 with the hygMX4. KK-125 was 
constructed from KK-30 by replacement of RNH1 with the kanMX4 cassette. KK-164 was 
generated from KK-125 by replacement of UNG1 with the natMX4 cassette. KK-170 was 
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made by introducing pol2-M644G mutation into KK-30 via integration-excision using 
plasmid p173-M644G [83]. 
Isogenic yeast haploid strains KK-158,159 were derived from FRO-767,768 [31]. KK-
158,159 were constructed from FRO-767-768 by replacement of UNG1 with the hygMX4 
cassette. 
2.3.2 AtRNL ligation assay  
Ribonucleotide (rNMP)-containing DNA oligonucleotide (oligo), Lig.47.R (see Table 
A.2), and its DNA-only control, Lig.47.D, were 5′ end-labeled with [γ-32P]ATP 
(PerkinElmer) by T4 polynucleotide kinase (New England BioLabs). Alkali treatment was 
carried out in 0.3 M NaOH for 2 hr at 55 °C. The resulting solution was neutralized and 
diluted. 100 nM of alkali-treated 5’-radiolabeled products were incubated in 50 mM Tris-
HCl, pH 7.5, 40 mM NaCl, 5 mM MgCl2, 1 mM DTT, 30 µM ATP (Sigma-Aldrich), and 
1 µM AtRNL [84] for 1 hr at 30 °C. After dilution, the ligated products and remaining 
substrates were treated with T5 exonuclease (NEB) for 2 hr at 37 °C. Aliquots were 
withdrawn after appropriate steps and quenched with 90% formamide. The products were 
analyzed by 15% (w/v) polyacrylamide, 8 M urea gel electrophoresis (urea-PAGE). 20-
100 Oligo Length Standard (Integrated Device Technology) was used as a ladder. 
Following electrophoresis, gels were exposed to a phosphor screen overnight. Images were 
taken with Typhoon Trio+ (GE Healthcare) and obtained with ImageQuant (GE 
Healthcare). Band intensities were quantified by Multi Gauge V3.0 (Fujifilm).   
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2.3.3 3’ base bias for AtRNL ligation assay 
rAMP, rGMP, rUMP, and rCMP-containing DNA oligos (Lig.30.rA, Lig.30.rG, Lig.30.rU, 
and Lig.30.rC, respectively; see Table A.2) were 5′ end-labeled with either hot [γ-32P]ATP 
(PerkinElmer) or cold ATP (Sigma-Aldrich) by T4 polynucleotide kinase (NEB). Each of 
hot rNMP-containing 5′-radiolabeled DNA oligos was mixed with other three cold 
equimolar DNA oligos. The mixtures were treated with 0.3M NaOH for 2 hr at 55 °C, 
neutralized, and diluted. 100 nM of alkali-cleaved products (25 nM of each base) were then 
incubated in 50 mM Tris-HCl, pH 7.5, 40 mM NaCl, 5 mM MgCl2, 1 mM DTT, 30 µM 
ATP (Sigma-Aldrich), and either 1 µM or 200 nM AtRNL [84] for 1 hr at 30 °C. After 
dilution, the resulting products were treated with T5 exonuclease for 2 hr at 37 °C. Aliquots 
were withdrawn after appropriate steps, quenched, and analyzed by urea-PAGE. 
2.3.4 rNMP bypass assay 
A DNA primer oligo, ByPrim (see Table A.2), was 5′ end-labeled with [γ-32P]ATP 
(PerkinElmer) by T4 polynucleotide kinase (NEB). The 5’-radiolabeled primer was 
annealed to either rCMP- or rUMP-containing template oligo (ByTemp.rC or ByTemp.rU, 
respectively). 100 nM of annealed substrates were incubated in 1X HF Buffer, 2 mM 
dNTPs, and 0.2 units of Phusion High-Fidelity DNA Polymerase (NEB) for 30 sec at 72 
°C. The reactions were quenched and analyzed by urea-PAGE. Bypass probability was 
calculated as the band intensity at the +1 position plus all longer products divided by the 
intensity at the −1 position (preceding the rNMP) plus all longer products, as described in 
Kokoska et al., 2003 [85]. 
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2.3.5 Double-stranded break repair (DSB) assay with rNMP-containing oligos 
Transformation with rNMP-containing DNA oligos, LEU2.rG and LEU2. rU (see Table 
A.2) and DNA-only oligos, LEU2.D and LEU2.dU, were done as described in Storici et 
al., 2007 [31]. Cells from each oligo transformation were plated to selective Leu- medium. 
For each transformation, 20 Leu+ transformants were selected. Colony PCR was performed 
on those transformants, amplifying with primers, LEU2.3 and LEU2.6, a 900-bp region in 
LEU2 locus, where a new StuI restriction site is expected. The resulting PCR products were 
treated with StuI (NEB) and analyzed by agarose gel electrophoresis to check the presence 
of the StuI restriction site. 
2.3.6 Ribose-seq library construction to map rNMPs in DNA 
Genomic DNA from S. cerevisiae cells grown in liquid rich medium containing yeast 
extract, peptone, and 2% (w/v) dextrose (YPD) for 2 days to stationary phase was extracted 
following the protocol “Preparation of Yeast Samples” in QIAGEN Genomic DNA 
Handbook. Genomic-tip 500/G (QIAGEN), Genomic DNA Buffer Set (QIAGEN), 
Proteinase K (QIAGEN), RNase A (QIAGEN), and Lyticase (Sigma-Aldrich) were used 
to extract genomic DNA from S. cerevisiae cells. Extracted genomic DNA was digested 
with SspI, DraI, and EcoRV (NEB) overnight at 37 °C to create a population of 500–3,000 
bp genomic fragments with an average size of ~1.5 kb. Assuming that rNMPs, if present, 
could be located in any position of each genomic fragment, an average of 1.5 kb allows a 
reasonable window of rNMP capture. Following confirmation of digestion by Experion 
Automated Electrophoresis System (BIO-RAD), the fragments were tailed with dATP 
(Sigma-Aldrich) by Klenow fragment (exo-) (NEB) for 30 min at 37 °C. The resulting 
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products were purified by spin-column (QIAGEN) and then ligated to preannealed double-
stranded (ds) adaptors (Adaptor.L/Adaptor.S, see Table A.2) that contain single dT 
overhangs and a randomized 8-base unique molecular identifier (UMI) by T4 DNA ligase 
(NEB) overnight at 15 °C. The products were purified using AMPure XP beads (Beckman 
Coulter). All subsequent purifications were done using AMPure XP beads. The adaptor-
ligated DNA fragments were incubated in 0.3 M NaOH for 2 hr at 55 ˚C to expose 2′,3′-
cyclic phosphate and 2′-phosphate termini of DNA at rNMP sites, followed by 
neutralization and purification. The resulting single-stranded (ss) fragments were incubated 
in 50 mM Tris-HCl, pH 7.5, 40 mM NaCl, 5 mM MgCl2, 1 mM DTT, 30 µM ATP (Sigma-
Aldrich), and 1 µM AtRNL [84] for 1 hr at 30 °C, followed by purification. The products 
and remaining fragments of DNA were treated with T5 exonuclease (NEB) for 2 hr at 37 
°C to degrade the background of unligated, linear ss DNA, leaving self-ligated ss DNA 
circles intact. Treatment with the 1 µM Tpt1 [84] in 20 mM Tris-HCl, pH 7.5, 5 mM 
MgCl2, 0.1 mM DTT, 0.4% Triton X-100, and 10 mM NAD+ (Sigma-Aldrich) for 1 hr at 
30 °C was used to remove the 2′-phosphate remaining at the ligation junction. After 
purification and resuspension, the libraries were PCR-amplified with one of the bar-coded 
primers, PCR.1.Index1-4, and PCR.2 (see Table A.2) using either Phusion High-Fidelity 
DNA Polymerase (NEB) or EconoTaq DNA Polymerase (Lucigen), confirmed by 6% 
polyacrylamide gel electrophoresis (PAGE), purified, and pooled for analysis by Illumina 
sequencing. 100 bp DNA Ladder (NEB) was used as a ladder. SYBR Gold Nucleic Acid 
Gel Stain (Life Technologies) was used to stain PAGE gels for visualization under 
ultraviolet light. Ribose-seq does not capture RNA primers of Okazaki fragments because 
the 5'-most rNMP is a 5'-triphosphate [86], and T4 DNA ligase used to attach the 
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sequencing adaptors absolutely requires a 5'-monophosphate [87]. Moreover, the rest of 
the primers are reduced to single nucleotides upon alkali treatment, and they will have no 
adaptor sequence ligated on. Ribose-seq also does not detect rNMP positions derived from 
residual RNA molecules or RNA/DNA hybrids not embedded in DNA (like cDNA) nor 
DNA abasic sites, which could have been ligated to the adaptor sequence by T4 DNA 
ligase. Following alkali treatment, RNA stretches are reduced to single nucleotides which 
are removed in subsequent purification steps; even if the 5-most rNMP is captured, the 
rNMP-containing ss circle would not have any sequence to be aligned to the reference 
genome. Abasic sites undergo both β- and δ-eliminations to yield 5′-phosphate and 3′-
phosphate ends [88, 89], which cannot be ligated by AtRNL. Because of the nature of 
alkaline hydrolysis within a stretch of rNMPs embedded in DNA, our ribose-seq captures 
only the 5’-most rNMP of the stretch of two or more rNMPs. Moreover, ribose-seq does 
not require rNMPs to be present at the same location from cell to cell, and can identify 
incorporated rNMPs with single-base precision. 
2.3.7 DNA sequencing 
Indexed sequencing libraries were mixed at equimolar concentrations and normalized to 
10 nM. Libraries were sequenced on an Illumina MiSeq, and 50 cycle single-end reads 
were collected. Raw sequencing reads are available at NCBI GEO [90] under accession 
GSE61464.  
2.3.8 Alignment of sequence and processing  
Reads were aligned to the S. cerevisiae genome (sacCer2) with bowtie using two different 
settings to report uniquely aligning and multiple aligning reads (`-m 1` and `--all`, 
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respectively). Aligned reads in BAM format were processed to remove PCR duplicates 
using umitools (https://github.com/brwnj/umitools), which filters reads that contain 
duplicate UMIs and reports reads with unique UMIs. Reads in this study had an 8-base 
UMI incorporated during ligation, corresponding to the first 8 cycles of raw FASTQ 
sequence. Following UMI removal, read depths at each 5′ position were calculated with 
BEDTools [91, 92].  
2.3.9 Nucleotide frequencies  
Nucleotide frequencies for mapped rNMP positions (i.e. the 5′ position of each aligned 
read) were calculated and normalized to genome frequencies (nuclear and mitochondrial 
genomes in sacCer2). The identity of the rNMP base is the reverse complement of the 5′ 
base of each read. Nucleotide frequencies of downstream sequences of incorporated 
rNMPs, including +1 position, cannot be affected by our approach of capturing rNMPs in 
DNA because the rNMPs and their upstream sequences are captured, sequenced and 
aligned to the reference genome. 
2.3.10 Replication corelations 
The density and identity of rNMPs present on leading and lagging strands were calculated 
relative to annotated origins of replication [93] and were further categorized by replication 
timing [94]. Data were filtered for specified replication timings (e.g. 25 minutes following 
release into S phase) and distances relative to the middle of each ARS annotation (e.g. 5.0 
kb up- and downstream of each ARS). 
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2.3.11 Determination of hotspots of rNMP incorporation in genomic DNA 
Two different analyses were conducted to identify hotspots of rNMP incorporation in 
genomic DNA. Peak calling was performed with macs2 (version 2.1.0.20140616) [95] with 
specific parameters (--keep-dup all --nomodel -s 25 --extsize 5 --call-summits). Peaks of 
length greater than 1,000 were filtered from further analysis, and remaining peaks with a 
q-value less than 0.001 were selected. A second analysis involved finding positions of 
rNMPs within the locus of interest with ribose-seq signal greater than the mean plus three 
standard deviations for each library from rnh201∆ (KK-100), rnh201∆ (KK-100, 
EconoTaq), rnh201∆ (KK-30), rnh1∆ rnh201∆ (KK-174), and rnh1∆ rnh201∆ (KK-125) 
cells. 
2.3.12 Data presentation and statistics 
Graphs were made using GraphPad Prism 5 (GraphPad Software). Nonparametric two-
tailed Mann-Whitney U-test [96] was implemented for statistical analysis of AtRNL 
ligation efficiencies, rNMP bypass probabilities, and the percentages of StuI-cut Leu+ 
transformants in DSB repair assay. Chi-square goodness of fit test[96] was used for 
statistical comparison of the distribution of rNMP reads to the expected Poisson 
distribution. 
2.4 Results  
2.4.1 Ribose-seq: Capturing rNMPs in DNA  
Our ribose-seq approach captures rNMP-terminated single-stranded (ss) DNA fragments 
generated by alkaline cleavage of rNMPs in DNA (Figure 2.1 and Figure A.1). We 
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exploited the unique ligation mechanism of Arabidopsis thaliana tRNA ligase (AtRNL), 
normally involved in tRNA maturation. AtRNL converts 2′,3′-cyclic phosphate ends of 
RNA to 2′-phosphate and ligate these to 5′-phosphate ends of RNA [84, 97] or DNA [97]. 
We demonstrated that AtRNL captures 2′,3′-cyclic phosphate or 2′-phosphate terminus of 
DNA derived from alkaline cleavage of a DNA oligonucleotide (oligo) at an embedded 
rNMP, ligating the 2′-phosphate end to the 5′-phosphate terminus of the same DNA 
molecule and producing a ss DNA circle containing an embedded rNMP. Self-ligation was 
strongly preferred over dimerization, as linear dimers were not detected (Figure 2.1a). 
Further, these ss DNA circles are resistant to T5 exonuclease enabling their enrichment 
relative to unligated linear DNA upon exonuclease treatment (Figure 2.1a). We did not 
observe any bias for the 3′ rNMP substrate of AtRNL, which captured an embedded rAMP, 
rCMP, rGMP, or rUMP with equal efficiency (P values > 0.05 in each case) (Figure A.2 
and Table A.3), nor was any bias observed in a previous study [98]. These data indicate 
that self-ligation is favored for AtRNL on 2′-phosphate-terminated ss DNA fragments as 
small as 22 nt (Figure 2.1a and Figure A.2), thus facilitating library construction and high-
throughput DNA sequencing. 
We applied ribose-seq to identify rNMPs embedded in nuclear and mitochondrial DNA of 
RNase H2-deficient budding yeast (strain KK-100, Table A.1) [6]. Genomic DNA was 
extracted from cells grown to stationary phase, and a mixture of three blunt-end restriction 
enzymes was used to fragment the DNA. Application of our rNMP-capture scheme (Figure 
2.1b) yields a library of DNA molecules (Figure A.3a) with an average size of ~350 bp, 
each of which maps to a single site of rNMP incorporation and its upstream sequence. In 
control experiments, we found that exclusion of either AtRNL (Figure A.3a) or alkali 
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treatment (Figure A.3b) prevented library formation, validating that captured molecules 





Figure 2.1 Capture of rNMPs in DNA via AtRNL for ribose-seq. (a) AtRNL was used 
to capture 2′,3′-cyclic phosphate or 2′-phosphate termini of DNA generated by alkaline 
cleavage of a single rGMP in the 32nd position of 5′-radiolabeled 47-nt ss DNA oligo, 
Lig.47.R (see Table A.2), ‘R’. A DNA-only oligo, Lig.47.D, was used as a control, ‘D’. 
5′-radiolabel is indicated by ‘P’ in purple. Treatment with T5 exonuclease was performed 
to confirm the presence of circular ligation product while the unligated, linear substrates 
are degraded. First left lane, ss DNA ladder. Ligation efficiency was about 50%, as 
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expected, because there is a mixture of 2′-phosphate and 3′-phosphate ends upon alkaline 
cleavage at the rNMP in DNA. (b) Ribose-seq method for mapping rNMPs in genomic 
DNA. Genomic DNA is initially fragmented, dA-tailed, and ligated to an UMI-containing 
sequencing adaptor. Alkali treatment denatures the DNA and cleaves at rNMPs in DNA, 
exposing 2′,3′-cyclic phosphate and 2′-phosphate termini, which are self-ligated to 5′-
phosphate ends by AtRNL. The linear, unligated fragments are degraded by T5 
exonuclease while the remaining rNMP-captured, circular DNA molecules, upon removal 
of 2′-phosphate at the ligation junction by a 2′-phosphotransferase Tpt1, are PCR-amplified 
and sequenced.  
 
2.4.2 Distribution and base composition of rNMPs in S. cerevisiae genome 
Ribose-seq library prepared from rnh201∆ cells (KK-100) was sequenced to a depth of ~2 
million reads, which were mapped to the yeast S. cerevisiae genome, allowing us to define 
rNMP locations along yeast nuclear and mitochondrial DNA with single-nucleotide 
resolution. This analysis uncovered widespread rNMP incorporation with a coverage of 
0.449 and 19.5 rNMP reads/kb in the nuclear and mitochondrial genome, respectively 
(Figure 2.2a and Table A.4). While broadly scattered, the rNMP sites in the nuclear and 
mitochondrial DNA were not randomly distributed (Figure 2.2b,c). We found no major 
Watson/Crick strand bias in ribonucleotide distribution throughout the genome (Figure 
2.2a), and the number of rNMPs identified per nuclear chromosome was proportional to 
chromosome size (Figure 2.2d).  
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Figure 2.2 Distribution of rNMP incorporation in S. cerevisiae genome. (a) Ribose-seq 
map of rNMPs in genomic DNA from rnh201∆ (KK-100) cells. The data, as peaks of 
rNMP reads in red, are shown for the individual nuclear chromosomes (Chr I–XVI) and 
the two strands of mitochondrial DNA (Chr M). The height of each peak corresponds to 
the number of reads. A comparison of nuclear and mitochondrial rNMP reads for Watson 
(W) and Crick (C) strands is also displayed. Raw sequencing reads are available at NCBI 
GEO [90] under accession GSE61464. The proportion of 2.5 kb windows containing an 
observed number of rNMPs (red bars) was calculated for nuclear (b) and mitochondrial (c) 
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and compared to random expectation based on Poisson frequencies (blue bars). The P 
values (sample sizes of 10,847 and 3347 for nuclear and mitochondrial, respectively) 
calculated from chi-square goodness of fit test are shown. (d) Chromosomal distribution 
of rNMPs (red bars) is compared to the size of each nuclear chromosome (black bars). 
 
We determined the identity and relative frequencies of incorporated rNMPs, the reverse 
complement of the 5′ base of each read, as well as flanking bases for the nuclear and 
mitochondrial genomes in rnh201∆ cells. At the site of rNMP incorporation, we found that 
rCMP and rGMP were incorporated more frequently than expected from the G+C content, 
while rAMP and in particular rUMP were incorporated less frequently than expected from 
the A/T content in both nuclear and mitochondrial genomes, indicating a strong bias in the 
rNMP spectrum considering the A+T rich content of these genomes in yeast (62% and 
83%, respectively) (Figure 2.3a,b). Looking at the absolute composition of the genomic 
rNMPs, we found 44% rC, 28.1% rG, 15.4% rA and 12.5% rU in the nuclear genome, and 
36.8% rC, 25.6% rA, 19% rG, and 18.7% rU in the mitochondrial genome (Table A.5). 
The difference in the base composition between nuclear and mitochondrial rNMPs is likely 




Figure 2.3 Identify and sequence contexts of rNMP incorporation in S. cerevisiae 
genome. Normalized frequency of nucleotides relative to (a) nuclear and (b) mitochondrial 
mapped positions of sequences from ribose-seq library of rnh201∆ (KK-100) cells. 
Position 0 is the rNMP. Negative and positive numbers correspond to upstream and 
downstream positions from the rNMP, respectively. Frequencies were normalized to either 
nuclear or mitochondrial genomic mononucleotide frequencies. Zoom-out (from position 
-100 to 100) of normalized frequency of nucleotides for (c) nuclear and (d) mitochondrial 
genomes. (e) Ratios of rNMPs on leading to lagging strand are shown for all ribose-seq 
libraries in this study. Early firing ARSs were selected by their replication timing (Trep) 
while two different flanking sizes were investigated. Horizontal dotted line marks the ratio 
of 1, when the number of rNMPs on leading strand equals the number of rNMPs on lagging 
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strand. Normalized frequency of nucleotides relative to mapped positions of sequences in 
(f) leading and (g) lagging strands from ribose-seq library of rnh201∆ (KK-100) cells. 
ARSs with Trep of no longer than 25 min were selected with flanking size of 10 kb. 
Frequencies were normalized to genomic mononucleotide frequencies of either leading or 
lagging strand of the selected ARSs and flanking size. Normalized frequency of nucleotides 
relative to (h) nuclear and (i) mitochondrial mapped positions of sequences from ribose-
seq library of pol2-4 rnh201∆ (KK-107) cells. Normalized frequency of nucleotides 
relative to mapped positions of sequences in (j) leading and (k) lagging strands from 
ribose-seq library ofpol2-4 rnh201∆ (KK-107) cells.  
 
The high level of rCMPs and low level of rUMPs observed both for nuclear and 
mitochondrial DNA in the rnh201∆ library are not attributable to differential bypass by the 
Pfu-based DNA polymerase used for PCR (Figure A.4 and Table A.6), as we also 
observed similar rNMP patterns using a Taq-based DNA polymerase (Figures A.5a,b and 
A.6a,b). Similarly, the nucleotide frequency derived from a ribose-seq library constructed 
from another rnh201∆ strain (KK-30, Table A.2) was comparable to that obtained from 
strain KK-100 both for nuclear and mitochondrial sites (Figures A.5c,d and A.6c,d). 
Additional deletion of the gene coding for RNase H1 (rnh1), generating rnh1 rnh201 
strains (KK-174 and KK-125), did not affect the nucleotide frequency of rNMP 
incorporation (Figures A.5e-h and A.6e-h). While some variation in the absolute rNMP 
counts were found among these different libraries in the mitochondrial DNA (Table A.5), 
the high level of rCMP and low level of rUMP remained constant, as well as a preferred 
rNMP incorporation in G+C rich regions of the mitochondrial DNA. These data support a 
model in which rNMPs in yeast genomic DNA are present as single, di-, or tri-nucleotides, 
which are not substrates of RNase H1 [53], and indicate that RNase H1 has minor impact 
on the distribution of genomic rNMPs.  
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2.4.3 UNG1 targets uracil from a dUMP but not rUMP embedded in DNA  
In order to test whether the low frequency of rUMP incorporation was a consequence of 
removal by the uracil N-glycosylase, Ung1, we deleted the UNG1 gene in the RNases H- 
defective background (rnh201 rnh1 ung1, strain KK-164) and mapped rNMP sites in 
these cells. Ung1 repairs dUMP from nuclear and mitochondrial DNA [99]. Whereas Ung1 
does not act on uracil in RNA (e.g. rRNA) [100], it is not known whether Ung1 can act on 
rUMP embedded in a DNA duplex. Results presented in Figures A.5i,j, A.6i,j, and Table 
A.5 show that the low level of rUMP incorporation in the chromosomal and mitochondrial 
genome of a rnh1∆ rnh201∆ ung1∆ strain was similar to rUMP incorporation in a rnh1∆ 
rnh201∆ strain, demonstrating that Ung1 does not target uracil in rUMP embedded in 
DNA.  
 
Figure 2.4 Targeting of rGMP and rUMP by RNase H2 and uracil DNA N-glycosylase 
during DSB repair in S. cerevisiae cells. (a) Diagram and sequence of the chromosomal 
leu2 region targeted by DNA-control LEU2.D, rGMP-containing LEU2.rG, dUMP-
containing LEU2.dU, and rUMP-containing LEU2.rU oligos (Table A.2). StuI recognition 
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sequence is underlined in turquoise. Position of either rGMP, dUMP, or rUMP was selected 
so that it is about 4-5 nt upstream of the G-T mispair. Both RNase H2-initiated excision 
repair (RER) and base excision repair (BER) remove a short ss DNA region downstream 
of the damage during the repair [1, 99]. (b) The oligos were transformed to either RNase 
H2- and uracil DNA N-glycosylase-proficient wild-type (WT; FRO-767,768), RNase H2-
deficient (rnh201; FRO-984,985), or DNA N-glycosylase-deficient (ung1; KK-158,159) 
S. cerevisiae cells (see Table A.1). Median percentages of StuI-cut Leu+ transformants 
from four independent transformations are shown with ranges as bars. For each 
transformation, 20 Leu+ transformants were selected for analysis. Mann-Whitney U-test 
was implemented for statistical analysis against the WT. P values of less than 0.05 are 
marked as asterisk. See Table A.7 for more statistics.  
 
Using a yeast assay of chromosomal double-stranded break (DSB) repair by DNA oligos 
carrying embedded rGMP, rUMP, or deoxyribose nucleotides only (Figure 2.4a), we 
demonstrate that Ung1 targets uracil from a dUMP but not an rUMP embedded in DNA, 
while RNase H2 targets only rNMPs (rGMP and rUMP in this experiment), but not dNMPs 
(Figure 2.4b and Table A.7). We attribute rNMP incorporation frequencies to the levels 
of corresponding dNTPs. dCTP and dGTP are typically the least abundant dNTPs [12, 
101], and therefore might be depleted faster than dTTP and dATP, increasing the 
probability of rCMP and rGMP incorporation over rUMP and rAMP. These results are also 
consistent with the finding that rCMP and rGMP are the most frequently incorporated 
rNMPs by DNA polymerases in vitro under physiological dNTP/rNTP concentrations [18, 
63]. This ability of DNA polymerases to incorporate rNMPs into genomic DNA could 
potentially serve as a mechanism to continue replication under conditions in which one or 
more dNTP pools are depleted.  In the presence of hydroxyurea, a known ribonucleotide 
reductase inhibitor, higher level of rNMPs are found incorporated in genomic DNA [53]. 
However, extensive rNMP incorporation would also result in increased breaks and 
genomic instability. 
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2.4.4 Pattern of sequences flanking rNMPs in S. cerevisiae DNA 
Downstream of incorporated rNMPs, we found that the +1 position was most frequently 
dA and less frequently dG both in the nuclear and in the mitochondrial genomes, with 42 
to 52% dA and 6 to 16% dG among all four deoxyribonucleotides (dA, dC, dG, and dT) 
(Table A.5). At the +1 position, dT was also frequent (31 – 40%) in the mitochondrial 
genome. In mitochondrial DNA, high level of dA or dT at the +1 position 3′ from the rNMP 
could reflect the high A+T content in the mitochondrial genome. It is also possible that the 
dA in +1 position influences rNMP incorporation by DNA polymerases. Alternatively, we 
speculate that dA in the +1 position might stabilize incorporated rNMPs, possibly by 
affecting base stacking and preventing its repair by non-RER mechanisms. It will be 
interesting to determine the nearest-neighbor thermodynamic parameters for single rNMPs 
in DNA duplex and, in particular, the stability trend for the base pair 3′ of the rNMP sites. 
We recently showed that single rGMPs embedded in a short DNA duplex have a marked 
effect on the elastic properties of DNA by altering the DNA structure at rNMP sites and 
the nucleotide 3′ to the rNMPs [37]. Thus, it is reasonable to think that the +1 position 3′ 
from the rNMP is prone to have altered structure, and it is the most critical site for signaling 
the presence of an rNMP in DNA because it is the closest nucleotide to the 2′-OH group of 
the rNMP.  
Sites of rNMP incorporation were flanked by sequence contexts that differ between the 
nuclear and mitochondrial DNA genomes. While nucleotide frequencies up- and 
downstream of rNMP sites in the nuclear genome were largely similar to background 
frequencies (Figure 2.3c), rNMP sites in mitochondrial DNA were primarily upstream of 
G+C-rich regions, concentrated in areas in which G+C content was 1.7 to 1.8-fold above 
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the background (Figure 2.3d). Interestingly, mitochondrial G+C tracts have been shown 
to have recombinogenic properties [102], and mitochondrial DNA recombination has been 
suggested to initiate mitochondrial DNA replication in yeast  [103]. Thus, it is possible that 
the presence of rNMP sites in yeast mitochondrial G+C clusters influences these 
recombination events in mitochondrial DNA.  
2.4.5 rNMP incorporation by replication DNA polymerases 
We next analyzed rNMP incorporation in the leading and lagging strands of yeast nuclear 
DNA. We selected 154 to 271 early-firing yeast autonomously replicating sequences 
(ARSs) (activated in the first 25 or 30 minutes, respectively) based on replication timing 
(Trep) [94]. We examined the type and abundance of rNMPs incorporated in regions 5 or 
10 kb upstream and downstream from selected ARSs. This analysis was conducted using 
all our ribose-seq libraries, including a library derived from yeast RNase H2-deficient cells 
containing the low fidelity Pol  mutant (rnh201 pol2-M644G, Table A.1). Because yeast 
Pol  is mainly responsible for leading strand synthesis during DNA replication, yeast cells 
containing the pol2-M644G mutation, which leads to increased rNMP incorporation, would 
be predicted to contain more rNMPs on the leading than on the lagging strand [41]. We 
found higher rNMP incorporation on the leading strand of DNA replication (Figure 2.3e), 
consistent with previous observations that the leading strand DNA Pol  incorporates more 
rNMPs than the lagging strand Pol  [12]. As expected, analysis of rNMPs from rnh201 
pol2-M644G cells revealed a stronger bias of rNMP incorporation on the leading strand 
compared to all other libraries (Figure 2.3e). However, the increase in rNMP incorporation 
by the low fidelity Pol  mutant did not change the overall rNMP spectrum, having similar 
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patterns of rNMP incorporation to libraries derived from wild-type Pol  strains (Figures 
A.5k,l and A.6k,l). Furthermore, we examined whether the spectrum of rNMP 
incorporation was different between the leading and the lagging strand of DNA replication. 
Cells containing either rnh201 or rnh1 rnh201 mutations had a similar spectrum of 
rNMP incorporation on the leading and the lagging strand (Figure 2.3f,g and Figure 
A.7a,b). In contrast, mapping of rNMPs in yeast cells carrying a mutant allele of DNA Pol 
 that is defective in proofreading activity (pol2-4, Table A.1), showed a lower frequency 
of rA versus rU in the nuclear but not in the mitochondrial genome (Figure 2.3h,i; Figure 
A.6m,n; and Table A.5), and showed a bias for lower rA than rU only on the leading strand 
(Figure 2.3j,k), which was not observed in libraries derived from wild-type nor low 
fidelity mutant Pol  strains. The rNMP spectra for a strain with proofreading-defective 
DNA Pol , (pol3-5DV, Table A.1) were not different from those containing the wild-type 
Pol  (Figures A.5m,n; A.6o,p; A.7c,d; and Table A.5). These results suggest that DNA 
Pol  can proofread rNMPs in DNA, in particular rUMPs, and that this activity is superior 
to DNA Pol , consistent with previous biochemical studies [18, 63].  
2.4.6 Hotspots of rNMP incorporation in S. cerevisiae genome  
We performed two types of analyses to determine potential hotspots of rNMP incorporation 
in S. cerevisiae genome. We identify enriched regions of rNMP incorporation in genomic 
DNA from ribose-seq data (see Materials and Methods). We found several regions of 
notable rNMP incorporation in mitochondrial DNA for each ribose-seq library in this 
study, and a few of these regions are displayed in Figure 2.5a. Because this analysis 
excludes all reads aligning to more than one position in the genome, a second analysis was 
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performed with respect to specific loci in order to identify single-nucleotide hotspots that 
were reproducibly present in multiple ribose-seq libraries (see Materials and Methods).  
 
Figure 2.5 Hotspots of rNMP incorporation within S. cerevisiae mitochondrial DNA, 
rDNA repeat, and Ty1. (a) Ribose-seq map of rNMPs in a 3 kb region (39,001–42,000) 
in mitochondrial DNA from rnh201∆ (KK-100) cells with enriched regions of rNMP 
incorporation. Peaks of rNMP incorporation are shown in red for the Watson (W) strand. 
Enriched regions of rNMPs with q-value of less than 0.001 are shown in blue. Position of 
restriction sites of enzymes used for genomic fragmentation is displayed in turquoise. (b) 
Ribose-seq map of rNMPs in COB locus of mitochondrial DNA from rnh201∆ (KK-100) 
cells (left). Zoom-in map (right) with sequence at the hotspot site (underlined). (c) Ribose-
seq map of rNMPs in rDNA repeat locus on Chr XII of genomic DNA from rnh201∆ (KK-
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100) cells (left). Because of the presence of two rDNA repeats on Chr XII in the reference 
genome (sacCer2), only the first repeat unit is shown as an example. Multiple-alignment 
data are shown. Zoom-in map (right) of the rDNA hotspot. (d) Ribose-seq map of rNMPs 
in Ty1 locus of genomic DNA from rnh201∆ (KK-100) cells (left). Because of the presence 
of multiple copies of Ty1 in the genome, YDRCTy1-1 on Chr IV is shown as an example. 
Multiple-alignment data are shown. Zoom-in map (right) of the Ty1 hotspot. The data, as 
peaks of rNMP reads in red, are shown for the Watson (W) and Crick (C) strands.  
 
We identified hotspots of rNMP incorporation within sequences present in multiple copies 
per yeast cell, i.e. the mitochondrial genome (~80 copies) [104], the ribosomal DNA 
(rDNA) repeats (~140) clustered on chromosome XII [105], and the yeast retrotransposon 
(Ty), of which there are ~30 copies encoded on multiple chromosomes [106]. In 
mitochondrial DNA, we found a marked hotspot at an rAMP on the Watson strand in the 
cytochrome oxidase B gene (COB) and the overlapping maturase BI3 and BI4 genes 
(Figure 2.5b and Table A.8), in addition to several other hotspots (Table A.8). In the 
rDNA locus, the strongest hotspot was found in gene RDN37-1 and the overlapping 
RDN25-1 at an rGMP (Figure 2.5c and Table A.8). In the yeast Ty1 sequence, we found 
a hotspot at an rAMP in the coding sequence of TY1A-1 (Figure 2.5d and Table A.8).  
The occurrence of such hotspots indicates that there are preferred sites for rNMP 
incorporation in the mitochondrial genome, rDNA, and Ty1 sequences. In addition to the 
recombinogenic properties of mitochondrial G+C clusters discussed above, yeast rDNA 
and Ty are also active in recombination [105, 107]. Frequent rNMP incorporation could 
trigger recombination, similar to rNMPs embedded in the mating type locus of 
Schizosaccharomyces pombe [73]. The rNMPs detected in Ty DNA could originate from 
cDNA rather than genomic DNA. Because rnh201 rnh1 cells have abundant Ty cDNA 
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[108], if rNMPs are incorporated in Ty1 during the process of reverse transcription, which 
forms the cDNA, we would expect a different rNMP pattern in Ty1 DNA in rnh201∆ rnh1∆ 
vs. rnh201∆ cells. Although we did not observe major differences in the rNMP spectra 
derived from rnh201∆ single mutant vs. rnh201∆ rnh1∆ cells at the Ty1 locus or in general 
(Table A.8; Figure 2.3e; Figures A.5; and A.6), it would be of interest to conduct in vitro 
tests to determine whether Ty reverse transcriptase incorporates rNMPs frequently 
opposite to RNA and/or DNA, and whether it has a particular bias for rNMP incorporation. 
2.5 Discussion 
rNMP incorporation has been extensively studied in recent years; however, determining 
the identity and locating sites of rNMP incorporation in genomic DNA has not yet been 
possible. We describe the development of ribose-seq to map sites of rNMPs in genomic 
DNA. Our ribose-seq approach specifically targets and captures rNMPs embedded in DNA 
via alkaline hydrolysis, resulting in DNA fragments with 2′,3′-cyclic phosphates or 2′-
phosphates which are subsequently ligated to adaptor sequences by AtRNL. Properties of 
alkaline cleavage of rNMPs and AtRNL ligation exclude Okazaki fragments and DNA 
abasic sites from our ribose-seq library, allowing construction of libraries containing stably 
incorporated rNMP sites and analysis by high-throughput DNA sequencing. Our ribose-
seq enabled the determination of the widespread but nonrandom distribution of rNMPs in 
budding yeast genomic nuclear and mitochondrial DNA with several hotspots. Base 
preference and strand bias relevant to replication of rNMP incorporation in yeast genomic 
DNA were found while flanking DNA sequences were also found to be a substantial factor 
for incorporation of rNMPs. Our findings with ribose-seq show both validation of the 
approach and determination of new aspects of rNMP incorporation in the yeast genome. It 
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would be interesting to determine the rNMP spectrum in cells with defects in rNMP 
removal pathways other than RER, either in RNase H2 wild-type or null cells growing 
under normal and/or stress conditions. Ribose-seq serves as foundation for such studies 
and as novel technology to better understand the genetic and epigenetic consequences of 
rNMPs in DNA, and their impact on the structure and function of DNA and chromatin. 
Moreover, specific signatures of rNMP incorporation may represent novel biomarkers for 
human diseases, such as AGS, cancer, and other degenerative disorders. 
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CHAPTER 3. ABASIC AND OXIDIZED 
RIBONUCLEOTIDES EMBEDDED IN DNA ARE 
PROCESSED BY HUMAN APE1 AND NOT RNASE H2 
 
The study in Chapter 3 consists of the work published in Nucleic Acid Research Vol. 45, 
No. 19 (2017) 11193-11212. All the RNase H2 assays in Figures 3.3 and B.3, and APE1 
experiments in Figures 3.4 and 3.6, along with initial APE1 enzymatic experiments on 
rNMPs and abasic rNMPs were my contributions to this study.   
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 Ribonucleotide 5’- monophosphates (rNMPs) are the most common non-standard 
nucleotides found in DNA of eukaryotic cells, with over 100 million rNMPs transiently 
incorporated in the mammalian genome per cell cycle. Human ribonuclease (RNase) H2 is 
the principal enzyme able to cleave rNMPs in DNA. However, whether RNase H2 may 
process abasic or oxidized rNMPs incorporated in DNA is unknown. The base excision 
repair (BER) pathway is mainly responsible for repairing oxidized and abasic sites into 
DNA. Here we show that human RNase H2 is unable to process an abasic rNMP (rAP site) 
or a ribose 8oxoG (r8oxoG) site embedded in DNA. On the contrary, we found that 
recombinant purified human apurinic/apyrimidinic endonuclease-1 (APE1) and APE1 
from human cell extracts efficiently process a rAP site in DNA and have weak 
endoribonuclease and 3’-exonuclease activities on r8oxoG substrate. Using biochemical 
assays, our results provide the first evidence of a human enzyme able to recognize and 
process abasic and oxidized ribonucleotides embedded in DNA. 
3.2 Introduction 
Incorporation of ribonucleotides monophosphate (rNMPs) in DNA is a frequent 
phenomenon, which is considered the most common type of ‘DNA damage’ occurring in 
normal cells [6, 70]. Ribose-seq and other approaches recently developed for mapping sites 
of rNMPs in DNA have shown widespread but not random distribution of rNMPs in 
chromosomal DNA of budding and fission yeast [68-71]. The number of rNMPs identified 
per nuclear chromosome was found to be proportional to chromosome size, and 
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quantitation approaches have estimated a 600 thousands rNMPs in budding yeast genome 
and over 100 millions in mouse genome [27]. 
The incorporation of rNMPs in genomic DNA may be due to: i) the disequilibrium in the 
cellular pool of deoxyribonucleotides (dNTPs) and ribonucleotides (rNTPs) [70]; ii) an 
incomplete elimination of RNA primers used in the generation of Okazaki fragments [18], 
iii) an oxidation of the deoxyribose sugar into ribose[24], and last but not least, iv) an 
imprecise 3’-exonucleolytic proofreading activity of replicative DNA polymerases, which 
do not discriminate rNMPs from dNMPs pool [12, 18, 70, 109]. Furthermore, taking into 
consideration all rNMPs that are synthesized during lagging strand synthesis, more than 
100 million rNMPs are introduced into the mammalian genome per cell cycle [27]. In 
addition, it has been estimated that the amount of rNTPs is generally 40–350 - fold higher 
than that of dNTPs in cycling cells [12, 13, 109] increasing the probability of incorrect 
rNMP incorporation during DNA replication and repair [12, 18, 70, 109].  
The effects of the 2′-hydroxyl group of the ribose sugar within an rNMP embedded in DNA 
are numerous: it mainly alters DNA elasticity and structure in a sequence dependent 
manner [2, 37, 110, 111] and affects the activity and function of several DNA-interacting 
proteins, in addition to increase the DNA fragility and mutability [2, 6]. Moreover, rNMPs 
in DNA can be template for DNA synthesis [30, 31], although the DNA polymerases 
processivity on rNMP tracts is reduced [31].  
The main pathway deputed to rNMPs removal is ribonucleotide excision repair (RER), in 
which the principal enzyme is RNase H2. It was demonstrated how RNase H2 deficiency 
in mammalian cells is associated to DNA damage repair activation and, in humans, to 
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pathology. RNase H2-null murine embryonic fibroblasts (MEFs) activate a p53-dependent 
damage response, whereas null-RNase H2 are embryonic lethal [44]. In humans, mutations 
in each of the three subunits of RNase H2 are associated with the neurological syndrome 
of Aicardi-Goutières (AGS), which causes severe brain dysfunction [54, 112, 113]. Altered 
RNase H2 function in AGS patients may result in increased level of rNMPs in DNA, which 
could in turn activate DNA damage response signaling and induce innate immune response 
[53, 114].  
Besides RER, other different DNA repair mechanisms are active to remove rNMPs 
embedded in DNA [27, 35]. In the absence of RNase H2, topoisomerase I cleavage [35], 
followed by nick processing by Srs2–Exo1, can remove some rNMPs [50, 56]. rNMPs in 
DNA can be also targeted by the nucleotide excision repair (NER) factors in bacteria [115]. 
However, in vitro experiments showed that human NER proteins are not active to remove 
rNMPs embedded in DNA [61]. Differently, the mismatch repair (MMR) mechanism 
targets mismatches with rNMPs both in E. coli and S. cerevisiae genomic DNA [29]. Until 
now, there is no proof that the base excision repair (BER) mechanism plays any role in 
removing rNMPs from DNA.  
BER is known to repair a wide spectrum of oxidative lesions in nuclear and mitochondrial 
DNA [64, 65], and preventing cancer [116, 117]. Abasic sites, which form by spontaneous 
hydrolysis of the N-glycosidic bond in DNA or following removal of a damaged base by 
BER glycosylases, are major targets or intermediate substrates in the BER pathway of 
DNA repair [8]. It has been estimated that up to 10,000 abasic sites are formed per human 
genome per day [5]. Despite the fact that spontaneous depurination occurs ~1,000 times 
slower in RNA than DNA [25], due to the high abundance of rNMPs in genomes, with 
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more than 100 million rNMPs transiently present in mammalian DNA during one 
replication cycle, considering rNMP incorporation by DNA polymerases during DNA 
replication and repair, and RNA primers of Okazaki fragments [27], the possibility that 
abasic and oxidized rNMPs (such as 7,8-Dihydro-8-oxo-riboguanosine) are present in 
DNA and are targets of BER is quite real and worth careful study. These data, together 
with other recent findings about the ability of S. pombe Pol 4, M. smegmatis DinB2 and 
human Pol β to insert and elongate oxidized rGMP when paired with dA during DNA 
replication [118-120], underscore the necessity to determine how cells can target and 
remove oxidized rNMPs or rAP sites from DNA.  
Because recent studies point towards a new function of BER in RNA surveillance [66, 67], 
there is high likelihood that BER could be involved in the processing of rNMPs in DNA, 
particularly in the case of chemically modified rNMPs, such as abasic and oxidized rNMPs. 
Identifying whether BER may target normal and modified rNMPs in DNA is important to 
better understanding the mechanism of genotoxicity of reactive oxygen species, the 
function and the impact of BER defects in human disease and cancer mechanisms. In the 
absence of proper repair mechanisms to cope with these kind of lesions, even a single or a 
few modified rNMPs present in a genome per cell cycle could lead to mutations and/or 
genomic rearrangements.  
Findings from our and other laboratories have revealed an important involvement of the 
apurinic/apyrimidinic endonuclease 1 (APE1) in RNA metabolism and RNA-decay [66, 
67, 121, 122]. APE1 is by far one of the most studied enzymes in the BER pathway for its 
altered expression in different human pathologies ranging from neurodegenerative to 
cancer disorders [123]. Its role in DNA repair is primarily due to its ability to act as an 
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endonuclease, specifically being able to cleave 5′ to deoxy- abasic sites, which results in a 
strand break with 3′-hydroxyl and 5′-phosphodeoxyribose termini. APE1 also has redox 
activity needed to modulate the DNA binding ability of several transcription factors [123]. 
As recently demonstrated, APE1 can endonucleolytically cleave abasic single-stranded 
RNA [66, 67, 122], has a 3′-RNA phosphatase activity, and a weak 3′-5′ exoribonuclease 
activity [124]. Moreover, it has been demonstrated that APE1 has nucleotide incision repair 
(NIR) activity on modified bases, such as 5,6-dihydro-2’-deoxyuridine, 5,6-
dihydrothymidine, 5-hydroxy-2’-deoxyuridine, 5-hydroxycytosine, which are directly 
repaired by APE1 bypassing the action of specific glycosylases [125-127]. Therefore, we 
hypothesized that APE1 can be involved in processing rNMPs in DNA, particularly in the 
case of abasic and oxidized rNMPs.  
Here, we found that eukaryotic RNase H2 from yeast, mouse and human is inactive on a 
rAP site in DNA in different assays. We discovered and characterized an unknown APE1 
activity on abasic ribonucleotide embedded in DNA. We then compared the ability of 
human RNase H2 to cleave at an oxidized ribonucleotide (r8oxoG) incorporated in a DNA 
substrate and analyzed the activities of 8-oxoguanine DNA glycosylase 1 (OGG1) and 
APE1 to recognize and cleave this particular type of damage. Our data demonstrate that 






3.3 Materials and Methods 
3.3.1 Double strand oligonucleotide description and annealing sequence 
All oligonucleotides and their complementary sequences used in this study are listed in 
Table B.1 (see Figure B.1). ss_dG_40 oligonucleotide and its reverse complementary 
sequence, ss_dC_40, were purchased from Invitrogen (Grand Island, NY, USA). ss_rG_40 
oligonucleotide and the DNA oligo containing a tetrahydrofuran abasic 
deoxyribonucleotide, ss_dF_40, or tetrahydrofuran abasic ribonucleotide, ss_rF_40, as 
well as ribo- 1’OH abasic containing oligonucleotide, ss_rOH, were purchased from 
Dharmacon (GE Healthcare, Lafayette, CO, USA). The 26-mer oligonucleotide containing 
a tetrahydrofuran, ss_dF, and its reverse complementary sequence ss_dC, were synthesized 
from Metabion International AG (Steinkirchen, Germany). The 25-mer dG-, rG-, d8oxoG- 
containing oligonucleotides and complementary oligonucleotides were synthesized from 
Metabion International AG (Steinkirchen, Germany).  
ss_dg_40, ss_rG_40, ss_dF_40 and ss_rF_40 oligonucleotides were 5′ end-labeled with [γ-
32P] ATP (PerkinElmer, Boston, MA, USA) by T4 polynucleotide kinase (PNK) (New 
England BioLabs, Ipswich, MA, USA) in a reaction mixture containing 10 µM ATP using 
10X PNK buffer (New England BioLabs, Ipswich, MA, USA). This labeling reaction was 
incubated at 37 °C for 1 hour, followed by inactivation at 65 °C for 20 minutes. The 
reactions were purified by using Illustra MicroSpin G-25 column (GE Healthcare, 
Buckinghamshire, UK).  
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The remaining remaining oligonucleotides were labelled with either IRDye700, IRDye800 
fluorophores or Cyanine5 at 5’ end, as specified in Table A.1, purified through RP-HPLC, 
checked in Mass Check and re-suspended in RNase- and DNase- free water.  
Synthesis of oligonucleotide containing an internal ribose 8-oxo-guanosine (r8oxoG) and 
an IRDye700 fluorophore at 5’ end was in-house carried out on an Applied Biosystems 
392 DNA/RNA synthesizer using the phosphoramidite chemistry, associated with the 
phenoxyacetyl protecting group for the nucleobases and the tertio-butyldimethylsilyle 
protecting group at the 2’-OH position of the ribonucleoside residue [128]. Upon 
completion, the oligonucleotide was de-protected in concentrated aqueous ammonia for 6 
hours at 55°C, followed by a desilylation step with triethylamine trihydrofluoride (8 hours 
at room temperature) [128] and was finally purified by preparative 20% denaturing PAGE 
using UV-shadowing detection. After desalting by size exclusion, the r8oxoG 
oligonucleotide was quantified by UV measurements at 260 nm and its purity was checked 
by RP-HPLC analysis together with MALDI-TOF mass measurements (Figure B.5a,b). 
Sample was then lyophilized and frozen at -20°C until use.  
All oligonucleotides oligonucleotides used in the present study were re-suspended in 
RNase- and DNase- free water at 100 µM. 100 pmol of each oligonucleotide was annealed 
with an excess of 150 pmol of its complementary DNA oligonucleotide (as indicated in 
Table B.1) in 10 mM TrisHCl pH 7.4 and 10 mM MgCl2, heated at 95°C and cooling down 




3.3.2 Plasmid and expression of recombinant proteins  
Plasmid and expression of human recombinant OGG1 enzyme was purified as described 
in Audebert et al., [129]. Plasmids and expression of human recombinant APE1 wild type 
(WT) and respective mutants (APE1 N∆33 and APE1 E96A) were produced as explained 
in Fantini et al., [130] and in Erzberger and Wilson [131]. Plasmid and expression of yeast, 
mouse and human recombinant RNase H2 were produced as explained in Chon et al., [47, 
132]. 
3.3.3  Cell lines and silencing experiments  
HeLa cells (human cervical carcinoma) (ATCC®, Milan, Italy) were grown in DMEM 
(EuroClone, Milan, Italy) supplemented with 10% fetal bovin serum (FBS-EuroClone, 
Milan, Italy), penicillin (100 U/ml), streptomycin (100 mg/ml) and l-glutamine (2 mM) 
(EuroClone, Milan, Italy) and cultured in a humidified incubator at 5% CO2 at 37°C. For 
silencing experiments, 15 × 104 cells were seeded and transfected with 5' 
UACUCCAGUCGUACCAGACCU 3' siAPE1 (100 pmol) or siGENOME SMART pool 
siRNase H2A (50 pmol) or 5’ CCA UGA GGU CAG CAU GGU CUG UU 3’ scramble 
control siRNA (100 pmol) (GE Dharmacon, Milan, Italy) by using Oligofectamine™ 
Reagent (GE Dharmacon, Milan, Italy) as per manufacturer’s indications. After 72 hours 
upon transfection, cells were harvested by trypsinization and centrifuged at 250 × g for 5 
minutes at 4°C. Supernatant was removed, and pellet was washed once with ice-cold 
phosphate-buffered saline without Calcium and Magnesium (PBS-Euroclone, Milan, Italy) 
and then centrifuged again (250 × g for 5 minutes at 4°C). 
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3.3.4 Preparation of nuclear cell extracts (NCE) 
After washing with PBS, cells were collected in cold PBS added with 0.1 M DTT and 0.5 
mM phenylmethylsulfonyl fluoride (PMSF). Cells were centrifuged at 800 × g for 10 
minutes at 4°C and the supernatant was removed. Pellet was re-suspended in a cold 
hypotonic solution containing 10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM MgCl2, 0.1 
mM EDTA pH 8.0 complemented with 0.1 mM DTT, 0.5 mM PMSF, 1 mM protease 
inhibitor (PI), 1 mM NaF, 1 mM Na3VO4. After centrifugation at 800 × g for 10 minutes 
at 4°C, cytosolic proteins (CCE) were collected whereas intact nuclei were pelleted. Pellet 
was washed to discard any contamination from cytosol and it was subsequently re-
suspended with a cold hypertonic solution 20 mM HEPES pH 7.9, 420 mM NaCl, 1.5 mM 
MgCl2, 0.1 mM EDTA pH 8.0, 5% glycerol complemented with 0.1 mM DTT, 0.5 mM 
PMSF, 1 mM PI, 1 mM NaF, 1 mM Na3VO4 and incubated on ice for 30 minutes. At the 
end, the sample was centrifuged at 15,000 × g for 20 minutes at 4°C and collected the 
supernatant containing nuclear proteins (NCE). Quantification of each sample was 
performed by colorimetric Bradford assays (Bio-Rad, Milan, Italy). 
3.3.5 Preparation of whole cell extracts (WCE) 
After washing with PBS, cells were harvested by trypsinization and centrifuged at 250 × g 
for 5 minutes at 4°C. The supernatant was removed, washed once with PBS and centrifuged 
again. Pellet was re-suspended in a lysis solution containing 50 mM Tris HCl (pH 7.4), 150 
mM NaCl, 1 mM EDTA, 1% wt/vol Triton X-100 supplemented with 1 mM PI, 1 mM 
DTT, 0.5 mM PMSF, 1 mM NaF and 1 mM Na3VO4. After centrifugation at 15,000 × g 
for 20 minutes at 4°C, the supernatant is considered as whole cell extract (WCE). Proteins 
 50 
of each sample were quantified using a colorimetric Bradford assays (Bio-Rad, Milan, 
Italy). 
3.3.6 Enzymatic activity assays 
To measure enzymatic activity of recombinant proteins and NCE on different substrates, 
each reaction was prepared following doses, time points and buffers specified in detail into 
the legend of each experiment. Final volume for each reaction was 10 µl. At the end of all 
reactions, samples were blocked with a stop solution, containing 99.5% v/v Formamide 
(SIGMA-ALDRICH, Milan, Italy) supplemented with 10X Orange Loading Dye (LI-COR 
Biosciences, Milan, Italy) and heated at 95°C for 5 minutes. Then, all samples were loaded 
onto a 7 M denaturing 20% polyacrylamide gel in TBE buffer pH 8.0 and run at 4°C at 
300V for 1 hour. Then, the gel was visualized with an Odyssey CLx Infrared Imaging 
system (LI-COR GmbH, Germany). The signals of the non-incised substrate (S) and the 
incision product (P) bands were quantified using Image Studio software (LI-COR GmbH, 
Germany). When using the ds_rOH:dC and ds_r8oxoG:dC oligonucleotides, a very small 
amount of cleavage product was seen in samples not treated with recombinant proteins 
and/or cell extracts due to the reactivity of this molecule, which was spontaneously 
degraded. During the analysis, this band has been always subtracted from bands obtained 
following treatment with recombinant proteins and/or extracts.  
For radioactive experiments, reactions were stopped by adding 2X denaturing PAGE gel 
buffer (0.01% bromophenol blue, 95% formamide and 20 mM EDTA pH 8.0) and heating 
to 95 °C for 5 min. After dilutions, the products were analyzed by 15% (wt/vol) 
polyacrylamide, 8 M urea gel electrophorersis (urea-PAGE). 20-100 Oligonucleotide 
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Length Standard (Integrated Device Technology, Coralville, IA, USA) was used as a ladder 
(M). After electrophoresis, gels were exposed to phosphor screen overnight. Images were 
taken with Typhoon Trio+ (GE Healthcare, Lafayette, CO, USA) and obtained with 
ImageQuant (GE Healthcare). Band intensities were quantified by Multi Gauge V3.0 
(Fujifilm). 
3.3.7 Electrophoretic mobility shift assay analysis (EMSA) 
Proteins binding to nucleic acids was assessed by EMSA analysis as already described by 
Fantini et al., [130]. Briefly, the indicated amounts of recombinant purified proteins or cell 
extracts were co-incubated with 250 fmol of the probe (25 nM) at 37°C for 30 minutes. 
Reactions were prepared in a buffer containing 8 mM HEPES, 10 mM KCl, 400 µM EDTA 
pH 8.0, 5 mM DTT and 2% glycerol in a 10 µl final volume. Moreover, salmon sperm 
DNA (SSD) (SIGMA-ALDRICH, Milan, Italy) was added like as DNA competitor. 
Samples were loaded onto an 8% w/vol native polyacrylamide gel in Tris-Sodium Acetate-
EDTA pH 8.0 (TAE) buffer and run at 4°C at 150V for 1 hour followed by 3 hours at 250V. 
3.3.8 Statistical analysis 







3.4.1 Human, yeast or mouse RNase H2 does not process an rAP site in DNA 
RNase H2 is the principal protein able to process paired and mismatched rNMP sites 
embedded in DNA by generating a nick to their 5′ side [29]. Up to now, whether RNase 
H2 can cleave a rAP site incorporated in a duplex DNA is unknown. In order to test this 
hypothesis, we measured RNase H2 ability to cleave a modified 25-mer DNA 
oligonucleotide, called ds_rOH:dC, in which a 1’-OH abasic rNMP was incorporated into 
a DNA substrate as shown in Figure 3.1a (see also Table B.1 and Figure B.1).  
 
                          
Figure 3.1 Scheme of substrates used to test cleavage of an rAP site in DNA. DNA 
nucleotides are in blue, RNA in red. The 5′ and 3′ ends of each DNA strand are indicated. 
(a) Scheme of double strand (ds) DNA 25-mer substrates (single strand (ss) oligonucleotide 
annealed to ss_dC containing-complementary oligonucleotide) containing a dGMP, rGMP, 
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dF and 1′ OH abasic rNMP (rOH) site in the 13th position. The ‘IRD700’ in green indicate 
IRDye 700 phosphoramidite dye tagged at the 5’ end. The ‘IRD800’ in green indicate 
IRDye 800 phosphoramidite dye tagged at the 5’ end. The ‘Cy5’ in green indicates cyanine 
dye tagged at the 5′-end of the top strand of the duplex. (b) Scheme of the ds_DNA 40-mer 
substrate (ss oligonucleotide annealed to its ss complementary oligonucleotide) containing 
a dGMP, rGMP, dF and rF site in the 20th position. The P in purple indicates radiolabelled 
32P at the 5′-end of the top strand of the duplex. The red arrow indicates the cleavage 
position by RNase H2 5’ to the rGMP site. 
 
Recombinant human RNase H2, composed of its three subunits, was purified as explained 
in Materials and Methods (Figure B.2) and its activity was tested on ds_rOH:dC 
oligonucleotide in parallel with dG- and rG- containing oligonucleotides as negative and 
positive controls, respectively. As reported in Figure 3.2, the enzyme had no activity on 
ds_dG:dC and ds_dF:dC (containing a tetrahydrofuran residue mimicking the abasic site) 
oligonucleotides, whereas it efficiently cleaved the canonical rG substrate as expected. In 
addition, we tested the mismatched rG- containing oligonucleotide, ds_rG:dA, confirming 
that RNase H2 protein is also active on this type of substrate (Figure 3.2a). On the other 
hand, no activity was detectable on ds_rOH:dC demonstrating that recombinant human 
RNase H2 is not able to process an abasic rNMP embedded in DNA. To confirm these data 
in cells, we tested the activity of RNase H2 protein obtained from nuclear cell extracts on 
the same substrates, as above (Figure 3.2b,c and Figure B.3b). To this aim, RNase H2 
expression was downregulated in HeLa cells through specific siRNA and the 
endoribonuclease activities of nuclear extracts from knocked down and control cells were 
then assayed. Western blotting analyses performed on nuclear extracts from control 
(Scramble) and knocked down (siRNase H2) cells demonstrated the efficiency of RNase 
H2 downregulation (about 50%) upon transfection with specific siRNA sequences (Figure 
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B.3a). We incubated Scramble or siRNase H2 cell extracts with different substrates for the 
indicated time points. Following knock-down of RNase H2, we found a decreased cleavage 
of ds_rG:dC, as expected (Figure 3.2c). Surprisingly, we found that ds_rOH:dC was also 
cleaved; however, ds_rOH:dC cleavage was completely unaffected by siRNase H2 cell 
extracts (Figure 3.2c). These data suggest that while human RNase H2 is inactive on an 




Figure 3.2 Human RNase H2 is not able to process an rAP site embedded in a duplex 
DNA substrate. (a) Representative denaturing polyacrylamide gel of oligonucleotides (25 
nM) incision by recombinant human RNase H2 (0.5 nM). The reaction was performed in 
RNase H2-buffer (20 mM Tris-HCl, 25 mM KCl, 0.1% BSA, 0.01% Tween20, 4 mM 
MgCl2, pH 7.4) for different time points, expressed in minutes and shown on the top of the 
figure, at 37°C. ds_dG:dC and ds_dF:dC oligonucleotides were used as negative controls 
whereas paired and mismatched ds_rG oligonucleotides as positive controls. S indicates 
the substrate position while P indicates the product position (left). Relative graph 
illustrating the time-course kinetics activity of the recombinant protein on ds_rG:dC and 
ds_rG:dA oligonucleotides. Data are expressed as mean + SD of three independent 
technical replicas (right). (b) Graph illustrating the time-course kinetics activity of NCE 
on ds_rG:dC in control and RNase H2-knocked down conditions. Enzymatic reaction was 
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performed at 37°C in RNase H2-buffer with 500 ng of NCE. Data are expressed as mean 
+ SD of three independent technical replicas. Standard deviation values were always less 
than 10% of the mean of the experimental points. (c) Graph illustrating the time-course 
kinetics activity of NCE on ds_rOH:dC oligonucleotide in control and RNase H2-knocked 
down conditions. Enzymatic reaction was performed at 37°C in RNase H2-buffer with 500 
ng of NCE. Data are expressed as mean + SD of three independent technical replicas. 
Standard deviation values were always less than 10% of the mean of the experimental 
points.  
 
To increase the stability of the abasic rNMP-containing oligonucleotide, we also used 
abasic substrates mimicked by tetrahydrofuran (F) residues, similarly to what commonly 
used for dNMP [133, 134]. We then tested whether RNase H2 from yeast or mouse may 
process an abasic rNMP, mimicked by a tetrahydrofuran ribonucleotide residue, embedded 
in a longer DNA sequence composed of 40-bp to evaluate a possible role of the length of 
the substrate in determining the inability of RNase H2 to process these substrates (Figure 
3.1b). We used single-stranded (ss) or double-stranded (ds) DNA substrates containing an 
abasic rNMP site (rF), an rGMP (rG), an abasic dNMP (dF) or a dGMP as internal controls 
(Table B.1). As expected, S. cerevisiae and mouse RNase H2 cleaved at the single rG in a 
DNA duplex substrate (lane 9 in Figure 3.3a,b) and had no activity on the rG embedded 
in the ss substrate (lanes 7 and 8 in Figure 3.3a,b). Importantly, as we found for human 
RNase H2, also S. cerevisiae and mouse RNase H2 complexes were inactive on the abasic 
rNMP, ds_rF:dC (lane 12 in Figure 3.3a,b). Together these results demonstrate the 
inability of eukaryotic RNase H2, both from yeast and mammalian origins, to process an 
abasic rNMP incorporated in DNA independently from the nature of the abasic site (either 
1’-OH or tetrahydrofuran residue) and the length of the substrate (either 25- or 40-mers).  
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Figure 3.3 Mouse and yeast RNase H2 are not able to process an rAP site embedded 
in duplex DNA substrate. (a and b) Denaturing PAGE gels showing cleavage result using 
10 nM of 40-mer radioactive substrate containing an rG or an rF site, without (lanes 1-6) 
or with (lanes 7-12) 10 nM of yeast RNase H2 protein (a) or 10 nM of mouse RNase H2 
protein (b). All reactions were carried out at 37 °C for 1 hour in yeast/mouse reaction 1X 
buffer (15 mM Tris-HCl pH 8.0, 50 mM NaCl, 10 mM MgCl2, 5% glycerol, 1 mM DTT 
and 0.1 mg/mL BSA). M indicates the DNA ladder and the black arrows on the left of each 
panel show specific band sizes. Lanes 1,7 have ss-substrate containing rG (ss_rG_40), 
lanes 2,8 have ss-substrate containing ss_rG_40 that is cooled slowly at room temperature 
to demonstrate the absence of any self-annealing structures, and lanes 3,9 show the ds-
substrate containing rG (ds_rG_dC). Lanes 4,10 have ss-substrate containing abasic ribo 
site (ss_rF_40), lanes 5,11 have ss_rF_40 that is cooled slowly in room temperature to 
observe any self-annealing; and lanes 6,12 have ds substrate containing abasic ribo site 
(ds_rF:dC). The percentages of cleavage of each reaction are displayed below the images 
as enzymatic activity (%).  
 
3.4.2 Human APE1 is able to process an rAP site embedded in DNA through its 
endonuclease catalytic domain 
To test the ability of APE1 to process abasic rNMPs in DNA, we purified human 
recombinant APE1 protein, as described in Materials and Methods section (Figure B.4a). 
The endonuclease activity of APE1 on ds_rOH:dC substrate was examined through 
cleavage assays. As a positive control for APE1 endonuclease activity, an oligonucleotide 
substrate containing a tetrahydrofuran residue mimicking the abasic site, called ds_dF:dC 
[133, 134], was used. As reported in Figure 3.4a, and measured through kinetics 
experiments in Table 3.1, APE1 processes the abasic rNMP as efficiently as the canonical 
deoxy-abasic site having a lower affinity for the ds_rOH:dC than the ds_dF:dC (11-fold 
increase of the KM) but a higher catalytic rate (27-fold increase in the kcat/KM ratio) (Table 
3.1). Moreover, APE1 was unable to process the rG- containing oligonucleotide, which is 
the preferential substrate of RNase H2 enzyme. To further characterize the enzymatic 
 59 
activity of APE1, we used the purified recombinant mutant APE1 E96A protein, in which 
the missense mutation of the residue in the catalytic site, characterized by the substitution 
of the glutamic acid in position 96 with alanine, causes a decreased enzymatic activity of 
the protein, lacking the ability to coordinate the Mg2+ ion in the catalytic site [133, 135, 
136] (Figure B.4b). In addition, we used the purified recombinant mutant APE1 NΔ33 
protein, in which the first 33 N-terminal residues, responsible for RNA-protein interaction 
but not affecting its enzymatic activity, have been deleted [5, 66] (Figure 3.4b). Following 
incubation of ds_rOH:dC with APE1 E96A mutant, there was barely any endonuclease 
activity, whereas the activity of APE1 NΔ33 mutant was comparable with that of the APE1 
WT protein (Figure 3.4b,c and Figure B.4c). These data demonstrate that the catalytic 
domain of APE1 is responsible for recognizing and cleaving a rAP site in dsDNA and that 
the N-terminal domain does not play any major role in the enzymatic activity on this 




Figure 3.4 Human PE1 efficiently processes an rAP site embedded in a duplex DNA 
substrate. (a) Representative denaturing polyacrylamide gel of oligonucleotides (0.25 
µM) incision by recombinant human APE1 (0.288 nM). The reaction was performed in 
APE1-buffer (20 mM Tris-HCl, 100 mM KCl, 0.1% BSA, 0.01% Tween20, pH 7.4) for 
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different time points, expressed in minutes and shown on the top of the figure, at 37°C. 
ds_dG:dC and ds_rG:dC oligonucleotides were used as negative controls, whereas 
ds_dF:dC oligonucleotide as positive control. S indicates the substrate position, while P 
indicates the product position (left). Relative graph illustrating the time-course kinetics 
activity of the recombinant protein on ds_dF:dC and ds_rOH:dC oligonucleotides. Data 
are expressed as mean + SD of three independent technical replicas. Standard deviation 
values were always less than 10% of the mean of the experimental points (right). (b) Graph 
illustrating the time-course kinetics activity of APE1 mutants on ds_dF:dC 
oligonucleotide. Data are expressed as mean + SD of three independent technical replicas. 
Standard deviation values were always less than 10% of the mean of the experimental 
points. (c) Graph illustrating the time-course kinetics activity of APE1 mutants on 
ds_rOH:dC oligonucleotide. Data are expressed as mean + SD of three independent 
technical replicas. Standard deviation values were always less than 10% of the mean of the 
experimental points.  
 












75 ds_dF:dC 14.2±6.98 0.95±0.33 12.7±4.39 0.95±0.16 
3.125 ds_rOH:dC 158±41.79 12.66±3.71 4054±1191.8 26±1.96 
Kinetic parameters (KM, VMAX and kCAT) were calculated from the measurements of the 
endonucleolytic reaction rates for APE1 on ds_dF:dS and ds_rOH:dS substrates. As 
described by Fantini et al [130], increasing concentrations of the substrate were incubated 
with a selecting concerntration of the protein (see first column in Table 3.1) in a time-
course experiment. Kinetic values were calculated using a Lineweaver-Burk plot analysis 
and represent the mean ± SD of three independent experiments. 
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Figure 3.5 APE1 knock down in human cells impairs the processing of an rAP site 
embedded in a duplex DNA substrate. (a) Graph illustrating the time-course kinetics 
activity of NCE on ds_dF:dC in control and APE1-knocked down conditions. Data are 
expressed as mean + SD of three independent technical replicas. Standard deviation values 
were always less than 10% of the mean of the experimental points. (b) Graph illustrating 
the time-course kinetics activity of NCE on ds_rOH:dC oligonucleotide in control and 
APE1-knocked down conditions. Enzymatic reaction was performed at 37°C in APE1-
buffer with 10 ng of NCE. Data are expressed as mean + SD of three independent technical 
replicas. 
 
To confirm that APE1 is the major enzyme capable of cleaving ribo-abasic containing sites 
in cells, we used nuclear cell extracts in which APE1 was knocked-down through specific 
siRNAs (Figure B.3a), as explained in Material and Methods. The endonuclease activity 
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of APE1-kd (siAPE1) cell extracts, was reduced on both ds_dF:dC (Figure 3.5a and 
Figure B.4d) and ds_rOH:dC (Figure 3.5b and Figure B.4d), as compared to its respective 
control SCR-treated extracts. As Western blot analysis shows (Figure B.3a), the 
expression of APE1 protein did not exert any effect on the expression of RNase H2 protein 
itself, demonstrating that the observed reduction of the processing activity of the abasic 
rNMP-containing substrate, observed with APE1-kd cell extracts, was likely due to the 
reduced expression of the APE1 protein. We further examined the specificity of the 




Figure 3.6 Recombinant human APE1 efficiently processes a tetrahydrofuran 
ribonucletotide mimicking an abasic residue site (rF) embedded in a duplex DNA 
substrate. (a) Cleavage result of 10 nM of 32P double-stranded oligonucleotides ds_dF:dC 
or ds_rF:dC substrates with different concentrations of APE1 WT protein (lanes 1-3 and 
7-9) and mutant APE1 E96A protein (lanes 4-6 and 10-12) at 37 °C for 1 hour in APE1-
reaction 1X buffer containing 50 mM Tris-HCl pH 7.5, 50 mM KCl, 10 mM MgCl2, 0.001 
mg/mL BSA and 0.05% Triton X-100. First lane on the left, M is a ssDNA ladder (barely 
visible) and the black arrows on the left show specific band sizes. Both oligonucleotides 
were incubated with 0 nM (lanes 1,4,7,10), 5 nM (lanes 2,5,8,11) or 10 nM (lanes 3,6,9,12) 
of APE1 WT protein (lanes 1-3 and 7-9) or mutant E96A protein (lanes 4-6 and 10-12), 
respectively. The percentages of cleavage of each reaction are displayed below the image 
as enzymatic activity (%). (b) Cleavage result of 10 nM ds_dF:dC or ds_rF:dC radioactive 
substrates using 12.5 ng of whole HeLa cell extracts untreated (lanes 1,3) and treated (lanes 
2,4) with 0.20 nM of Compound #3, a specific APE1-endonuclease inhibitor, at 37 °C for 
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10 min. The black arrows on the left of the gel image indicate the size of uncut and cut 
substrates following denaturation. The cleavage percentage of this experiment is displayed 
below the image as enzymatic activity (%). (c) Histograms showing data from four 
independent experimental replicas shown in panel (b) with ranges as bars. P values of less 
than 0.05 are marked by asterisk. WCE, whole cell extracts. 
  
We tested the activity of the APE1 E96A mutant to cleave at a ds_rF:dC substrate 
compared to that of APE1 WT (Figure 3.6a). As a control, the activity on the ds_dF:dC 
substrate was also analyzed. As it can be observed, mutant E96A showed a reduced 
cleavage on the ds_rF:dC substrate. Indeed, APE1 WT gave a 96% of cleavage at 5 and 10 
nM (lanes 2 and 3), whereas mutant APE1 E96A had 32% cleavage at 5 nM and 38% at 
10 nM (lanes 5 and 6). Cleavage of ds_rF:dC by APE1 WT was 89% at 5 nM and 90% at 
10 nM (lanes 8 and 9), and there was minimal activity for APE1 E96A on the ds_rF:dC 
substrate in the same conditions (lanes 11 and 12). Moreover, pre-treatment of cell extracts 
with 0.2 nM of Compound #3 (i.e. N-(3-(benzo[d]thiazol-2-yl)-6-isopropyl-4,5,6,7-
tetrahydrothieno[2,3-c]pyridin-2-yl)acetamide)), a specific APE1 endonuclease inhibitor 
[134, 137], exerted a significant inhibitory effect upon APE1 enzymatic activity on both 
ds_dF:dC in DNA and ds_rF:dC substrates demonstrating that the main enzymatic activity 
of cell extracts was due to APE1 function (Figure 3.6b,c).These data demonstrate that 
human APE1 is the major enzyme capable of specifically cleaving at abasic rNMPs in 
DNA while being unable to process normal rNMPs, which are the preferential substrates 




3.4.3 Human RNase H2 does not process an r8oxoG embedded in a duplex DNA 
An abasic site can be generated spontaneously or following the processing of an oxidized 
lesion from a specific glycosylase. While known glycosylases (such as OGG1) are 
responsible for this activity on 8oxo-dG, no enzyme is known to be able to process the 
oxidized rG substrate. We then focused our attention on r8oxoG removal. The r8oxoG 
containing oligonucleotide was in-house synthesized and, as observed from MALDI-MS 
analysis and HPLC purification (Figure B.5a,b), the undesirable presence of secondary 
products of the chemical synthesis of this substrate can be excluded.  
First, we investigated whether human RNase H2 was able to recognize and cleave at 
r8oxoG site using an oligonucleotide containing this type of lesion called ds_r8oxoG:dC 
(Figure 3.7a, see also Table B.1, Figure B.1). In these experiments, we always compared 
the specific enzymatic activity of RNase H2 with that exerted on the canonical ds_rG:dC 
substrate, as positive control, and using the ds_d8oxoG:dC oligonucleotide as negative 
control. As Figure 3.7b shows, while the ds_rG:dC oligonucleotide was efficiently 
processed by RNase H2, the same activity was not observed for ds_r8oxoG:dC. As 
expected, the d8oxoG-containing oligonucleotide was not cleaved by RNase H2. These 
data confirm that RNase H2 was not able to process modified rNMPs embedded in DNA. 
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Figure 3.7 Human RNase H2 is not able to process an r8oxoG site embedded in a 
duplex DNA substrate. (a) Scheme of ds_DNA 25-mer substrates (single strand (ss) 
oligonucleotide annealed to ss_dC containing- or ss_dA containing-complementary 
oligonucleotide) containing a d8oxoG, r8oxoG and dF site in the 13th position. The 
‘IRD700’ and ‘IRD800’ in green indicates IRDye 800 phosphoramidite and IRDye700 
phosphoramidite dye tagged at the 5’ end. (b) Representative denaturing polyacrylamide 
gel of oligonucleotides (25 nM) incision by human recombinant RNase H2 (5 fmol). 
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Reaction was performed in RNase H2-buffer (20 mM Tris-HCl, 25 mM KCl, 0.1% BSA, 
0.01% Tween20, 4 mM MgCl2, pH 7.4) at 37°C. ds_rG:dC and ds_d8oxoG:dC 
oligonucleotides were used as positive and negative controls, respectively. Time points are 
shown on the top of the figure. S indicates the substrate position, while P indicates the 
product position. (c) Representative denaturing polyacrylamide gel of oligonucleotides 
(0.25 µM) incision by nuclear HeLa cell extracts (NCE). In order to discriminate the 
activity of RNase H2, 500 ng of NCE in which RNase H2 expression was previously 
knocked down through specific siRNA (indicated as siRNase H2) were tested in 
comparison to control cells (Scramble) at different time points (minutes), shown on top of 
the figure. The endoribonuclease activity detected for r8oxoG oligonucleotide was 
indicated with an asterisk on the right side of each panel. S indicates the substrate position 
while P indicates the product position.  
 
Similarly, we confirmed these data using RNase H2-kd nuclear extracts from HeLa cells. 
As expected, control nuclear extracts (Scramble) displayed a time-dependent 
endoribonuclease activity on ds_rG:dC, whereas the down regulation of RNase H2 protein 
expression (siRNase H2) was associated with a marked reduction of the endoribonuclease 
activity on the same substrate (Figure 3.7c). On the contrary, once we tested the ability of 
the nuclear extracts on ds_r8oxoG:dC oligonucleotide, we found only a weak 
endoribonuclease activity on it (see the band indicated by an asterisk), which was not 
affected by RNase H2 silencing (Figure 3.7c). These data support the conclusion that the 
r8oxoG site in DNA is not recognized by human RNase H2. 
3.4.4 OGG1 has neither lyase nor glycosylase activities on oxidized rG substrate 
We then tested whether enzymes of the BER pathway may be involved in processing the 
r8oxoG substrate. To this purpose, we used recombinant purified human OGG1 and APE1 
proteins (Figures B.4a and B.5c). OGG1 protein belongs to the bi-functional glycosylases 
family having both lyase and glycosylase activities on oxidized dG [138]. We examined 
the processing activity of OGG1 on r8oxoG substrate in comparison to the d8oxoG-
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containing oligonucleotide, as a positive control. First, we tested the ability of OGG1 to 
recognize an r8oxoG site through electrophoretic mobility shift assay (EMSA). As shown 
in Figure 3.8a, increasing amount of recombinant OGG1 formed a stable retarded complex 
with the r8oxoG oligonucleotide in a dose-dependent manner. As confirmed in the data 
shown in Figure B.5e, OGG1 binding was specific for the modified r8oxoG- containing 
oligonucleotide (lanes 2 and 3). Indeed, the same retarded band was observed when the 
recombinant OGG1 was incubated with the positive control ds_d8oxoG:dC (lanes 11 and 
12) but not with the negative controls: ds_rG:dC (lanes 5 and 6) and ds_dG:dC (lanes 8 
and 9). 
Furthermore, we tested the lyase activity of OGG1 on different substrates. Figure 3.8b 
shows that when we incubated increasing amounts of recombinant protein for 30 minutes 
at 37°C with different substrates, OGG1 was able to process only the canonical substrate 
ds_d8oxoG:dC in a dose response manner (Supplementary Figure B.5d), whereas no 
lyase activity was apparent for any of the other substrates used, including the 




Figure 3.8 Human OGGI has neither lyase nor glycosylase activities on r8oxoG-
containing oligonucleotide. (a) Representative native EMSA polyacrylamide gel of 
OGG1 binding on ds_r8oxoG:dC oligonucleotide (25 nM) is shown. The ‘Bound’ arrow 
indicates the retarded complex between OGG1 and the probe whereas the ‘Free’ arrow the 
unbound substrate. Amounts of OGG1 protein, expressed in pico moles, are shown on the 
top of the figure. Reactions were performed as explained in “Material and Methods” 
section. (b) Representative denaturing polyacrylamide gel of lyase activity of human 
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OGG1 on different duplex DNA oligonucleotides (25 nM). Doses of OGG1 protein 
expressed in femto moles are shown on the top of the figure. Reactions were performed in 
OGG1-buffer (20 mM Tris-HCl, 100 mM KCl, 0.1% BSA, 0.01% Tween20, pH 7.4) at 
37°C for 30 minutes. S indicates the substrate position, while P indicates the product 
position. (c) Representative denaturing polyacrylamide gel of incision by different doses 
of APE1 co-incubated with a fixed amount of OGG1 (3.125 nM) on different duplex DNA 
oligonucleotides (25 nM) in order to investigate glycosylase activity of OGG1. Different 
doses of APE1 protein, expressed in femto moles, are shown on top of the figure. Reactions 
were performed in a buffer containing 20 mM Tris-HCl, 100 mM KCl, 0.1% BSA, 0.01% 
Tween20, pH 7.4 at 37°C for 30 minutes. S indicates the substrate position while P 
indicates the product position. Moreover, at the right of the panel, a longer product of about 
12 nucleotides is indicated by an asterisk whereas a smaller one of 11 nucleotides is 
indicated by a double asterisk. (d) Histograms represent the dose response of OGG1 
glycosylase activity on ds_d8oxoG:dC and paired and mismatched ds_r8oxoG 
oligonucleotides. ds_d8oxoG oligonucleotide was used as a positive control whereas 
ds_dG:dC and ds_rG:dC oligonucleotides were used as negative controls. The activity is 
reported as percentage of substrate converted to product. Data are expressed as mean + SD 
of three independent technical replicas.  
 
Since OGG1 is the major glycosylase enzyme in the BER pathway, coordinating with the 
downstream endonuclease APE1, which is able to recognize and process the abasic site 
generated by the glycosylase activity of OGG1 [65, 139, 140], we measured its glycosylase 
activity on the same substrates using recombinant purified APE1 (Figure 3.8c). In this 
case, we co-incubated a fixed amount of recombinant OGG1 with increasing amounts of 
APE1 for 30 minutes. While OGG1 displayed a robust glycosylase activity on the 
canonical ds_d8oxoG:dC substrate, particularly in the presence of the APE1 protein, we 
detected only a weak activity on ds_r8oxoG:dC oligonucleotide (indicated by a single 
asterisk) (Figure 3.8d). Moreover, the presence of an additional higher mobility band, 
increasing as a function of APE1 concentration (indicated with a double asterisk) was 
observed only in the case of the ds_r8oxoG:dC substrate. We conclude that OGG1 has 
neither lyase nor glycosylase activity on the r8oxoG substrate, and that APE1 can weakly 
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process this substrate alone. With respect to APE1 activity, a detailed description is 
explained in the next paragraph.  
3.4.5 APE1 has a weak endo-/exo-nuclease activities on the r8oxoG-containing substrate 
depending on Mg2+ concentration and on the presence of its N-terminal domain 
Based on the above presented data, we then checked whether APE1 ‘per se’ had any 
endoribonuclease activity on ds_r8oxoG:dC substrate (Figures 3.9 and 3.10). Compared 
to the ds_dF:dC substrate, APE1 displayed a modest, though significant, processing 
activity on both ds_r8oxoG:dC and ds_r8oxoG:dA oligonucleotides, while no activity was 
observed in the case of the dG- and the d8oxoG-containing substrates (Figure 3.9a,b), as 
expected. As observed above, the appearance of an additional faster migrating cleavage 
product (indicated by a double asterisk corresponding to a 11-nt product in Figure 3.8d) 
was visible in the case of the ds_r8oxoG:dC substrate, which might be associated with a 
recently identified 3’-exonuclease activity by the protein [124]. We checked the occurrence 
of the cleavage at the expected ribonucleotide sites, by oligonucleotide sequences of 
increasing length, ranging from 10 to 16 nucleotides, as molecular markers (Figure B.6a) 
and through alkaline hydrolysis experiments (Figure B.6b). As it is visible (Figure B.6a), 
cleavage products of the ds_r8oxoG:dC oligonucleotide were of the expected size and 
comprised between 11- and 12- nucleotides and are thus compatible with endonucleolytic 
cleavage occurring only at the 5’ side of the lesion (fragment 12-nt long) and with a 3’-
exonuclease activity giving rise to the fragment of 11-nt long. In order to exclude that the 
observed cleavage product was due to the processing of a residual non-annealed 
oligonucleotide possibly present after the annealing reaction, we incubated APE1 protein 
with single stranded oligonucleotide (ss_r8oxoG) and compared the cleavage product with 
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the annealed oligonucleotide (ds_r8oxoG:dC). Comparing the result with both ss_dF and 
ds_dF:dC oligonucleotides, a product was detectable only using the double stranded 
oligonucleotides as substrates. No bands were observed using the ss_r8oxoG 
oligonucleotide (Figure B.6c) demonstrating the requirement for secondary structured 
oligonucleotide sequences for efficient enzymatic activities by APE1. In contrast, using the 
oligonucleotide containing the mismatched ds_r8oxoG:dA, most of the fragments 
produced after incision by the AP endonucleolytic activity (indicated with a single asterisk) 
were not further degraded by the exonucleolytic activity (Figure 3.9a). Therefore, these 
data demonstrate that the APE1 enzymatic activity on the r8oxoG substrate requires a 
dsDNA molecule and exonuclease activity is dependent on the paired nucleotide, possibly 
as a consequence of a different stereochemical geometry between the 8oxoG:A and the 
8oxoG:C. 
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Figure 3.9 Human APE1 shows a weak endo- and a 3’-exonuclease activities on 
r8oxoG substrate. (a) Representative denaturing polyacrylamide gel of APE1 incision on 
different duplex DNA oligonucleotides (25 nM), in which ds_dF:dC oligonucleotide was 
used as a positive control, whereas ds_dG:dC and ds_rG:dC oligonucleotides were used as 
negative controls. The doses of APE1 protein used, expressed in femto moles, are shown 
on the top of the figure. On the right side, a schematic representation of the cleavage 
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products, showing the position of the ribonucleotide (red box with R) embedded in the 
DNA oligonucleotide and the APE1 cleavage on it, producing a longer product of about 12 
nucleotides (*) and a smaller one of 11 nucleotides (**). Reactions were performed in 
APE1-buffer containing 20 mM Tris-HCl, 100 mM KCl, 0.1% BSA, 0.01% Tween20, pH 
7.4 for 30 minutes at 37°C. S indicates the substrate position while P indicates the product 
position. (b) Relative graph indicates a dose-response APE1 activity on paired and 
mismatched ds_r8oxoG:dC oligonucleotide in comparison to ds_dF:dC positive control. 
Data are expressed as mean + SD of three independent technical replicas. 
 
It has been previously demonstrated that the exonuclease activity of APE1 strictly depends 
on salt concentrations [141]. We therefore tested whether the 3’-exonuclease activity 
observed on the ds_r8oxodG:dC shared some common features (in terms of dependence 
on the ionic strength conditions) with the 3’-exonuclease activity on mispaired DNA, as 
previously described [141]. Firstly, we determined the optimal MgCl2 (Figure 4.10a) and 
KCl (Figure 4.10b) concentrations required for the 3’-exonuclease activity. Indeed, the 3’-
exonuclease activity was present up to a concentration of 2 mM MgCl2. An inhibitory effect 
was apparent at MgCl2 concentrations above 4 mM. At the same time, the 3’-exonuclease 
activity was poorly affected at KCl concentration equal to 100 mM. These results are in 
line with previous data on 3’-mispaired DNA [141] and suggest that the observed 3’-
exonuclease activity strongly depends on the electrostatic interaction of APE1 with the 
substrate during the cleavage reaction and with the role of Mg2+ ions. 
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Figure 3.10 Human APE1 activities on r8oxoG substrate depend on mono- and di-
valent cations. (a) Representative denaturing polyacrylamide gel of APE1 (5 nM) incision 
on ds_r8oxoG:dC oligonucleotide under different MgCl2 concentrations that is expressed 
in mM (top) performing a reaction long 30 minutes in APE1 buffer. S indicates the 
substrate position while P indicates the product position. Moreover, at the right of the panel, 
a longer product of about 12 nucleotides is indicated by an asterisk whereas a smaller one 
of 11 nucleotides is indicated by a double asterisk Also shown on the right is a schematic 
representation of the cleavage products, showing the position of the ribonucleotide (red 
box with R) embedded in the DNA oligonucleotide and the APE1 cleavage on it, producing 
a longer product of about 12 nucleotides (*) and a smaller one of 11 nucleotides (**). 
Relative graph shows the ratio between two products obtained as a function of MgCl2 
concentration (bottom). (b) Representative denaturing polyacrylamide gel of APE1 (5 nM) 
incision on ds_r8oxoG:dC oligonucleotide under different KCl concentrations in 
combination with two different MgCl2 concentrations, 1 mM and 10 mM (top) performing 
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a reaction long 30 minutes in a buffer containing 20 mM Tris-HCl, 0.1% BSA, 0.01% 
Tween20, pH 7.4. S indicates the substrate position, while P indicates the product position. 
Moreover, at the right of the panel, a longer product of about 12 nucleotides is indicated 
by an asterisk whereas a smaller one of 11 nucleotides is indicated by a double asterisk. 
Relative graph shows product levels in association with different salts concentrations 
(bottom). 
 
After choosing the optimal salts conditions, in which both endo- and exo- activities of 
APE1 (100 mM KCl and 1 mM MgCl2) are present, we then evaluated whether the 
enzymatic activity of APE1 on ds_r8oxoG:dC was dependent on the same catalytic site 
responsible for the endonuclease activity observed on abasic dsDNA and abasic rNMP. To 
this aim, the enzymatic activity of the E96A mutant was compared to that of the WT protein 
(Figure B.6d). These data demonstrate that the APE1 E96A mutant has a reduced 
endoribonuclease activity showing no 3’-exonuclease activity over the ds_r8oxoG:dC 
substrate. Due to the effect of salt concentration on this latter activity, we also tested the 
enzymatic activity of the APE1 NΔ33 deletion mutant (Figure B.6d). Interestingly, while 
this protein retained the endoribonuclease activity of the WT protein, its 3’-exonuclease 
activity was abolished. Moreover, treatment with APE1 inhibitor Compound #3 confirmed 
that the catalytic site responsible for the endonuclease activity is also responsible for the 
endoribonuclease activity over the r8oxoG substrate (Figure B.6e). These results show that 
APE1 has a weak, though significant, endoribonuclease activity on r8oxoG substrates with 
an additional specific 3’-exonuclease activity dependent on: i) the kind of pair: i.e. 
ds_r8oxoG:dC or ds_r8oxoG:dA; ii) salt concentrations (i.e. Mg2+); iii) the presence of the 
33 N-terminal domain. 
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 Overall, our data demonstrate that BER enzymes but not RER are involved in the 
processing of non-canonical rNMPs, such as abasic or oxidized, incorporated in DNA. 
Because the repair pathway catalyzed by APE1 towards the oxidized rG is fundamentally 
different from that of BER, since no bases are excised, we can conclude that the observed 
effect could be ascribed to an alternative damage-specific endonuclease initiated repair 
pathway, previously referred to as either alternative excision repair (AER) or nucleotide 
incision repair (NIR) (as reviewed in [142, 143]).  
3.4.6 APE1 and RNase H2 do not biochemically and functionally interact  
To support the functional independence between BER and RER, we tested whether APE1 
and RNase H2 proteins functionally interact. We tested whether this hypothesis was 
confirmed in HeLa cells transfected with siRNAs specific for APE1 and RNase H2 mRNAs 
to knock down the corresponding endogenous proteins. Whole cell extracts were prepared 
as explained in Materials and Methods section, and Western blotting analysis was used to 
check the effective protein down regulation (Figure B.7a). Then, we checked the ability 
of APE1 and RNase H2 from cell extracts to recognize the ds_r8oxoG:dC substrate. We 
performed EMSA with cell extracts from control (Scramble) and APE1-kd (siAPE1) or 
RNase H2-kd (siRNase H2) cells. As demonstrated in Figure B.7b, incubation of cell 
extract from control cells displayed a retarded band containing APE1-complex, as also 
demonstrated by supershift EMSA experiments with anti-APE1 specific antibody (B.7c,d). 
The intensity of the retarded complex was decreased upon APE1-kd (siAPE1) (Figure 
B.7b, lane 4) and upon the double APE1/RNase H2-kd (siAPE1 + siRNase H2) (lane 6) 
but not upon RNase H2 silencing alone (siRNase H2) (lane 5), confirming that APE1 is 
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involved in a protein complex able to recognize r8oxoG damage in which RNase H2 is not 
present.  
3.5 Discussion 
Increasing body of evidence supports the notion that incorporation of rNMPs in DNA is a 
frequent phenomenon, having profound detrimental effects on genome stability of both 
prokaryotes and eukaryotes [6, 38, 70, 144]. In humans, as well as in yeast and bacteria 
including Archaea, the main processing pathway responsible for repairing of these lesions 
is the RER pathway, which involves the RNase H2 enzyme [1, 145]. RNase H2 importance 
in higher organisms is testified by its essentiality for embryonic development in mouse 
[146]. Moreover, RNase H2 mutations in humans are causally linked to the onset of AGS, 
a rare autoimmune inflammatory disease [34, 147]. It can be hypothesized that among the 
many millions rNMPs that are introduced in the mammalian genome per cell cycle [27], 
not only canonical rNMPs are incorporated but also damaged rNMPs (such as abasic and 
oxidized). Indeed, like deoxyribonucleotides, rNMPs are also susceptible to oxidative 
insults [24, 148], and a significant generation of abasic sites formation has been 
demonstrated upon RNA oxidation and alkylation [149]. While the role of RNase H2-
initiated RER mechanism of DNA repair in recognizing and cleaving rNMPs embedded in 
DNA is well established [27, 44], nothing is known regarding the DNA repair pathways 
involved in the removal of damaged rNMPs.  
BER is the main mechanism coping with the repair of non-distorting single-base lesions, 
such as abasic sites and oxidized bases [64]. Interestingly, emerging literature, including 
ours, pointed to a new function of BER in RNA quality control surveillance and RNA-
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decay with the functions of SMUG1, PARP1 and APE1 in RNA processing [66, 150]. At 
present, however, there is no evidence that BER may cope with the removal of rNMPs 
from DNA. Identifying whether BER may target unmodified and/or modified rNMPs in 
DNA is important to better understanding the mechanism of genotoxicity of oxidative 
stress and the impact of BER defects in human disease, cancer mechanisms, and for the 
development of new anticancer strategies.  
In this work, we demonstrate that an abasic rNMP embedded in DNA is targeted by APE1 
of BER rather than RER in eukaryotic systems (Figure 3.11a). We have found that 
eukaryotic RNase H2 enzymes from yeast, mouse and human, and from human cell extracts 
are unable to process abasic rNMPs in DNA, whereas recombinant human APE1 is able to 
efficiently cleave this type of damage (Figures 3.2 and 3.3). APE1 processes the rAP site 
as efficiently as the canonical deoxy-abasic site as measured by kinetic data (Table 3.1). 
Data using catalytic inactive APE1 mutants (E96A) clearly demonstrate that the 
endonuclease active site of APE1 is required to perform the endoribonuclease activity on 
a ribose abasic site in dsDNA. Differently, the cleavage activity of the 33N-terminal 
truncated mutant, which does not impact the catalytic function of the enzyme but is 
involved in the release of the product upon cleavage [130], is comparable to that of wild-
type APE1. This last result demonstrates that the unstructured N-domain is dispensable for 
the enzymatic reaction on the abasic ribonucleotide site. Moreover, using HeLa nuclear 
cell extracts that were siRNA-depleted of APE1 or RNAse H2 proteins, we showed that 
the processing activity of the abasic rNMP in DNA depends only on the presence of APE1 
and not on RNase H2. These results highlight a new role of APE1 in repairing abasic 
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rNMPs embedded in DNA, demonstrating that the catalytic site of APE1 and the 
mechanism of product release is similar to that of the canonical deoxy-substrate. 
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Figure 3.11 Model for repair of oxidized rNMPs and rAP sites embedded in DNA by 
APE1. (a) 8oxo-ribonucleotides could be generated in the cellular nucleotide pool or even 
when they are already incorporated in DNA as a result of an oxidation of the sugar (1) 
and/or the base (2). After the evidence that human RNase H2 is not able to process an 
oxidized rNMP embedded in DNA, we found that APE1 shows a weak but significant 
activity on it (3). Similarly, RNase H2 does not process an abasic rNMP embedded in 
DNA, which could be generated spontaneously or by the r8oxoG processing, and again 
APE1 possesses a strong activity on this type of damage (4). Because APE1 activity on 
8oxo-ribonucleotides in DNA is low, we hypothesize that other proteins (some 
glycosylases?) may participate in their repair. (b) Structural models with the active site of 
RNase H2 and APE1 with an rNMP or an abasic rNMP. T. maritima (left) and human 
APE1 (right) is in a complex with DNA having a single rNMP or single abasic residue, 
respectively. DNA is indicated in blue, while the single rNMP and the abasic residues are 
shown in red as sticks. The arrows points towards ribose or G base or abasic sites in the 
panels. Proteins are shown in green except for three of the several regions on APE1 that 
engulf the abasic sugar which are in magenta. PDB for RNase H2 is 303-F; for APE1 as 
1DEW.  
 
Abasic rNMPs embedded in DNA may be generated by spontaneous hydrolysis or by the 
action of an unknown glycosylase on oxidized rNMPs, such as r8oxoG. Furthermore, a 
potentially significant, yet poorly characterized, source of rNMPs incorporated in DNA is 
the oxidative stress. rNMPs were shown to form during oxidative DNA damage both in 
vitro and in vivo [24]. Therefore, it is also possible that abasic and oxidized DNA is 
converted into RNA. It was estimated that spontaneous depurination occurs 1,000 times 
slower in RNA than DNA [151]. For example, the rate of depurination in DNA under 
physiological conditions is estimated to be 1 out of 100,000 purines every cell cycle. This 
rate gives 10,000 abasic sites per day in human cells [26]. Considering the remarkable 
abundance of rNMPs in DNA, which could be as many as 600,000 rNMPs in budding yeast 
genomic DNA, and therefore a factor of 250 higher in mammalian genomic DNA 
(150,000,000) [27], i.e. >300 millions in the human diploid DNA per cell cycle, it is not 
unrealistic to anticipate that cells may contain a non-negligible number of abasic rNMPs 
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in DNA, or oxidized rNMPs. Interestingly, abasic RNA results significantly more stable 
than abasic DNA, suggesting that specific enzymatic mechanisms should exist in vivo to 
cope with this harmful lesion [152]. In addition, in conditions of oxidative DNA damage, 
such as in cancer cells, the likelihood of such base modifications can increase. Moreover, 
recent studies already suggested that r8-oxoGTP is formed in vivo under oxidative stress 
conditions and may be incorporated during replication into DNA by S. pombe, M. 
smegmatis and human [118-120]. Moreover, the introduction of r8oxoG in DNA can be 
catalyzed by human DNA Pol  [120]. However, the level and function of Pol  in cells 
are highly regulated by complex signaling mechanism and interactome networks [153]. 
Therefore, the probability of r8oxoG incorporation into genomic DNA is still question 
under debate and theoretical estimation of the possible number of these incorporations 
needs experimental proves.  Being spontaneous formation of rAP sites a rare event, it is a 
key question to find activities producing rAPs following processing of oxidized rNMPs in 
DNA. In addition, a possible RER and BER involvement in removal of r8oxoG from DNA 
has been proposed in other reports [120, 154]. Work in our laboratory is ongoing along 
these lines to address these fundamental issues. Considering these observations, we focused 
our attention on which BER protein, if any, may be involved in recognition and cleavage 
of oxidized rNMPs (r8oxoG) embedded in DNA. First, we tested the RNase H2 activity on 
r8oxoG substrate and our data clearly demonstrate that RER is not involved in processing 
of oxidized rNMPs embedded in DNA (Figure 3.7). Based on these findings, we explored 
a potential role of the BER pathway. First, we showed that the human OGG1, the main 
glycosylase enzyme able to recognize and repair oxidized dG through its lyase and 
glycosylase activities, has neither a lyase nor a glycosylase activity on an oxidized rG site 
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embedded in a DNA substrate, despite its ability to efficiently bind the oxidized substrate 
(Figure 3.8), in agreement with recent findings [154]. Interestingly, we discovered that 
APE1 has a weak endoribonuclease activity on r8oxoG site embedded in a DNA substrate, 
and shows a 3’-exonuclease activity (Figures 3.9 and 3.10), similarly to the 3’-
exonuclease activity on DNA demonstrated previously [133, 135]. In line with previous 
results, the 3’-exonuclease activity of APE1 is strictly dependent on Mg2+ concentration 
and on the presence of the first 33 amino acids. The importance of the N-terminal domain 
is to be attributed to different reasons: i) it bears the majority of the positive charges of 
APE1; ii) is the target of the main post-translational modifications of the protein (i.e. 
acetylation, ubiquitination, proteolysis); iii) is involved in modulating the interaction with 
different protein partners, and finally iv) may modulate the catalytic rate, probably acting 
on the koff  of the catalytic reaction due to increased speed of product release [67, 130, 155]. 
These unexpected results, which suggest that APE1 3’-exonuclease activity strongly 
depends on the electrostatic interaction of APE1, involving its unstructured N-terminal 
domain, with the substrate [133], may be explained on the basis of the previously 
characterized ability of APE1 to process some particular structured RNA species in a 
specific manner [67].The activity of APE1 on r8oxoG embedded in DNA does not hide the 
possibility that a similar activity could be exerted on RNA molecules too. This finding 
could represent the first demonstration of an enzyme able to recognize and process oxidized 
RNA [155]. To date, RNA oxidation has been shown to exert detrimental physiological 
effects and to be a common feature in different human pathologies ranging from ageing to 
neurodegenerative and cancer diseases [156]. For instance, oxidized RNA [157] or RNA 
containing abasic sites [152] show inhibitory effects on reverse transcriptase activity, 
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whereas oxidized mRNA [158, 159] or mRNA with abasic sites [160] exhibit compromised 
translation activity as well as translation fidelity [161]. The weak endo- and 3’-exonuclease 
activities on r8oxoG- containing substrate and their dependence on Mg2+-concentrations 
and on the presence of the first N-terminal domain residues of APE1 are fully in agreement 
with the previously described nucleotide incision repair (NIR) function by APE1 on several 
oxidized substrates, such as: 5,6-dihydro-2’-deoxyuridine, 5,6-dihydrothymidine, 5-
hydroxy-2’-deoxyuridine, 5-hydroxycytosine [125-127]. Notably, the limited activity 
obtained in the experimental conditions we used (also after changing the pH conditions, 
data not shown) are in agreement with previous reports on the NIR function by APE1 on 
some particular substrates such as the αdG:dG and the 5OH-dC:dG [126]. In addition, the 
biochemical characterization through MALDI-MS and HPLC analyses we performed 
(Figure B.5a,b) may be suggestive for the existence of an equilibrium between different 
conformational species of r8oxoG dsDNA, excluding any possible bias due to contaminant 
present in the oligonucleotide used for the assays. Therefore, these findings underscore the 
importance of identifying the enzyme(s) responsible for the recognition and efficient 
processing of the r8oxoG substrate, in order to further extend our studies and our 
understanding of this hot scientific topic. 
We observed that OGG1 is unable to process the r8oxoG substrate, while being perfectly 
able to specifically bind it, similar to what recently published by Sassa et al.,[154]. At 
present, it is possible to speculate that though the base-flipping occurs, the enzymes is 
unable to hydrolyze the N-glycosidic bond and has no lyase activity maybe as a 
consequence of the steric hindrance with the 2’OH of the ribose which renders the C1’ 
unavailable for the nucleophilic attack by the catalytic site. Differently from our results, 
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Sassa et al., found no enzymatic activity by APE1. This discrepancy with our results may 
be due to the different experimental conditions for the enzymatic assays, i.e. higher Mg2+ 
concentrations and the use of a small amount of EDTA, both aspects already demonstrated 
to strongly affect the APE1 enzymatic activity on the r8oxoG substrate. A comparative 
experiment we performed (Figure B.8) was indeed supportive of this hypothesis, 
reinforcing the importance of the experimental conditions when studying the non-canonical 
functions of APE1 protein. Interestingly, Sassa et al showed that the commercially 
available prokaryotic RNase HII preserves the ability to remove an oxidized rNMP in a 
DNA duplex. Contrary to these results, our findings show that eukaryotic RNase H2 is 
completely inactive on a substrate containing an oxidized rNMP. These data suggest that 
the ability to process r8oxoG in DNA has been lost during evolution and deserves further 
studies.  
To explain why APE1 recognized the abasic rNMP in DNA and RNase H2 did not, we 
compared the model structures of DNA with an rNMP or a rAP site in the RNase H2 and 
APE1 active site, respectively (Figure 3.11b). RNase H2 recognizes the RNA-DNA 
junction with the substrate participating in catalysis. Prior to incision by RNase H2, the 
rNMP base is hydrogen bonded to the complementary DNA strand base [45]. If the rNMP 
is abasic, there is no hydrogen bonding to stabilize the complex required for RNase H2. 
Rather, an orphan base on the complementary DNA strand is present. We hypothesized 
that the lack of the hydrogen bonding between the abasic rNMP and the opposite 
deoxyribonucleotide interferes with the capacity of RNase H2 to recognize an abasic rNMP 
and cleave it. Thus, the role of recognizing and cleaving abasic rNMPs is not specific of 
RNase H2. Differently from RNase H2, APE1 specifically recognizes and cleaves an 
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abasic distortion in DNA, and basically engulfs the sugar-phosphate further distorting the 
DNA [162], as seen in Figure 3.11b. Here, we predicted that the ribose extra OH would 
have only minor influence on the structure. Therefore, this could explain why the abasic 
rNMP, like an abasic deoxyribonucleotide in DNA, was efficiently cleaved by APE1.  
Experiments are underway in order to address if other glycosylases may process oxidized 
rNMPs in order to generate abasic rNMPs, which are then efficiently processed by APE1. 
We previously demonstrated that APE1-defective cells have increased oxidized rRNA 
content upon oxidative stress [67]. This result has now a molecular explanation in the 
observed endoribonuclease activity of APE1 over r8oxoG containing oligonucleotides and 
will deserve further attention in our future studies. Regarding the formation of abasic 
ribonucleotides in DNA, this is still a matter of debate. The existence of specific N-
ribohydrolases, including the toxin ricin, has been already documented [163] to be able to 
generate abasic rNMPs in RNA molecules, besides spontaneous generation [149]. A role 
for the YB-1 protein in recognizing oxidized ribonucleotides sites in RNA has also been 
hypothesized [164], but no specific enzymatic mechanisms able to remove the oxidized 
base has been described, yet. The accumulation of the r8oxoG substrates, which occurs on 
RNA upon silencing of APE1 expression, may thus be explained under the assumption that 
enzymatic removal of oxidized rNMPs may represent the limiting step in the process. 
Besides its direct activity on r8oxoG, APE1 could be stimulated by a glycosylase activity 
allowing a faster turnover as demonstrated for DNA substrates [165]. Work is in progress 
along these lines to better inspect this mechanism and the putative glycosylase enzymes 
involved. Moreover, since APE1 is overexpressed in different types of cancer, such as 
ovarian, gastro-esophageal, pancreaticobiliary, lung and breast cancers [166, 167], it would 
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be interesting to determine whether any correlation exists between its expression level and 
presence of modified rNMPs in cancers.  
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CHAPTER 4. CAPTURE OF RIBONUCLEOTIDES IN 
YEAST GENOMIC DNA USING RIBOSE-SEQ 
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Experiments conducted in yeast cells have recently shown abundant presence of 
ribonucleotides (rNMPs) embedded both in nuclear and mitochondrial DNA. Indeed, 
rNMPs are the most frequent, non-standard nucleotides found in cellular DNA. rNMPs 
have a highly reactive 2’-hydroxyl group in the ribose sugar that gives rise to genome 
instability by altering the structure, function, and properties of DNA. In order to profile 
rNMPs embedded in yeast genomic DNA, as well as any other genomic DNA of interest, 
we developed ‘ribose-seq’. Ribose-seq utilizes Arabidopsis thaliana tRNA ligase 
(AtRNL), which enables ligation of 2’-phosphate termini of DNA molecules terminating 
with an rNMP to the 5’-phosphate end of the same DNA molecules. Thus, a unique feature 
of ribose-seq is its capacity to specifically and directly capture the rNMPs present in DNA. 
Here we describe how ribose-seq is applied to yeast Saccharomyces cerevisiae DNA to 
capture rNMPs that are incorporated in the yeast genome and build libraries of rNMP 
incorporation for high-throughput sequencing. We also provide advancements over our 
original ribose-seq protocol, which are described at the end of the Introduction section 
while the specific details are provided in the methods part of this chapter. 
4.2 Introduction 
Recent mapping of ribonucleotides (rNMPs) embedded in yeast genomic DNA to single-
nucleotide resolution has unraveled initial important aspects of rNMP incorporation in 
DNA, suggesting that rNMPs could have a profound impact on DNA metabolic functions 
[168]. Our group developed ribose-seq technique to map rNMPs in DNA and applied it to 
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determine the profile of rNMP incorporation in yeast nuclear and mitochondrial DNA [70]. 
We and others have found that rNMPs are widely distributed in the yeast genome both in 
nuclear and mitochondrial DNA; however, sites of rNMPs are not random [68-71]. Using 
yeast cells deficient for ribonuclease H2, which is the major enzyme responsible for the 
removal of rNMPs in DNA, a significant bias of rNMP incorporation was found between 
leading and lagging strand of DNA replication sites in yeast DNA. A predominant presence 
of rNMPs in the leading strands was revealed in all reports that analyzed rNMPs in budding 
or fission yeast DNA [68, 71, 169]. Moreover, rNMPs were found to have hotspots of 
incorporation in yeast nuclear and mitochondrial DNA, and abundant incorporation was 
observed at G/C rich regions in mitochondrial DNA of S. cerevisiae cells [70].  
rNMPs have been found to be the most abundant non-standard nucleotides in DNA of any 
cell type that has been analyzed so far [6]. A major source of rNMP incorporation in the 
genome is by DNA polymerases. Many DNA polymerases have been shown to incorporate 
rNMPs in DNA, including yeast replicative polymerase Pol , δ, and  [27]. The presence 
of rNMPs in DNA can have positive and negative consequences. The presence of two 
rNMPs at the mating type locus is believed to activate mating type switching in fission 
yeast [42]. In addition, due to the prevalence of rNMPs on the leading versus the lagging 
strand of DNA replication, rNMPs can act as a strand discrimination signal for eukaryotic 
mismatch repair [40, 170]. On the other hand, due to the presence of the highly reactive 2’-
hydroxyl group in the ribose sugar, rNMPs in DNA can cause genomic instability of the 
cells [2]. rNMPs have also been shown to modify the structural, and mechanical properties 
of DNA [37]. The presence of rNMPs results in increased mutation rates and chromosomal 
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abnormality [53, 171]. Moreover, accumulation of rNMPs was found to be associated with 
defects in RNase H2 in cells of Aicardi Goutieres syndrome patients [55].  
In order to better understand the significance and the consequences of rNMP incorporation 
in DNA, it is important to uncover the genomic sites of rNMPs incorporation in different 
genetic backgrounds and in cells grown in different conditions. The ribose-seq protocol is 
based on the activity of a special ligase, the tRNA ligase of Arabidopsis thaliana (AtRNL), 
which we showed to ligate 5’-phosphate end of DNA to a 2’-phosphate end of a DNA 
terminated with an rNMP [70]. Alkali denatures DNA strands, hydrolyzes RNA into 
ribonucleotides with a 2’,3’-cyclic phosphate, 3’ phosphate or 2’-phosphate end, and 
cleaves at an rNMP in DNA generating a ssDNA fragment terminated by a 2’,3’-cyclic 
phosphate, 3’ phosphate or 2’-phosphate. Upon alkali treatment, the AtRNL converts 2’,3’-
cyclic phosphate ends into a 2’-phosphate ends and attaches all terminal rNMP sites with 
a 2’-phosphate end of a DNA fragment with unknown sequence to a 5’-phospate end of a 
DNA adaptor for Illumina sequencing. By exploiting AtRNL activity, the ribose-seq 
protocol cannot capture unligated RNA primers of Okazaki fragments or any site of single 
or double-strand break in DNA, because in none of these cases the DNA displays a 2’-
phospate end upon alkali treatment [70]. Thanks to this unique feature, the ribose-seq 
technique can be applied to study and characterize the pattern of rNMP incorporation in 
practically any cell type of interest, including yeast cells of any species, ploidy, and genetic 
background. Moreover, ribose-seq can also be applied to profile rNMPs in yeast or other 
cell types that are grown in any desired conditions, that have been treated using any 
mutagen, drug, DNA damaging agent, toxicant of interest, or exposed to any chosen 
environmental factor [70].  
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Figure 4.1 Timeline of ribose-seq protocol. A yeast culture is grown in YPD liquid 
medium at 30 °C for 2 days. On day 3, genomic DNA is extracted from the yeast cells and 
fragmented by blunt-ended restriction enzymes. On day 4, ribose-seq adaptors are 
prepared, and the fragmented double-strand DNA (dsDNA) undergoes dA-tailing reaction. 
This is followed by ribose-seq adaptor ligation on day 4. On day 5, the dsDNA fragments 
ligated to the adaptors are treated with alkali. The alkali treated DNA is split in two 
samples. One sample is incubated in the presence of AtRNL (AtRNL+), the other not 
(AtRNL-). The AtRNL+ sample is then treated with T5 Exonuclease (T5 Exo+) or without 
(T5 Exo-) to degrade the unligated single-strand DNA (ssDNA). The AtRNL- sample is 
treated only with T5 exonuclease. All samples are further treated with Tpt1 to remove the 
2’ phosphate. On day 6, the Tpt1-treated samples are amplified by PCR in two rounds (PCR 
round 1 using PCR.1 and PCR.2 primers and PCR round 2 to attach the i5 and i7 indexes 
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for Illumina sequencing). After that, the PCR products are loaded onto a non-denaturing 
polyacrylamide gel (PAGE) for visualization of the ribose-seq library and gel purification 
before sequencing. From the beginning to the end, ribose-seq library preparation can be 
performed.  
 
Figure 4.1 provides a scheme of the steps and the timeline of the procedure to build ribose-
seq libraries from yeast genomic DNA. Briefly, yeast cells of the chosen strain are 
incubated in the desired conditions and are collected to reach approximately 1010 cells 
(Figure 4.2). The yeast cells are lysed to extract at least ~40 g of yeast genomic DNA, or 
more. The DNA is then fragmented using restriction enzymes to produce blunt-ended 
fragments with an average size of ~450 base pairs (bp) in length (Figure 4.2). This is 
followed by dA-tailing and ligation to a double-strand adaptor that contains a molecular 
barcode (Figure 4.2). The fragments are treated using alkali to denature the DNA strands 
and cleave rNMP sites by exposing the 2’,3’-cyclic phosphate or 2’-phosphate at the rNMP 
termini of the DNA fragments, which are recognized by AtRNL (Figure 4.3). By utilizing 
AtRNL, we ligate the 2’-phosphate ends of each rNMP-terminated single-stranded (ss) 
DNA fragment to its opposite 5’-phosphate end, thereby resulting in single-stranded 
circular DNA forms that contain the embedded rNMP next to the adaptor for Illumina 
sequencing. This is followed by degradation of the unligated ssDNA fragments using T5 
Exonuclease, and treatment with 2’-phosphotransferase Tpt1 to remove the 2’-phosphate 
at the ligation junction in the circular forms containing the rNMP (Figure 4.3). The circular 
molecules are then PCR-amplified to generate a ribose-seq library that contains the rNMPs 
and their upstream sequences (Figure 4.4). The PCR product is then loaded into a PAGE 
gel to detect the libraries together with control samples (Figure 4.5). A smear 
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corresponding to the ribose-seq library after 15 cycles of PCR 1 and 13 cycles of PCR 2 is 
seen in lane 5 of the gel image shown in Figure 4.5. No smear is seen after the same number 
of PCR cycles for the control AtRNL- sample, lane 3 in the same gel image. To reduce the 
number of PCR 1 and 2 cycles, we run 10 cycles for PCR1 and 7 cycles for PCR 2 for the 
extraction of the ribose-seq library. Because this lower number of cycles often does not 
allow detection of the ribose-seq library product on PAGE (lane 5 in Figure 4.6), we also 
perform PCR 2 with 15 cycles to visualize the ribose-seq library product if present (lane 6 
in Figure 4.6). The ribose-seq product of several reactions generated using PCR 1 with 7 
cycles and PCR 2 with 10 cycles is then loaded in multiple wells of another PAGE gel to 
extract the ribose-seq library within a size-range of 200-700 bp to exclude any primer 
dimers and long products that are not proficient sequencing (Figure 4.7). Overall, the 
ribose-seq protocol for yeast genomic DNA takes 7 days. The amplified DNA library is 
sequenced and subsequently analyzed using our Ribose-Map bioinformatics toolkit [172].   
In this protocol, we provide a detailed procedure of ribose-seq starting from extraction of 
yeast genomic DNA (gDNA) to the preparation of libraries for sequencing. We also include 
modifications to the original-described ribose-seq method [70]. (i) We redesigned the 
molecular barcode-containing adaptor by making it shorter and removing overlapping 
sequences. (ii) We cut the genome of interest in smaller fragments (~450 bp). (iii) We 
introduced two rounds of PCR and reduced the PCR cycle number. (iv) We cut and purify 
a specific size-range of the ribose-seq library from the non-denaturing gel to eliminate any 
primer dimers generated during PCR and long products that are not proficient for 
sequencing because these have low affinity to the flow cells in the Illumina sequencing 
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systems. By including these improvements, the efficiency of ribose-seq increased up to a 
factor of 1,000. 
4.3 Materials 
Prepare all solutions using RNase/DNase free water. Store all solutions and reagents at 
room temperature (unless indicated otherwise).  
4.3.1 Yeast genomic DNA extraction 
1. YPD liquid (for 1 L)–10 g of yeast extract, 20 g of bacto peptone and 20 g of 
dextrose. Autoclave at 121 °C for 20 min (See Note 1).  
2. 250 mL glass flasks.  
3. 250 mL Nalgene plastic flasks.  
4. Buffer A–Dissolve 182.2 g of sorbitol in 600 mL of water. Add 200 mL of a 
0.5 M Na2EDTA (pH 8.0) solution. Add 1 mL of B-mercaptoethanol (14.3 M). 
Finally adjust the volume to 1 L with water.  
5. Zymolyase 20T (US Biological): Add 0.05 g from 20 KU stock.       
6. RNase A. 
7. Buffer B–Dissolve 76.42 g of guanidine HCl, 11.17 g of Na2EDTA·2H2O, and 
3.63 g of Tris base in 600 mL of water. Add 250 mL of 20% Tween-20 solution 
and 50 mL of 10% Triton X-100 solution. Use NaOH to adjust the pH to 8.0 
and adjust the volume to 1 L with water.  
8. Proteinase K powder (US Biological): Prepare a stock solution of 20 mg/mL. 
 97 
9. Buffer C–Dissolve 43.83 g of NaCl and 10.46 g of MOPS in 800 mL of water. 
Use NaOH to adjust the pH to 7.0 and add 150 mL of isopropanol and 15 mL 
of 10% Triton X-100 solution. Adjust the volume to 1 L with water.  
10. Buffer D–Dissolve 58.44 g of NaCl and 10.46 g of MOPS in 800 mL of water. 
Use NaOH to adjust the pH to 7.0 and add 150 mL of isopropanol. Adjust the 
volume to 1 L with water. 
11. Buffer E–Dissolve 73.05 g of NaCl and 6.06 g of Tris base in 800 mL of water. 
Use HCl to adjust the pH to 8.5 and add 150 mL of isopropanol. Adjust the 
volume to 1 L with water.  
12. 50 mL conical tubes. 
13. QIAGEN Genomic-tip 500/G. 
14. 1.5 mL Eppendorf tubes. 
15. Isopropanol. 
16. Cold 70% ethanol.  
17. DNase/RNase-free water. 
18. Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific). 
4.3.2  Annealing of ribose-seq adaptor oligonucleotide  
1. Adaptor.L oligonucleotide (HPLC-purified, 5′-P-NNC CGN NNN NNA GAT 
CGG AAG AGC GTC GTG TAG GGA AAG AGT GTT GAT GAT AGA 
TCC GTG TCG CAA CT -3′) (Integrated DNA Technologies) (See Note 2). 
2. Adaptor.S oligonucleotide (HPLC-purified, 5′-P-GTT GCG ACA CGG ATC 
TAT CAA CAC T -Am-3′) (Integrated DNA Technologies) (See Note 2). 
3. Annealing Buffer–500 mM Tris-HCl, pH 7.5, 2.5 M NaCl, 50 mM EDTA). 
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4. illustra MicroSpin G-25 Column (GE Healthcare Life Sciences). 
4.3.3 Ribose-seq 
4.3.3.1 Fragmentation of DNA 
1. 40 g of genomic DNA. 
2. 10X NEBuffer 2 (New England Biolabs). 
3. 20 U/L DraI (New England Biolabs). 
4. 20 U/L EcoRV (New England Biolabs). 
5. 5 U/L SspI (New England Biolabs). 
6. 10 U/L AluI (New England Biolabs). 
7. PCR Purification Kit (QIAGEN). 
4.3.3.2 dA-Tailing and adaptor ligation 
1. 10 mM dATP (Sigma-Aldrich). 
2. 10X NEBuffer 2 (New England Biolabs). 
3. 5 U/L Klenow Fragment (3′→5′ exo–) (New England Biolabs). 
4. PCR Purification Kit (QIAGEN). 
5. 10X T4 DNA Ligase Reaction Buffer (New England Biolabs) 
6. 400 U/L T4 DNA Ligase (New England Biolabs). 
7. Agencourt RNAClean XP (Beckman Coulter). 
4.3.3.3 Alkali Treatment 
1. 2 M NaOH (See Note 3). 
2. 2 M HCl. 
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3. pH Litmus Paper. 
4. Agencourt RNAClean XP (Beckman Coulter). 
4.3.3.4 AtRNL-Ligation 
1. 10 M purified AtRNL protein (prepared in our laboratory). 
2. 10X AtRNL Reaction Buffer–500 mM Tris-HCl (pH 7.5), 400 mM NaCl, 50 
mM MgCl2, 10 mM DTT, and 300 µM ATP. 
3. Agencourt RNAClean XP (Beckman Coulter). 
4.3.3.5 T5-Exnuclease Degradation 
1. 10X NEBuffer 4 (New England Biolabs). 
2. 10 U/L T5 Exonuclease (New England Biolabs). 
3. Agencourt RNAClean XP (Beckman Coulter). 
4.3.3.6 Tpt1 Reaction 
1. 20 M purified Tpt1 protein (prepared in our laboratory). 
2. 10X Tpt1 Reaction Buffer–200 mM Tris-HCl (pH 7.5), 50 mM MgCl2, 1 mM 
DTT, and 4% Triton X-100. 
3. 50 mM NAD+ (Sigma-Aldrich) 
4. Agencourt RNAClean XP (Beckman Coulter). 
4.3.3.7 PCR Amplification of DNA libraries  
1. PCR.1 oligonucleotide (Desalted, 5’-GTG ACT GGA GTT CAG ACG TGT 
GCT CTT CCG ATC TTG ATA GAT CCG TGT CGC AAC-3’) (Integrated 
DNA Technologies). 
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2. PCR.2 oligonucleotide (Desalted, 5’-ACA CTC TTT CCC TAC ACG AC-3’) 
(Integrated DNA Technologies). 
3. PCR.701.Index oligonucleotide (Desalted, 5’-CAA GCA GAA GAC GGC 
ATA CGA GAT CGA GTA ATG TGA CTG GAG TTC AGA CGT GT-3’) 
(Integrated DNA Technologies) (See Note 4).  
4. PCR.501.Index oligonucleotide (Desalted, 5’-AAT GAT ACG GCG ACC 
ACC GAG ATC TAC ACT ATA GCC TAC ACT CTT TCC CTA CAC GAC-
3’) (Integrated DNA Technologies) (See Note 5).  
5. 5X Q5 Reaction Buffer (New England Biolabs). 
6. 2 U/L Q5 High-Fidelity DNA Polymerase (New England Biolabs). 
7. 10 mM dNTPs (New England Biolabs). 
4.3.3.8 PAGE Visualization 
1. Non-denaturing 6% Polyacrylamide (29:1) Mini-Gel 
2. 10X TBE Buffer. 
3. 6X Sucrose Loading Buffer – Add 0.4 g of Sucrose, 0.00025 g of Bromophenol 
blue, 0.00025 g of Xylene cyanol, and 120 μL of 500 mM EDTA (pH 8.0) and 
adjust the volume to 1 mL with water.  
4. Quick-Load 50 bp DNA Ladder (New England Biolabs).  
5. SYBR Gold Nucleic Acid Stain (Thermo Fischer Scientific). 
a. M NaCl. 
6. 3-mL Syringe.  
7. 15 mL conical tubes. 
8. 0.2-micron filter.  
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9. Razor blade. 
4.3.4 Equipment 
1. New Brunswick Incubator Shaker I. 
2. Eppendorf Centrifuge 5424. 
3. Eppendorf Centrifuge 5810. 
4. Beckman Coulter Avanti J-E Centrifuge. 
5. Water bath. 
6. Qubit 3.0 (Thermo Fischer Scientific). 
7. NanoDrop Spectrophotometer (Thermo Scientific). 
8. Applied Biosystems Thermal Cycler 2720. 
9. Mini-PROTEAN Tetra Cell (BIO-RAD). 
10. Gel Imaging System (UV-light). 
11. 2100 Bioanalyzer Instrument (Agilent). 
12. Illumina Sequencing machine. 
 
4.4 Methods  
All procedures are carried out at room temperature unless specified otherwise. 
4.4.1 Yeast genomic DNA extraction  
1. Inoculate 150 mL of YPD liquid medium with yeast strain into a 500 mL glass 
flask and shake vigorously at 30 °C for 2 days. 
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2. Transfer the culture to a 250 mL Nalgene polypropylene bottle and pellet the 
yeast cells by centrifuging at 5,000 x g at 4 °C for 5 min. Discard the 
supernatant.  
3. Resuspend the pellet in 12 mL of DNase/RNase free water by vortexing and 
proceed to pellet the cells by centrifuging at 5,000 x g at 4 °C for 10 min. 
Discard the supernatant. 
4. Resuspend the pellet in 12 mL of Buffer A by vortexing at maximum speed to 
homogenize the cells as thoroughly as possible.  
5. Transfer the resuspended cells into a 50 mL conical tube and add 0.05 g of 
zymolase and incubate at 30 °C for 1 h (see Note 6). 
6. Pellet the spheroblasts by centrifuging at 5,000 x g at 4 °C for 10 min.  
7. Resuspend the pellet in 15 mL of Buffer B with 30 μL of RNase A and mix the 
tube thoroughly.  
8. Add 400 μL of Proteinase K stock solution and incubate at 50 °C for at least 1 
h. 
9. Pellet the cell suspension by centrifuging at 5,000 x g at 4 °C for 15 min. 
Transfer the supernatant to a new 50ml conical tube. 
10. Vortex the supernatant for 10 s and apply it to an equilibrated QIAGEN 
Genomic-tip 500/G. Allow the genomic tip to empty by gravity flow (see Note 
7).  
11. Wash the tip twice with 15 mL of Buffer QC.  
12. Elute the genomic DNA by adding 15 mL of pre-warmed Buffer QF (see Note 
8).  
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13. Briefly vortex the eluted genomic DNA and distribute 750 μL into 1.5 mL 
Eppendorf tubes. Add 525 μL of isopropanol to each tube.  
14. Vortex the tubes briefly and incubate them at -80 °C for 5 min. After that, pellet 
the mixture at 15,000 rpm at 4 °C for 20 min (see Note 9).  
15. Add 200 μL of cold 70 % ethanol into the tubes. Vortex the tubes briefly and 
centrifuge at 15,000 rpm at 4 °C for 10 min.  
16. Remove the supernatant carefully by pipetting without disturbing the pellet and 
air-dry the pellets for 10 min.  
17. Resuspend the DNA pellet with 15 μL of DNase/RNase free water and incubate 
the tubes at room temperature overnight.  
18. Collect the eluted DNA into a 1.5 mL tube and measure the concentration of 
the DNA using Qubit 3.0 High-Sensitivity DNA kit (see Note 10).  
4.4.2 Preparation of ribose-seq adaptor  
1. Resuspend each oligonucleotide (oligo) of ribose-seq adaptor in DNase/RNase-
free water to a concentration of 50 M and 500 M, respectively.  
2. Set up the mixture for preparing ribose-seq adaptor as follows: 
Annealing Buffer 3 L 
50 M Adaptor.L 25 L 
500 M Adaptor.S 12.5 L 
H2O 9.5 L 
Total 50 L 
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3. Perform annealing by heating the mixture to 95–100 °C and gradually cooling 
to room temperature until the temperature drops to 30–32 °C. The annealed 
ribose-seq adaptor is at a concentration of 25 M (see Note 11). 
4. Desalt the mixture by using a spin column. In our laboratory, illustra MicroSpin 
G-25 Column is utilized. 
5. Use NanoDrop to quantify the amount of desalted double-stranded ribose-seq 
adaptor. Typically, the concentration of double-strand adaptors ranges from 10-




Figure 4.2 Scheme of the first steps of the ribose-seq protocol from the yeast culture 
to the adaptor ligation. Yeast cells are grown in 150 mL of YPD liquid medium for 2 
days. Genomic DNA is extracted on day 3. Fragmentation of genomic DNA is conducted 
overnight at 37 °C. On day 4, the fragmented DNA is dA-tailed at 37 °C for 30 min, 




4.4.3.1 Fragmentation of genomic DNA 
1. Set up 8 identical reactions of restriction enzyme digestion of genomic DNA 
as follows. In this protocol, we use AluI, DraI, EcoRV, and SspI (see Note 
12). 
10X NEBuffer 2 12 L 
Genomic DNA 5 g (x L) 
10 U/L AluI 3 L 
20 U/L DraI 3 L 
20 U/L EcoRV 3 L 
5 U/L SspI 3 L 
H2O 96-x L 
Total 120 L 
 
2. Incubate at 37 °C overnight. 
3. Purify the fragmented DNA using a spin column. In this protocol, we use the 
QIAGEN spin column from their PCR Purification Kit. Two digestion 
reactions can be purified using a single column with elution volume of 30 L 
per spin column. 
4. Use Qubit 3.0 (dsDNA HS Assay Kit) to quantify the amount of fragmented 
DNA. Typically, the concentration of the resulting DNA is ~200 ng/L, 
following the reaction conditions listed above. Approximately, 20 g of 
fragmented genomic DNA is subject for subsequent steps of the protocol. 
4.4.3.2 dA-Tailing and adaptor ligation 
1. Set up 4 dA-tailing reactions as follows: 
10X NEBuffer 2 5 L 
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10 mM dATP 1 L 
200 ng/L Fragmented DNA 
5g (x L) 




Total 50 L 
 
2. Incubate at 37 °C for 30 min and purify using QIAGEN spin column. Elute 
dA-tailed DNA with 30 L of water (see Note 13). 
3. Set up 4 sequencing adaptor-ligation reaction as follows: 
10X T4 DNA Ligase Buffer 5 L 
10 M ds-ribose-seq adaptor 5 L 
dA-tailed DNA 30 L 
400 U/L T4 DNA Ligase 5 L 
H2O 5 L 
Total 50 L 
 
4. Incubate at 15 °C overnight. 
5. Purify using Agencourt RNAClean XP with elution volume of 30 L. 
4.4.3.3 Alkali-treatment 
1. Set up 4 alkali-treatment reactions as follows: 
2 M NaOH 7.5 L 
Adaptor-ligated 30 L 
H2O 12.5 L 
Total 50 L 
 
2. Incubate at 55 °C for 2 h. 
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3. Neutralize with 2 M HCl to pH 7. Use pH Litmus Paper to check the pH. 
Typically, 7.5–8 L is needed for neutralization.  
4. Purify using Agencourt RNAClean XP with elution volume of 45 L.  
5. Heat the Alkali-treated DNA at 95 °C for 3 min to ensure complete 
denaturation of dsDNA and immediately chill on ice for 2 min. 
 
 
Figure 4.3 Scheme of the core steps of ribose-seq to capture the rNMPs embedded in 
DNA by alkali and AtRNL ligation. Adaptor ligated dsDNA is treated with 2M NaOH at 
55 °C for 2 h to denature the dsDNA and cleave 3’ to the rNMP sites. Alkali treatment 
generates 2’,3’-cyclic phosphate, 3’ phosphate or 2’-phosphate ends at each rNMP site. 
AtRNL does not recognize 3’-phosphate ends, but converts 2’,3’-cyclic phosphate ends to 
2’-phospate ends and ligates each 2’-phosphate end to its 5’-phospate end in an 
intramolecular-ligation reaction at 30 °C for 1 h. T5 exonuclease is then used to degrade 
the unligated ss linear fragments at 37 °C for 2 h. The resulting circular ssDNA fragments, 
each containing an rNMP, are treated with Tpt1 to remove the 2’-phosphate. Tpt1 reaction 
is carried out at 30 °C for 1 h.  All of these reactions are performed in a single day (see 
Figure 4.1).  
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4.4.3.4 Self-ligation (circularization) of 2’-phosphate terminal of rNMP to 5’-phosphate 
of the DNA by AtRNL 
1. Set up 4 reactions, one without AtRNL (AtRNL–) and 3 with (AtRNL+), as 
follows: 
 [AtRNL–] 
10X AtRNL Reaction Buffer 2 L 
Alkali-treated DNA 6.3 L 
H2O 11.7 L 
Total 20 L 
 [AtRNL+] 
10X AtRNL Reaction Buffer 2 L 
Alkali-treated DNA 12.6 L 
10 M AtRNL 2 L 
H2O 3.4 L 
Total 20 L 
 
2. Incubate at 30 °C for 1 h. 
3. Purify using Agencourt RNAClean XP and elute with 30 L for AtRNL- reaction 
and with 20 L each for AtRNL+. 
4.4.3.5 Removal of linear ssDNA 
1. Set up 4 reactions, one without T5 Exonuclease (AtRNL+ T5Exo–) and one 
with T5 Exonuclease (AtRNL– T5Exo+) and 2 with T5 Exonuclease and 




10X NEBuffer 4 5 L 
AtRNL– DNA 30 L 
10U/L T5 Exonuclease 5 L 
H2O 10 L 
Total 50 L 
[AtRNL+ T5Exo–] 
10X NEBuffer 4 5 L 
AtRNL+ DNA 20 L 
H2O 25 L 
Total 50 L 
[AtRNL+ T5Exo+] 
10X NEBuffer 4 5 L 
AtRNL+ DNA 20 L 
10U/L T5 Exonuclease 5 L 
H2O 20 L 
Total 50 L 
 
2. In order to maximize the amount of DNA that is available for a ribose-seq 
library, AtRNL– T5Exo– sample is omitted.   
3. Incubate at 37 °C for 2 h. 




4.4.3.6 Removal of 2’-phosphate 
1. Set up 4 reactions with Tpt1, one for AtRNL– T5Exo+, one for AtRNL+ 
T5Exo–, and 4 for AtRNL+ T5Exo+ products, as follows: 
 [Tpt1+] 
10X Tpt1 Reaction Buffer 4 L 
50 mM NAD+ 8 L 
DNA 26 L 
20 M Tpt1 2 L 
H2O 10 L 
Total 40 L 
 
2. Final reaction concentration of Tpt1 is 1 M. DNA indicates either AtRNL– 
T5Exo+, AtRNL+ T5Exo–, or AtRNL+ T5Exo+ product. 
3. Incubate at 30 °C for 1 h. 













Figure 4.4 PCR reactions of ribose-seq. PCR amplification of circular ss products each 
containing an rNMP is performed by using two rounds of PCR. PCR round 1 is performed 
to amplify the ribose-library and to introduce the sequences of Illumina TruSeq index 
primers, and PCR round 2 is performed to attach specific TruSeq indexes i7 and i5. 
 
4.4.4.1 PCR 1 
1. Set up first PCR round 1 to amplify and introduce the sequences of Illumina 
TruSeq Index primers. To run 4 PCR reactions, one without template DNA 
(Primers only) and three with template DNA (AtRNL– T5Exo+ Tpt1+, 
AtRNL+ T5Exo– Tpt1+, or AtRNL+ T5Exo+ Tpt1+ products, as follows: 
[Primers-only] 
5X Q5 Reaction Buffer 10 L 
10 mM dNTPs 1 L 
10 M PCR.1 2.5 L 
10 M PCR.2 2.5 L 
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Q5-HF DNA Polymerase 0.5 L 
H2O 33.5 L 
Total 50 L 
 [Template+] 
5X Q5 Reaction Buffer 10 L 
10 mM dNTPs 1 L 
10 M PCR.1 2.5 L 
10 M PCR.2 2.5 L 
Template DNA x L 
Q5-HF DNA Polymerase 0.5 L 
H2O 33.5-x L 
Total 50 L 
 
2. Template DNA indicates either AtRNL– T5Exo+ Tpt1+, AtRNL+ T5Exo– 
Tpt1+, or AtRNL+ T5Exo+ Tpt1+ products and use 15 L, 5 L, and 30 L 
respectively.  
3. Run PCR with the following settings: 
Cycle Step Temperature Time Cycles 












Final Extension 72 °C 2 min 1 




4.4.4.2 PCR 2 
1. PCR round 2 is performed to attach specific Illumina TruSeq indexes i7 and i5 
(see Note 14). Set up 4 PCR reactions, one for each corresponding template 
DNA from the previous PCR reaction.   
5X Q5 Reaction Buffer 10 L 
10 mM dNTPs 1 L 
10 M PCR.3 2.5 L 
10 M PCR.4 2.5 L 
Template DNA x L 
Q5-HF DNA Polymerase 0.5 L 
H2O 33.5-x L 
Total 50 L 
 
2. Template DNA indicates either primers only, AtRNL– T5Exo+ Tpt1+, 
AtRNL– T5Exo+ Tpt1+, or AtRNL+ T5Exo+ Tpt1+ product from the previous 
PCR reactions and only 5 L for each reaction. 
3. Run PCR with the following settings: 
Cycle Step Temperature Time Cycles 












Final Extension 72 °C 2 min 1 





1. Prepare loading samples, as follows: 
[DNA Ladder] 
6X Sucrose Loading Buffer 2 L 
Quick-Load 50 bp DNA Ladder 2 L 
H2O 8 L 
Total 12 L 
 [PCR Products] 
6X Sucrose Loading Buffer 2 L 
PCR Product 10 L 
Total 12 L 
 
2. The samples are loaded on 6% Non-denaturing polyacrylamide gel with Quick-
Load 50 bp DNA Ladder (New England Biolabs) as the ladder. 
3. Stain the gel in 1X SYBR Gold for 40-45 min. 
4. Visualize under UV light.  
5. An exemplary gel image is shown in Fig. 5. AtRNL+ T5Exo+ Tpt1+ sample will 
be library, while Primers-only; AtRNL– T5Exo+ Tpt1+, and AtRNL+ T5Exo– 
Tpt1+ samples will be the controls.  
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Figure 4.5 An example of ribose-seq library from yeast genomic DNA of S. cerevisiae 
cells. (Left) PCR products were analyzed by PAGE. Lane 1, 100 bp DNA Ladder; lane 2: 
control with PCR primers only (P); lane 3: control sample AtRNL-, T5 Exo+ and Tpt1+; 
lane 4: control sample AtRNL+, T5 Exo- and Tpt1+; lane 5: sample of ribose-seq library 
AtRNL+, T5 Exo+ and Tpt1+. PCR cycle numbers for PCR round 1 and PCR round 2 are 
as indicated at the bottom of the gel image. The smear seen in lane 5 shows the presence 
of ribose-seq library. (Right) PCR products are analyzed by PAGE. Lane 1, Quick-Load 
50 bp DNA Ladder; lane 2: control with PCR primers only (P); lane 3: control sample 
AtRNL-, T5 Exo+ and Tpt1+; lane 4: control sample AtRNL+, T5 Exo- and Tpt1+; lane 
5: sample of ribose-seq library AtRNL+, T5 Exo+ and Tpt1+ performed with low PCR 
cycles; lane 6: sample ribose-seq library AtRNL+, T5 Exo+ and Tpt1+ performed with 
high PCR cycles to confirm the presence of ribose-seq library. PCR cycle numbers for PCR 
round 1 and PCR round 2 are as indicated at the bottom of the gel image. The smear seen 





4.4.6 Size selection and gel purification 
1. Perform multiple PCR reactions with the template DNA (AtRNL+ T5Exo– 
Tpt1+) to obtain sufficient ribose-seq library and load them on a non-denaturing 
polyacrylamide gel. 
2. Use a sterile razor blade to cut out a slice of gel from all of the lanes 
corresponding to 200-700 bp. Transfer the gel piece into a 3-mL syringe to 
break down into smaller pieces in a 15 mL conical tube. 
3. Add 3 mL of 0.1 M NaCl solution into the 15 mL conical tube and place it onto 
a rotator to incubate at 4 C overnight. 
4. Filter the gel-submerged NaCl solution using a syringe with a 0.2-micron filter 
and perform ethanol precipitation.  




                       
Figure 4.6 Size selection and gel purification of a yeast ribose-seq library before 
sequencing. Lane 1: Quick-Load 50 bp DNA Ladder; lanes 2-9: multiple samples of PCR 
round 2 with 7 cycles are run on a polyacrylamide gel for size selection and gel purification 
of a yeast ribose-seq library. DNA fragments between 200 bp and 700 bp are chosen (P: 
Primers-only, black-boxed region: selected area to be cut to extract and purify the ribose-
seq library of interest).  
 
4.5 Notes 
1. Other yeast media and growth conditions can also be used, as far as the culture 
contains ~ 1010 cells. We typically obtain about 150-300 μg of genomic DNA, 
although ~40 is μg needed. 
2. “L” and “S” stand for “Long” and “Short”, respectively. “N” represents 
nucleotides of any base (A, C, G or T), as part of a random sequence.  
3. Always use freshly prepared 2 M NaOH solution.  
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4. Bold letters indicate the specific index. In this example, we use TruSeq CD Index 
701. 
5. Bold letters indicate the specific index. In this example, we use TruSeq CD Index 
501. 
6. The amount of Zymolase can change depending on the volume of cell culture. 
Zymolase breaks down the cell wall to result in spheroblasts. 
7. Equilibrate the Qiagen Genomic-tip 500/G with 10 mL of Buffer QBT before 
use. Vortex the supernatant before adding to the tip column. Additionally, pre-
warm Buffer QF to 50 °C. 
8. Pre-warmed Buffer QF can increase the yield of genomic DNA extraction. 
9. The tubes are incubated at -80 °C to ensure effective precipitation. 
10. In our laboratory, we typically obtain about 150-300 μg of genomic DNA. 
11. 5-fold excess amount of Adaptor.S is added to ensure that all of the Adaptor.L 
molecules are annealed to Adaptor.S. The remaining single-stranded Adaptor.S 
molecules are removed in the subsequent purification step. 
12. Genomic DNA could be digested with a different set of restriction endonucleases 
that create blunt-ended fragments. Select those whose sites are well distributed 
in the genome and whose digestion results in fragments smaller than 
approximately 450 bp. In addition, it is recommended to use at least two sets of 
restriction enzymes to build two independent ribose-seq libraries for the same 
DNA samples to ensure that results obtained are independent from the restriction 
enzymes used. 
 119 
13. Use a QIAGEN spin column for each reaction not to exceed the maximum 
binding capacity of the column. 
14. In our example, we use TruSeq Indexes D701 and D501 to prepare the library. 
Alternatively, other Illumina TruSeq Indexes could be used.  
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5.1 Summary  
The cellular pools of ribonucleotides (rNTPs) are much higher than deoxyribonucleotides 
(dNTPs). Ribonucleoside monophosphates (rNMPs) are incorporated during DNA 
replication and repair of DNA damage. The presence of a highly reactive 2’-hydroxyl 
group in the ribose sugar alters the DNA properties, structure and function, thereby leading 
to genomic instability. We developed a technique called ribose-seq, described in Chapter 
2, which enables us to make libraries of rNMP sites by directly capturing the rNMPs 
embedded in DNA. We modified our original method to improve the efficiency of ribose-
seq technique over a factor of 1,000. In addition to mapping rNMPs in RNase H2 defective 
cells, we can now capture rNMPs in wild type (WT) RNase H cells. Overall, through 
multiple analyses, we found differences in the genomic composition of rNMPs in WT and 
RNase H mutant cells. At the site of incorporation, rCs and rGs were incorporated more 
frequently than expected, and low incorporation of rAs and particularly rUs were observed. 
Additionally, we have also obtained rNMP spectra in an RNase H2 mutant that lacks the 
interaction domain with the proliferation cell nuclear antigen (PCNA), and in a mutant, 
that impairs RNase H2 function at single rNMPs in DNA but not at long RNA-DNA 
hybrids. We found that removal of rNMPs in yeast does not require binding to PCNA, and 
rNMPs are primarily present as single nucleotides. From ribose-seq analysis of different 
strains of S. cerevisiae, and different yeast species including S. paradoxus and S. pombe, 
we found that presence or absence of RNase H2 does not affect the pattern of rNMP 
incorporation in yeast mitochondrial genome, whereas it impacted the rNMP profile in the 
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nuclear genome of these yeast species. Shown here are specific frequencies of rNMPs and 
a few examples of hotspots of rNMP incorporation in mitochondrial and nuclear genomes 
of WT and RNase H2 mutant cells. 
5.2 Introduction 
Modifications of nucleotides in DNA pose a major threat to the genomic integrity of the 
cells. rNMPs are considered to be the most common type of DNA lesion [6]. There are 
several sources of rNMP incorporation in the genome: (i) many DNA polymerases can 
incorporate rNMPs into genomic DNA, including human replicative DNA polymerase 
Pol δ [18], human mitochondrial Pol γ [75], yeast replicative Pol α, β and ε [12], and E. 
coli Pol V [16], (ii) incomplete elimination of RNA primers during Okazaki fragment 
maturation, and (iii) oxidative damage of deoxyribose resulting in formation of  rNMPs 
[24]. So far, there are two known positive effects of rNMPs in DNA. The presence of 
two rNMPs in the mating type locus stalls the leading strand synthesis and helps initiate 
the replication-coupled recombination event, thus leading to mating type switching in 
S. pombe [42]. Secondly, the presence of rNMPs in DNA act as strand discrimination 
signals during lagging-strand synthesis by evoking a mismatch repair [170]. A lot is 
known about the negative consequences of rNMPs in DNA. The presence of rNMPs 
in DNA is deleterious as it leads to breaks, mutations and genome instability [68-71]. 
rNMPs embedded in DNA can alter its structural and mechanical properties [37].  
rNMPs are efficiently removed from DNA by ribonucleotide excision repair (RER) 
[1]. RNase H2 of RER can cleave single and longer stretches of rNMPs in DNA. 
RNase H1 can target stretches of rNMPs in DNA containing four or more rNMPs. 
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Deletion of RNases H results in accumulation of rNMPs in yeast cells, and does not 
affect the survivability of cells, but deletion of either RNase H1 or H2 in mice is 
embryonic lethal.  RNase H2-null murine embryonic fibroblasts (MEFs) activate a 
p53-dependent damage response [53]. In humans, hypomorphic mutations in any of 
the three subunits of RNase H2 are associated with the neurological syndrome of 
Aicardi- Goutieres (AGS) [54, 112].  
Given the importance of RNase H2 in maintaining genome stability and its role in actively 
removing rNMPs, it is important to determine the location, identity and distribution of 
rNMPs in genomic DNA. Currently, there are four methods that can be used to map of 
rNMPs in DNA [68-71]. Among the four methods, ribose-seq, a technique that our lab 
developed in 2015 (discussed in Chapter 2), is the only method that can directly capture 
the rNMPs embedded in DNA, whereas the other methods locate nucleotides upstream or 
downstream of rNMP sites. Additionally, ribose-seq is specific to directly capturing 
rNMPs embedded in DNA and does not capture unprocessed Okazaki fragments, RNA 
primers, nicks or abasic sites in DNA.  
Since then, a few studies have tried to understand the rNMP profile in genomic DNA. In 
order to understand if the changes in the levels of dNTPs affect frequency of rNMPs 
incorporated, Wanrooij et al. 2017 altered the ratio of dNTP/rNTP levels and observed an 
inverse relationship between the concentration of individual dNTPs and the amount of the 
corresponding rNMPs in mitochondria DNA, whereas in nuclear DNA the rNMP 
incorporation was only affected in the absence of RER [173]. Also, in the same study, they 
showed that the overall cellular dNTP pool dictates the relative frequencies of rNMPs 
embedded in mitochondrial DNA and are not affected by the presence or absence of RNase 
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H2. In human mitochondrial cells, it was shown that rNMPs were used as building blocks 
to maintain DNA replication when dNTP pools were limiting [174]. Despite these studies, 
a comprehensive genome wide mapping of rNMPs in nuclear and mitochondria of RER-
proficient (active RNase H2) and RER-deficient cells is still missing.   
In Chapter 4, we describe modifications made to the ribose-seq technique to capture the 
rNMPs more efficiently. Using the modified ribose-seq, we not only mapped rNMPs in 
RNase H2-null cells but also generated a profile of rNMPs in RNase H2 wild type (WT) 
cells. Using our ribose-seq analysis, we determined the spectrum of rNMPs in different 
yeast strains, and obtained the spectrum of rNMP incorporation in these cells. Additionally, 
we utilized several RNase H2-defective strains to compare the rNMP incorporation pattern 
between each other, and also compared these spectra with that obtained from WT RNase 
H cells. We observed that the rNMP incorporation pattern of the mitochondrial DNA 
genome is similar both in WT and RNase H-defective cells, thereby providing evidence 
that support absence of RNase H2 activity on rNMPs in mtDNA. Finally, we also compared 
the rNMP distribution in S. cerevisiae, S. paradoxus and S. pombe.  All these results are 
helpful to better understanding the profile of rNMPs in genomic DNA.  
5.3 Materials and methods  
5.3.1 Construction of yeast strains 
All the yeast strains used in this study are presented in Table C.1. We used haploid 
Saccharomyces cerevisiae strains from different background: E134, BY4742, and YFP17. 
In addition to S. cerevisiae, we also used Saccharomyces paradoxus (DG2204), and 
Schizosaccharomyces pombe (JZ105). All RNH201 deletion strains were made by 
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replacing RNH201 via transformation with a PCR product containing hygMX4 or kanMX4 
cassette flanked by 50 nucleotides of sequence homologous to regions upstream and 
downstream of RNH201 ORF. KK-172 was made from KK-44 by replacement of RNH1 
with the kanMX4 cassette. Yeast strains SB-285 and SB-286 were derived from KK-44 by 
using the delitto perfetto method [175] and then by popping out the CORE cassette by a 
pair of oligonucleotides, 202PIP.F and 202PIP.R to mutate the proliferating cell nuclear 
antigen (PCNA) interacting peptide box, which is present in Rnh202 to make rnh202-
FF346,347AA[44, 132].  SB-311 was derived from KK-2 by using the delitto perfetto 
[175] method to generate rnh201-P45D and rnh201-Y219A by using oligonucleotides, 
RNH P45D.60 and RNH Y219A.60 to result in a RNase H2 ribonucleotide excision 
defective (RED) [132] mutant. All mutations were confirmed by sequence analysis of PCR 
products obtained from amplification of a DNA region surrounding the specific mutation. 
5.3.2 Ribose-seq library preparation 
Ribose-seq libraries were prepared as previously described with some modifications 
(REF). Specifically, 40 g of yeast genomic DNA were fragmented using restriction 
enzymes to produce blunt-ended fragments with an average size of 450 base pairs (bp) in 
length. Multiple sets of restriction enzymes were used for different library preparation, as 
shown in Table C.2. The different combinations used were (i) RsaI and HaeIII, (ii) DraI, 
EcoRV and SspI and (iii) DraI, EcoRV, SspI and AluI. Following restriction digestion, the 
fragmented DNA was purified by spin column (Qiagen). The fragments were tailed with 
dATP (Sigma-Aldrich) by using exo- Klenow fragment (NEB) for 30 min at 37 °C and 
purified by using spin column. Following dA-tailing and purification, the DNA fragments 
were annealed with a double-stranded adaptor (Adaptor.L1 or Adaptor.L2 with Adaptor.S, 
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Table C.3) by using T4 DNA ligase (NEB) incubating overnight at 15 °C. Following 
overnight ligation, the products were purified using AMPure XP beads (Beckman Coulter). 
The annealed fragments were treated with 0.2 M NaOH for 2 h at 55 °C to denature the 
DNA strands, and to cleave at the rNMP sites resulting in 2’-3’-cyclic phosphate and 2’-
phosphate termini. This is followed with neutralization using 0.2 M HCl and purification 
using AMPure beads. All the successive purification steps were performed using AMPure 
XP Beads.  The single-strand (ss) DNA fragments were incubated with 1 M Arabidopsis 
thaliana tRNA ligase (AtRNL), 50 mM Tris-HCl pH 7.5, 40 mM NaCl, 5 mM MgCl2, 1 
mM DTT and 30 M ATP for 1 h at 30 °C, followed by purification. AtRNL aids in ligating 
the 2’-phosphate ends of rNMP-terminated ssDNA fragment to its opposite 5’-phosphate 
end, which results in a single-circular DNA. The fragments were then treated with T5 
Exonuclease (NEB) for 1 h 30 min at 37 °C to degrade the unligated ssDNA fragments. 
After purification, the circular fragments were incubated with 1 M 2’-phosphotransferase 
(Tpt1), 20 mM Tris-Hcl pH 7.5, 5 mM MgCl2, 0.1 mM DTT, 0.4% Triton X-100 and 10 
mM NAD+ for 1 h at 30 °C to remove the 2’-phosphate present at the ligation junction. 
After Tpt1 treatment and purification, the circular fragments were PCR-amplified using 
two rounds of amplifications to result in ribose-seq library.   
A first round of PCR was performed to amplify and introduce the sequences of Illumina 
TruSeq Index primers. The primers (PCR.1 and PCR.2) used for the first round were the 
same for all libraries.  A second round of PCR was performed to attach specific indexes i7 
and i5 for each library. The sequences of PCR primers and indexes can be found in Table 
C.3. PCR rounds 1 and 2 were performed using Q5-High Fidelity polymerase (NEB) for 
10 and 7 cycles respectively (unless specified otherwise). Following the PCR cycles, the 
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ribose-seq library was loaded on a 6% non-denaturing polyacrylamide gel and stained 
using 1X SYBR Gold (Life Technologies) for 40-45 min. Fragments between 200-700 bp 
were cut and gel purified using the crush and soak method [176]. The resulting ribose-seq 
libraries were mixed at equimolar concentrations and normalized to 1.5 nM. The libraries 
were sequenced on an Illumina MiniSeq in the Molecular Evolution Core Facility at 
Georgia Tech.  
5.3.3 Processing and alignment of sequencing reads.  
The sequencing reads consist of an eight-nucleotide UMI, a three-nucleotide molecular 
barcode, the tagged nucleotide (the nucleotide tagged during ribose-seq from which the 
position of the embedded rNMP is determined), and the sequence directly downstream 
from the tagged nucleotide. The embedded rNMP and the sequence upstream from the 
rNMP is the reverse complement of the tagged nucleotide and the tagged nucleotide’s 
downstream sequence, respectively. The UMI corresponds to cycles 1-6 and 10-11, the 
molecular barcode corresponds to cycles 7-9, the tagged nucleotide corresponds to cycle 
12, and the tagged nucleotide’s downstream sequence corresponds to cycles 13+ of the raw 
FASTQ sequences. 
Before aligning the sequencing reads to the reference genome, the reads were trimmed 
based on sequencing quality and custom ribose-seq adaptor sequence using cutadapt 1.16 
(-q 15 -a ‘AGTTGCGACACGGATCTCTCA’) [177]. In addition, reads shorter than 62 
bases after trimming were discarded. Following quality control, the Alignment and 
Coordinate Modules of the Ribose-Map toolkit were used to process and analyze the 
sequencing data [172]. First, the Alignment Module filtered the trimmed reads by the 
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corresponding molecular barcode, aligned the filtered reads to the reference genome 
(sacCer2), and de-duplicated the aligned reads based on their UMI and aligned positions. 
Next, the Coordinate Module used the alignment results to determine the chromosomal 
coordinates of the embedded rNMPs and per nucleotide coverage of the embedded rNMPs. 
To allow comparison between sequencing libraries of different read depth, the per 
nucleotide coverage was calculated by normalizing rNMP counts to counts per hundred.  
5.3.4 rNMP composition in the genome  
The fasta files generated from sequencing the ribose-seq libraries are extracted using 
bedtool getfasta (bedtools v2.27.0). Each rNMP is counted separately, then divided by the 
total number of rNMPs incorporated in that corresponding library to obtain the rNMP 
percentage.  
5.3.5 DNA sequence context of embedded rNMPs 
Using the Sequence Module of Ribose-Map, the frequencies of the nucleotides at the sites 
of embedded rNMPs and 100 nucleotides upstream and downstream from those sites were 
calculated for both the nuclear and mitochondrial genomes. The nucleotide frequencies 
were then normalized to the frequencies of the corresponding region of the sacCer2 
reference genome. 
5.3.6 Data presentations 
Graphs and plots were made using GraphPad Prism 5 (GraphPad Software).  
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5.4 Results  
5.4.1 rNMP incorporation in WT vs RNase H2-null cells of S. cerevisiae   
After performing the modified ribose-seq on WT and rnh201 cells, sequencing and 
analyzing the data, we first examined the absolute frequencies of rNMPs in the genome, 
and observed a noticeable difference in the rNMPs embedded in nuclear and mitochondria 
DNA. The absolute composition of genomic rNMPs were also different between WT and 
rnh201 cells (Table 5.1).  
Table 5.1 Absolute rNMP composition in the genomic DNA of WT and rnh201  cells.  
 WT rnh201 
 nDNA mtDNA nDNA mtDNA 
rA 26.75% 27.88% 21.14% 33.86% 
rC 29.79% 24.60% 46.58% 34.89% 
rG 11.07% 31.89% 24.99% 27.52% 
rU 32.39% 15.63% 7.29% 3.73% 
Shown in the table are the percentages of each rNMP quantified from ribose-seq libraries 
of WT (FS106) and rnh201 (FS138) of S. cerevisiae (BY4742 background). nDNA and 
mtDNA stand for nuclear DNA and mitochondrial DNA, respectively.    
 
On normalizing the rNMP frequencies by the base composition of dNMPs of sacCer2 
genome (Table 5.2), we observed a variation in relative frequencies of rNMPs in 
mitochondria DNA and nuclear DNA. In WT cells, rCMP levels are higher in nuclear 
DNA, whereas rGMP was highest in mitochondria DNA, followed by rCMP (Figure 5.1). 
In rnh201, rC is most abundant, followed by rG and rA, and rU is the least incorporated 
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in nuclear DNA of rnh201 cells. On comparing rNMP frequencies in mitochondrial DNA 
between WT and rnh201, there is a slight increase in rC and rA, slight decrease in rG but 
very low incorporation of rU in mitochondrial DNA of rnh201 cells (Figure 5.1).  
Table 5.2 Base composition of genomic DNA in S. cerevisiae, S. paradoxus, and S. 
pombe. 
 S. cerevisiae  S. paradoxus S. pombe 
 Nuclear Mitochondria Nuclear Mitochondria Nuclear Mitochondria 
A 30.85% 41.45% 30.81% 42.35% 31.97% 34.96% 
C 19.15% 8.55% 19.19% 7.65% 18.03% 15.04% 
G 19.15% 8.55% 19.19% 7.65% 18.03% 15.04% 
T 30.85% 41.45% 30.81% 42.35% 31.97% 34.96% 
Shown above are the individual percentages of dNMPs (A, C, G and T) in nuclear and 
mitochondria genome of S. cerevisiae (sacCer2), S. paradoxus (NCBI database), and S. 





Figure 5.1 Normalized ratios of rNMP frequency in genome of S. cerevisiae. The 
observed frequencies of rNMPs from Table 5.2 were divided by the expected frequencies 
of each base in nuclear DNA (nDNA) and mitochondrial DNA (mtDNA) of sacCer2 
genome (Table 5.1). Shown here are bar graphs representing mean with standard deviation 
for WT (n=7) and rnh201 (n=10).  
 
Next, we studied the DNA sequence context at the site of rNMP embedded in DNA. This 
helps us to identify specific sites of rNMP incorporation and to characterize the 
surrounding DNA sequence context (100 nucleotides upstream and downstream) (Figure 
5.2). On comparing the plots generated from WT and rnh201 ribose-seq libraries, we 
observe the following: (i) a difference in spectrum of rNMP in nuclear genome between 
WT and rnh201. There is no bias toward a specific rNMP in the nuclear DNA of WT as 
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the frequencies of nucleotides are similar to the background frequencies. In contrast, we 
observe rCMP and rUMP as most and least frequently incorporated rNMP, respectively, in 
the nuclear DNA of rnh201 cells.  
 
Figure 5.2 Identity and sequence context of rNMP incorporation in genomic DNA of 
S. cerevisiae. Shown here are the normalized nucleotide frequencies relative to mapped 
positions of sequences from ribose-seq library of WT (left side two columns) and rnh201 
(right side two columns). Position 0 is the rNMP. + and – nucleotides are downstream and 
upstream dNMPs, respectively. Zoom-out and zoom-in of nucleotide frequencies are 
shown in the top and bottom row, respectively. S. cerevisiae strain used were KK-2 (WT, 
BY4742) and SB-285 (rnh201).      
 
(ii) Similar rNMP incorporation pattern in mitochondrial genome of WT and rnh201, 
indicating that RNase H2 does not have a marked role in removing rNMPs in mitochondrial 
DNA. This is consistent with a recent study that demonstrated that yeast mitochondria lack 
an efficient mechanism (RER) for removing rNMPs that are misincorporated by 
mitochondrial polymerase during replication [173, 174]. (iii) Although, mitochondria 
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being rich in A+T content (82.9%), the site of rNMP incorporation was within or 
downstream of G+C rich regions (Figure 5.2). The vast majority of G and C nucleotides, 
despite being only 17.1%, in the mitochondrial genome of S. cerevisiae, are clustered 
together [178]. It could be possible that these rNMPs in the G+C rich regions can help 
trigger DNA recombination, which can in turn initiate DNA replication in mitochondria of 
yeast [102].  
Comparing the overall rNMP frequencies in nuclear DNA of WT and rnh201, we noticed 
an increase in rCMP and rGMP frequencies in rnh201 cells, and a strong decrease in 
frequency of rUMP (Table 5.1, Figures 5.1 and 5.2). Despite the difference in absolute 
percentages of rG, rC and rA in mitochondria DNA (Table 5.1), we found that rCs and rGs 
were incorporated more frequently than expected, hence at the site of rNMP incorporation 
we found higher frequency of rC or rG incorporation than of rA (Figure 5.2). rUMPs were 
found to be the least incorporated in nuclear and mitochondrial genome. We previously 
showed that rUMPs are not removed by uracil-N-glycosylase 1 (UNG1), as shown in 
Chapter 1. Low frequency of rUMP in genomic DNA may be due to the high concentrations 
of dTTPs in the nucleotide pool. dCTP and dGTP are the least abundant dNTPs, therefore 
they might be depleted faster than dTTP and dATP, thereby lowering the incorporation rate 
of rUMP [18].   
5.4.2 Fragmentation of genomic DNA using different sets of restriction enzymes 
A crucial step in the preparation of a ribose-seq library is the fragmentation of genomic 
DNA using blunt-ended restriction enzymes. To test if the restriction enzymes used 
resulted in any bias to the rNMP incorporation, we used three different sets of restriction 
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enzymes (Table C.2). Comparing rNMP incorporation in rnh201 cells when fragmented 
using different restriction enzymes: DraI + EcoRV + SspI, RsaI + HaeIII, or DraI + EcoRV 
+ SspI + AluI, we observed no major differences in the spectrum of rNMPs in both nuclear 
and mitochondrial genome (Figure 5.3). On using RsaI + HaeIII, we saw a slight variation 
in mitochondria plots. This is likely due to the sequence recognition of HaeIII and RsaII as 
compared to the other sets, but the overall pattern of rNMP incorporation stayed the same. 
Additionally, we analyzed four independent libraries for rnh201 strains and found that 
replicate libraries yielded similar results (Figure C.1).  
 
Figure 5.3 Identity and sequence context of rNMP incorporation in S. cerevisiae 
rnh201 genome when using different restriction enzymes for fragmentation of 
genomic DNA. Shown here are normalized nucleotide frequencies relative to mapped 
positions of sequences from ribose-seq library rnh201. Position 0 is the rNMP. + and – 
nucleotides are downstream and upstream dNMPs, respectively. Zoom-out and zoom-in of 




5.4.3 Comparing rNMP incorporation in different S. cerevisiae background 
To examine if the rNMP incorporation that we observed were consistent in different S. 
cerevisiae strains, we prepared ribose-seq libraries from additional S. cerevisiae strains. 
Shown in Figure 5.4 and 5.5 are rNMP incorporation pattern obtained from YFP17 and 
E134. The pattern of rNMP incorporation from these backgrounds were similar to that 
observed when using BY4742 strain (Figure 5.2), both WT and rnh201 cells. After 
normalization of of rNMP frequencies by the base composition, we observed that rC and 
rG were frequently incorporated, while rA and particularly rU were the least incorporated 
rNMP (Figures 5.4 and 5.5).  
 
Figure 5.4 Identity and sequence context of rNMP incorporation in S. cerevisiae 
YFP17 genome. Shown here are normalized nucleotide frequencies relative to mapped 
positions of sequences from ribose-seq library of WT (left side two columns) and rnh201 
(right side two columns). Position 0 is the rNMP. + and – nucleotides are downstream and 
upstream dNMPs, respectively. Zoom-out and zoom-in of nucleotide frequencies are 




Figure 5.5 Identity and sequence context of rNMP incorporation in S. cerevisiae E134 
genome. Shown here are normalized nucleotide frequencies relative to mapped positions 
of sequences from ribose-seq library of WT (left side two columns) and rnh201 (right 
side two columns). Position 0 is the rNMP. + and – nucleotides are downstream and 
upstream dNMPs, respectively. Zoom-out and zoom-in of nucleotide frequencies are 
shown in the top and bottom row, respectively.     
 
5.4.4 rNMP profile in DNA of various RNase H2-mutants of S. cerevisiae  
RNase H2 recognizes both single rNMP embedded in DNA as well as stretches of RNA in 
DNA. Several mutants of RNase H2 have been characterized to perform different 
functions. A separation of function mutant of RNase H2 (Rnh201-P45D,Y219A), called 
ribonucleotide excision defective (RED), was found to retain its activity on RNA-DNA 
hybrids but not on single rNMPs [132]. So, analyzing the rNMP spectrum of RNase H2-
RED would give us a better understanding of the location preferences for single rNMPs in 
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DNA. In addition to a RED strain, we also performed ribose-seq on a mutant carrying 
mutation in the Rnh202 subunit of RNase H2. Studies in vitro have suggested an additional 
role of RNase H2 during DNA replication. Rnh202, subunit of RNase H2, has a PCNA-
interacting peptide domain (PIP-box) which mediates the interaction of RNase H2 and 
PCNA, and localizes the RNase H2 to the replication fork [132]. Contrary to that, in vitro 
studies in human cells showed that RNase H2 can remove rNMPs in a PCNA-independent 
manner [46]. The absolute genomic composition of rNMPs are shown in Table 5.3 for WT, 
rnh202-PIP, rnh201 and rnh201-RED strains.  
Table 5.3 Absolute composition of genomic rNMPs in WT, PIP, rnh201, and RED 
mutants.  
 WT PIP mutant rnh201 RED mutant 
 nDNA mtDNA nDNA mtDNA nDNA mtDNA nDNA mtDNA 
rA 26.75% 27.88% 31.03% 45.65% 21.14% 33.86% 24.07% 32.91% 
rC 29.79% 24.60% 25.22% 32.37% 46.58% 34.89% 37.54% 21.53% 
rG 11.07% 31.89% 15.52% 16.78% 24.99% 27.52% 30.32% 39.06% 
rU 32.39% 15.63% 28.23% 5.30% 7.29% 3.73% 8.07% 6.50% 
Shown above are the percentages of each dNMPs (A, C, G and T) estimated in nuclear and 
mitochondria DNA of WT, PIP (Rnh202-FF346,347AA), rnh201, and RED (Rnh201-
P45D,Y219A) mutants. nDNA and mtDNA stand for nuclear DNA and mitochondrial 
DNA, respectively.  
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Figure 5.6 Normalized ratios of rNMP in WT, rnh202-FF346,347AA, rnh201, and 
rnh201-P45D,Y219A cells. The observed rNMP frequencies (Figure 5.1 and 5.6) were 
divided by the expected proportion of bases shown in Table 5.2. Shown here are bar graphs 
from one library of each mutant.  
 
On normalizing the relative frequencies of rNMPs, we observed that rG was the preferred 
rNMP in mitochondria DNA of RED and WT cells, whereas rC was the preferred in 
mitochondria DNA of PIP and rnh201 cells (Figure 5.6). On the contrary, in nuclear 






Figure 5.7 Profile of rNMP incorporation in RNase H2 mutants from S. cerevisiae 
BY4742 cells. Normalized nucleotide frequencies relative to mapped positions of 
sequences from ribose-seq library of WT (left side two columns) and rnh201 (right side 
two columns). Position 0 is the rNMP. + and – nucleotides are downstream and upstream 
dNMPs, respectively. Zoom-out and zoom-in of nucleotide frequencies are shown in the 
top and bottom row.    
 
Overall, the spectra of rNMP incorporation in rnh202-PIP and WT cells were similar 
(Figure 5.5), suggesting that in vivo RNase H2 can remove rNMPs via a PCNA-
independent manner. Interestingly, the spectra of rNMP incorporation in rnh201 and 
rnh201-RED cells were similar (Figure 5.5), which suggests that rNMPs may primarily be 
present in the form of single nucleotides embedded in DNA.   
5.4.5 Pattern of rNMP incorporation in S. paradoxus and S. pombe 
Having determined the rNMP profile in S. cerevisiae, we wanted to analyse the pattern of 
rNMP incorporation in S. paradoxus (budding yeast more similar to S. cerevisiae) and S. 
pombe (fission yeast). S. cerevisiae is evolutionarily closer to S. paradoxus, and more 
distant to S. pombe [179, 180]. The A+T and G+C content of S. cerevisiae and S. paradoxus 
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are similar, but the G+C content of S. pombe’s mitochondrial DNA is almost twice than 
that of budding yeast (Table 5.2).   
On performing ribose-seq analysis, we quantified the absolute composition of genomic 
rNMPs (Table 5.4). As observed in S. cerevisiae (Table 5.1 and Figure 5.1), there was a 
difference in pattern of rNMP incorporation between WT and rnh201 cells of S. 
paradoxus and S. pombe. Higher incorporation of rG and rC were seen in WT and rnh201 
strains of S. paradoxus, respectively. In S. pombe, rC and rU were more frequently 
incorporated in WT nuclear DNA, whereas a higher incorporation of rA was observed in 
nuclear DNA of rnh201. rC was abundant in WT and rnh201 mitochondria of S. 
paradoxus, whereas rG was incorporated frequently in WT and rnh201 mitochondria of 
S. pombe. 
Table 5.4 Absolute composition of genomic rNMPs in S. paradoxus and S. pombe.  
 S. paradoxus S. pombe 
 WT rnh201 WT rnh201 
 nDNA mtDNA nDNA mtDNA nDNA mtDNA nDNA mtDNA 
rA 16.10% 25.58% 16.12% 33.66% 30.73% 24.88% 51.88% 31.45% 
rC 22.06% 39.67% 49.25% 34.40% 24.43% 21.89% 18.86% 23.69% 
rG 42.19% 30.90% 28.44% 29.03% 8.56% 47.47% 21.21% 31.25% 
rU 19.65% 3.85% 6.19% 2.90% 36.27% 10.76% 8.05% 13.61% 
Shown above are the absolute percentages of each rNMPs (A, C, G and U) in nuclear and 
mitochondria DNA of WT and rnh201 of S. paradoxus and S. pombe. 
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Upon normalizing the rNMP frequencies in nuclear and mitochondrial DNA, we found a 
relatively higher incorporation of rG and rC in S. paradoxus, which was similar to the 
pattern seen in S. cerevisiae (Figures 5.1 and 5.8). In S. pombe, we observed a higher 
frequency of rG incorporation in mitochondrial DNA of both WT and rnh201 cells, 
whereas rC and rA frequencies were higher in nuclear DNA of WT and rnh201 cells.  
 
Figure 5.8 Normalized ratios of rNMP frequency in S. paradoxus and S. pombe. The 
observed frequencies from Table were divided by the proposition of each base in nuclear 
DNA (nDNA) and mitochondrial DNA (mtDNA). The absolute rNMP composition used 
are shown in Table C.4. Shown here are bar graphs representing mean with standard 
deviation for S. paradoxus WT (n=2) and rnh201 (n=1), and S. pombe WT (n=2) and 
rnh201 (n=2). 
Next, we examined the site of rNMP incorporation and the dNMP sequence context at the 
site of rNMP incorporation. The spectra of rNMP incorporation in the mitochondrial DNA 
of WT and rnh201 cells in S. paradoxus were similar to that of S. cerevisiae, where 
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rNMPs were frequently located within or around the G+C rich regions, whereas this was 
not observed in S. pombe (Figures 5.2, 5.4, 5.5, 5.9 and 5.10). Although S. pombe had a 
higher mitochondrial G+C content, the G+C clustering is a unique feature of budding 
yeasts (Figure 5.8).  
 
Figure 5.9 rNMP incorporation in WT and rnh201 cells of S. paradoxus. Normalized 
nucleotide frequencies relative to mapped positions of sequences from ribose-seq library 
of WT (left side two columns) and rnh201 (right side two columns). Position 0 is the 
rNMP. + and – nucleotides are downstream and upstream dNMPs, respectively. Zoom-out 
and zoom-in of nucleotide frequencies are shown in the top and bottom row.    
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Figure 5.10 rNMP incorporation in WT and rnh201 cells of S. pombe. Normalized 
nucleotide frequencies relative to mapped positions of sequences from ribose-seq library 
of WT (left side two columns) and rnh201 (right side two columns). Position 0 is the 
rNMP. + and – nucleotides are downstream and upstream dNMPs, respectively. Zoom-out 
and zoom-in of nucleotide frequencies are shown in the top and bottom row. 
 
5.5 Discussion  
Despite the existence of at least four rNMP mapping techniques, the rNMP profile of cells 
having an active RER mechanism is completely missing, and the profile in RER defective 
cells has only been minimally characterized. Here, we used the optimized ribose-seq 
technique, as discussed in Chapter 4, to capture rNMPs in yeast wild-type RNase H2 cells 
and compare the rNMP spectrum of WT RNase H2 cells with that obtained in RNase H2-
null and other RNase H2 mutant cells. First, we observed that by using different sets of 
restriction enzymes to fragment the genomic DNA, we could not detect major differences 
in the rNMP spectra in both nuclear and mitochondrial DNA of yeast S. cerevisiae. In 
 144 
addition to confirm reproducibility of the results, the use of different sets of restriction 
enzymes was exploited to obtain a larger coverage of the genome with the preparation of 
the ribose-seq libraries. We found that the levels of rNMP incorporation were different 
between WT and rnh201 strains. The overall composition of genomic rNMPs varied 
depending on the presence or absence of RNase H2 in nuclear DNA, but had almost no 
impact on the mitochondrial DNA. By inspecting the identities of the rNMPs at the sites 
of incorporation in nuclear and mitochondrial DNA of rnh201 cells, we found that rC was 
more frequently incorporated than rG, whereas rA, and particularly rU were the least 
preferred. In WT cells, rC was preferred in nuclear DNA, whereas rG had higher 
incorporation frequency in mitochondrial DNA of WT cells. An overall summary of the 
highest and lowest rNMP incorporated in nuclear and mitochondrial genome is shown in 
Table 5.5.  
Table 5.5 rNMP incorporation in nuclear and mitochondria DNA of WT and rnh201 
cells of S. cerevisiae, S. paradoxus, and S. pombe.   
 WT RNase H2-null 
DNA Nuclear Mitochondria Nuclear Mitochondria 
 Highest Lowest Highest Lowest Highest Lowest Highest Lowest 
S. cerevisiae  A,C G C U C U C U 
S. paradoxus C,G G C U C U C U 
S. pombe C G G U A U C,G U 
Shown here are the identity of rNMP that are most and least (relative frequency) 
incorporated in WT and RNase H2-null of S. cerevisiae, S. paradoxus, and S. pombe. The 
rNMPs shown here are collective representation of normalized frequency plots that are 
shown in Figures 5.2, 5.4, 5.5, 5.9 and 5.10.  
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The rNMP incorporation frequencies may be attributed to the variation in the levels of 
corresponding dNTPs. dCTP and dGTP are the least abundant dNTPs, and hence might be 
depleted faster than dTTP and dATP, increasing the probability of rCMP and rGMP 
incorporation over rAMP and rUMP. Also, the low incorporation of rU could be due to the 
abundance of dTTPs in the nucleotide pool.  
Interestingly, by performing ribose-seq on rnh202-PIP and rnh201-RED, we found that the 
profile of rNMPs from rnh202-PIP cells looked similar to that of WT cells, and the rNMP 
profile in rnh201-RED cells was similar to that obtained in rnh201 cells. The rNMP 
incorporation pattern in mitochondrial genome of WT and various RNase H2 mutant cells 
looked very similar to each other, thus providing additional evidence that support absence 
of RNase H2 activity on single rNMPs in mitochondria.  
From ribose-seq analysis of different strains of S. cerevisiae, and different yeast species, S. 
paradoxus and S. pombe, we found that presence or absence of RNase H2 does not affect 
the pattern of rNMP incorporation in yeast mitochondrial genome, whereas it impacted the 
rNMP profile in the nuclear genome of these yeast species. We also observed similarity in 
rNMP profile between S. cerevisiae and S. paradoxus, but distinct rNMP profile in S. 
pombe. This was especially noticeable in the mitochondrial DNA. rNMPs were seen to be 
incorporated in G+C rich region of S. cerevisiae and S. paradoxus, and not in S. pombe. 
In addition to studying the rNMP incorporation pattern, there are several other analyses 
that we are currently performing using our ribose-seq data. For example, we can look at 
the distribution and hotspots of rNMP incorporation throughout the genome. In Figure 
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5.11, we can observe the distribution of rNMPs in the mitochondrial genome of WT and 
rnh201 cells. Using our ribose-seq analysis, we can map the location of rNMPs in 
genomic DNA to look for hotspots. For example, we found hotspots of rNMPs downstream 
of the COX2 gene that were present in WT and rnh201 cells of several S. cerevisiae strains 
(Figure 5.12).  
Overall, our findings strongly suggest that rNMPs may not be randomly incorporated in 
the genome. Currently, we are analyzing if the sequence context has a role in determining 
the identify of rNMP incorporation adjacent to them. In addition to that, some of the 
questions we pose are; Can we derive specific rules for rNMP incorporation in yeast DNA? 
It would then be interesting to extend the application of our ribose-seq method to study 
rNMP incorporation also in higher eukaryotes. How does the rNMP spectrum change from 
yeast to human in nuclear and mitochondrial DNA? Does rNMP incorporation follow 
specific rules that are conserved across the evolutionary tree, or does every organism have 
their unique rNMP pattern? 
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Figure 5.11 Distribution of rNMP incorporation in mitochondrial genome of S. cerevisiae. Ribose-seq map of rNMPs in 
mitochondrial DNA of WT (top) and rnh201 (bottom) showing persistent rNMPs in the genome of mitochondria. X-axis represents 
the coordinate of nucleotides in the mitochondrial DNA and y-axis is per nucleotide rNMP coverage and is calculated as (number of 
rNMPs in a specific spot/total rNMPs in the corresponding library) multiplied by 100.   
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Figure 5.12 Hotspots of rNMP incorporation in COX2 region of mitochondria DNA in S. cerevisiae. Genome browser view of 
rNMP peaks (hotspots) observed in several S. cerevisiae WT and rnh201 libraries. 
 
 149 
5.6 Acknowledgements  
We thank A. V. Bryksin, N. Djeddar, S. Biliya, and F. O. Vannberg for technical advice, 
and all of the Storici lab members for discussions and suggestions during the course of this 
project. This work was supported by the National Institutes of Health (R01ES026243-01 
to F.S.), the Parker H. Petit Institute for Bioengineering and Bioscience at the Georgia 
Institute of Technology (12456H2 to F.S.), and the Howard Hughes Medical Institute 
Faculty Scholar grant (55108574 to F.S.). 
  
 150 
CHAPTER 6. CONCLUSIONS AND FUTURE 
PERSPECTIVE 
6.1 Overall conclusions 
• Optimized the ribose-seq protocol to enhance the capability of capturing rNMPs by 
a factor of 1000, and using this modified method we map the profile of rNMPs in 
WT and RNase H2-null cells of S. cerevisiae, S. paradoxus, and S. pombe.  
• In WT nuclear DNA of S. cerevisiae, S. paradoxus, and S. pombe, there is no 
specific bias to rNMP that is most incorporated, whereas we observe rG to be the 
least incorporated. In RNase H2-null cells of S. cerevisiae and S. paradoxus, rC is 
more abundant in nuclear DNA, whereas rA is abundant in S. pombe.  rU is the 
least incorporated in RNase H2-null cells of S. cerevisiae, S. paradoxus, and S. 
pombe.  
• The pattern of rNMPs in mitochondrial DNA from WT and RNase H2-null of S. 
cerevisiae and S. paradoxus are similar. We observed rC as most abundantly 
incorporated rNMPs, whereas in S. pombe rG is most abundantly incorporated. In 
all three yeast species, we observe rU as the least incorporated rNMP in 
mitochondrial DNA. 
• RNase H2 has a stronger activity on rNMPs in nuclear DNA as compared to 
mitochondrial DNA.  
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• rNMPs are incorporated within the G+C region of S. cerevisiae and S. paradoxus. 
rUMP is the least incorporated rNMPs in all mitochondrial DNA and rnh201 
nuclear DNA.  
• The low frequency of rUMPs is not due to the removal of rUMPs by UNG1 of the 
BER pathway. 
• Yeast, mouse and human RNase H2 does not cleave abasic rNMPs, whereas human 
APE1 can recognize and cleave an abasic rNMP. 
• Abasic rNMP cleavage is specific to APE1 as the use of compound #3 drastically 
reduced the cleavage activity of APE1.  
• Identified a new role of APE1 in removing abasic rNMPs in genomic DNA.  
6.2 Impact and future perspectives 
There are abundant evidences that demonstrate the deleterious effects of misincorporation 
of rNMPs, but only a very few positive consequences of having rNMPs in DNA are known. 
Considering that rNMPs are the most frequent non-standard nucleotides, studying the 
rNMP profile of genomic DNA will help us better understanding both helpful and harmful 
effects of rNMPs embedded in DNA. Having developed an rNMP mapping technique that 
directly captures the rNMPs, ribose-seq, we set out to modify and optimize our current 
ribose-seq method to generate a powerful and effective system for mapping rNMPs in DNA 
of any kind. Using this modified method, we reveal the identity and distribution of rNMPs 
in genomic DNA of RNase H2 wild-type and several RNase H2 mutant cells of S. 
cerevisiae, S. paradoxus, and S. pombe. From our ribose-seq analysis, we noticed a 
difference in the overall content of rNMPs incorporated in nuclear and mitochondrial DNA 
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between WT and RNase H2-null cells. On normalizing the relative frequencies of 
nucleotides, we observed that rC and rG are more frequently incorporated in the genome 
(in most cases). rA and particularly rU, are the least incorporated rNMPs. This is especially 
interesting in mitochondria. Despite mitochondrial DNA being A+T rich, we found higher 
incorporation of rC and rG in G+C rich regions. This was observed in wild-type and RNase 
H2 mutants of budding yeasts, and not fission yeast. In rnh201 cells, we found a higher 
incorporation of rC, followed by rG, rA and low levels of rU incorporation. Additionally, 
using our analysis, we plan on identifying hotspots of rNMP incorporation in the genome.  
In the absence of RER, Top1 has been shown to cleave rNMPs in DNA [35, 57]. rNMP-
induced genome instability has been shown to result in 2-5 bp deletions that are dependent 
on Top1 activity. Using ribose-seq, we can identify where top1-dependent deletions occur 
in the genome after rNMP incorporation and persistence. It has been suggested that Top1-
mediated cleavage at rNMPs may be related to a role in transcription rather than actually 
removing rNMPs from the genome. Therefore, comparing the profile of rNMPs in WT, 
RNase H2-null, Top1-null, and both RNase H2-null and Top1-nul cells can help identify 
sites that are target of Top1 versus RNase H2 in genomic DNA. As discussed in section 
1.5.2 of the Introduction when Top1 cleaves at rNMPs that are part of a short DNA repeated 
sequence, it can lead to small deletions in DNA. Thus, it will be relevant to identify hotspot 
sites of rNMP incorporation, which could cause Top1-dependent mutations, not only in 
nuclear but also in mitochondrial DNA. Yeast has a Top1 that is equally active in nuclear 
and mitochondria, whereas there is a specialized Top1mt in mitochondria of human cells 
[181]. Very little is known about rNMP removal in mitochondria, hence it will be 
interesting to study if Top1 has a role in removing rNMPs in mitochondria.  
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In the course of my research, the modifications we made to ribose-seq have transformed 
the original protocol mainly applicable to RNase H2-defective cells into a robust technique. 
We improved the capacity of ribose-seq to capture rNMPs up to a factor of 1,000! Now, 
ribose-seq allows us to explore rNMP incorporation into DNA of potentially any cell type 
of any organisms under any conditions. For example, using ribose-seq we can identify 
rNMP incorporation in cells undergoing high level of DNA damage, such as oxidative 
stress. Moreover, it would be of interest to study rNMP incorporation in higher eukaryotic 
systems. As mutations in human RNase H2 subunits are associated with the 
neurodegenerative syndrome of AGS, ribose-seq mapping of system having partial loss-
of-function RNase H2 can provide insights into how rNMP distribution affects AGS [54]. 
In addition to performing genome wide mapping, using our ribose-seq method, we can 
perform deep sequencing on a specific region to detect rNMPs. For example, we can 
construct ribose-seq libraries from telomeric, centromeric or any specific region of normal 
and diseased cell lines, and compare the rNMP profile in those regions between normal 
and diseased state. This would provide us information on regions that are more vulnerable 
to rNMP incorporation. Also, performing deep sequencing of ribose-seq libraries can help 
us characterize presence of rNMPs in repeated regions. At least 55% of the human genome 
comprise of repetitive elements, such as retrotransposons, simple sequence repeats and 
satellite DNA sequences [182]. As these elements play important roles in shaping genomes 
during evolution, and have been implicated in etiology of many human diseases, 
performing ribose-seq analysis to understand the identity and location of rNMPs in repeat 
sequences by deep-sequencing will help us gain information on the potential role of rNMPs 
in these repeated sequences.  
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It is well known that genomic instability is a hallmark of cancer; hence, analysis of rNMP 
spectra in cancer cells will reveal any correlation between rNMPs and cancer. On 
performing DNA-seq and ribose-seq on specific cancer cells/tissues, we can compare the 
DNA-seq profile to that of rNMP profile from ribose-seq to look for specific mutations in 
cancer cells/tissues. This could help in development of newer and more effective strategies 
for cancer treatment. Therefore, characterizing the rNMP profile in certain types of 
diseased cells can help us in better understanding the molecular mechanisms of these 
diseases, and possibly aid to develop effective tools for diagnostic and treatment of these 
diseases.  
As of now, we are able to capture rNMPs from a heterogeneous population of cells. It will 
be interesting to determine the rNMP profile in a single cell. As eukaryotic cell populations 
are heterogeneous in nature, performing single-cell ribose-seq analysis will help us to 
understand mechanisms that are not seen when studying a bulk population of cells. This 
will prove to be very useful in mapping rNMPs within tumors. As tumors likely contain 
multiple sub-clones of cancer cells, we may be able to perform single-cell analysis of 
rNMPs. Using our analysis, we can accurately determine the pattern of rNMPs in a single-
cell, as well as obtain genome wide reads of rNMPs.   
Although using ribose-seq (and other methods) we can effectively capture rNMPs 
embedded in DNA, currently we cannot distinguish between a single rNMP or rNMPs 
coming from stretches of rNMPs in DNA. Due to alkali treatment, we can only capture the 
5’-rNMP in a stretch of rNMPs.  Therefore, having a RNase H2 mutant that cannot 
recognize stretches of rNMPs but can cleave at single rNMPs in DNA (reverse activity of 
RNase H2 RED mutant), and comparing the rNMP spectrum of these mutants both in the 
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presence and in the absence of RNase H1, which also targets stretches of rNMPs in DNA, 
we can identify the location of single rNMPs versus stretches of rNMPs.  
Among the many rNMPs that are misincorporated in a given genome, not only canonical 
rNMPs are incorporated but also modified rNMPs such as abasic rNMPs might be found 
in DNA [27, 149]. rNMPs are susceptible to oxidative damage which could result in a 
significant generation of abasic rNMPs [8]. The role of RNase H2 in recognizing and 
cleaving rNMPs is well established but nothing was known about pathways that can cleave 
abasic rNMPs in DNA. In this research project, we demonstrated that an abasic rNMP 
embedded in DNA is targeted by APE1 of BER rather than RER in eukaryotic systems. 
We found that RNase H2 from yeast, mouse and human cell are unable to process abasic 
rNMP. We also showed that UNG1 of BER pathway did not target rUMP embedded in 
DNA. Our results highlight a new role of APE1 in repairing abasic rNMPs embedded in 
DNA. As APE1 overexpression is observed in different types of cancers [166, 167], such 
as ovarian, lung and breast cancers, it would be interesting to determine if there is any 
correlation between overexpression of APE1 and presence of abasic rNMPs. As we are 
understanding more and more about the role of rNMPs in genomic DNA, it would be of 
significance to study the consequence of abasic rNMPs, and other modified rNMPs in 
DNA.  
We believe that our work will serve as a foundation for future studies aimed in better 
understanding the physiological and pathological significance of rNMPs in DNA. Our 
discovery of a novel function of BER pathway highlights the importance of exploring the 
capacity of additional DNA repair mechanisms to target rNMPs in DNA.   
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APPENDIX A. Supplementary Materials for Chapter 2 
Table A.1. All strains used in this chapter 
a 
Strain Relevant genotype Source 
KK-100 
MATα ade5-1 lys2-14A trp1-289 his7-2 leu2-
3,112 ura3-52 rnh201Δ::hygMX4 
this study 
KK-30 
hoΔ hmlΔ::ADE1 MATa-inc hmrΔ::ADE1 ade1 
leu2-3,112 lys5 trp1::hisG ura3-52 leu2::HOcs 
mataΔ::hisG rnh201Δ::hygMX4 
this study 
KK-174 KK-100 rnh1Δ::kanMX4 this study 
KK-125 KK-30 rnh1Δ::kanMX4 this study 
KK-164 KK-125 ung1Δ::natMX4 this study 
KK-170 KK-30 pol2-M644G this study 
KK-107 KK-100 pol2-4 this study 
KK-120 KK-100 pol3-5DV this study 
b 
Strain Relevant genotype Source 
FRO-767,768 
hoΔ hmlΔ::ADE1 MATa-inc hmrΔ::ADE1 
ade1 leu2-3,112 lys5 trp1::hisG ura3-52 
ade3::GAL::HO leu2::HOcs mataΔ::hisG 
Storici et al., 
200743 
FRO-984,985 FRO-767,768 rnh201Δ::kanMX4 
Storici et al., 
200743 
KK-158,159 FRO-767,768 ung1Δ::hygMX4 this study 





Table A.2. List of oligos used in this chapter  
Name Length (nt) Sequence (5’-3’) with end modifications Purification 
Lig.47.D 47 CCCGAGTGTGATCATCTGGTCGCTGGGGAATGAGTCAGGCCACGGCG PAGE 
Lig.47.R 47 CCCGAGTGTGATCATCTGGTCGCTGGGGAATrGAGTCAGGCCACGGCG PAGE 
Lig.30.rA 30 NNNNNNNNNNNNNNNNNNNNNrANNNNNNNN PAGE 
Lig.30.rG 30 NNNNNNNNNNNNNNNNNNNNNrGNNNNNNNN PAGE 
Lig.30.rU 30 NNNNNNNNNNNNNNNNNNNNNrUNNNNNNNN PAGE 

























ByTemp.rC 46 NNNNNNNrCNNNNNNNNAGATCGGAAGAGCGTCGTGTAGGGAAAGAG PAGE 
ByTemp.rU 46 NNNNNNNrUNNNNNNNNAGATCGGAAGAGCGTCGTGTAGGGAAAGAG PAGE 

















LEU2.3 20 ATGTCTGCCCCTAAGAAGAT Desalted 
LEU2.6 20 TGCCAAAGAATAAGGTCAAC Desalted 
	
Name, length, and sequence of oligos used in this study are described. The purification 
type and the specific experiments in which the oligos were used are indicated. 
Ribonucleotides are in red, preceded by ‘r’. End modifications of phosphate and amino 
groups are indicated by ‘P’ and ‘Am’, respectively. All PAGE-purified oligos were 
synthesized by Thermo Scientific Dharmacon with exceptions for Lig.47.D and Adaptor.L, 
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which were synthesized by Life Technologies and IDT, respectively. All desalted oligos 
were synthesized by Eurofins Genomics.  
 
Table A.3 Results of 3’ base bias for AtRNL ligation 
 a 
Base Circular Dimer Circular dimer 
A 48% (44–49) 4.3% (1.8–7.1) 1.5% (0.71–2.1) 
G 47% (44–48) 4.0% (2.6–5.8) 1.5% (0.88–2.3) 
U 47% (45–49) 4.4% (2.1–5.1) 1.5% (0.73–2.0) 
C 47% (44–49) 4.5% (1.9–5.0) 1.4% (0.59–1.8) 
 b 
P value G U C 
A 0.4857 0.8857 1.0000 
G – 0.8857 0.6857 
U – – 1.0000 
 c 
 d 
P value G U C 
A 1.0000 1.0000 0.6857 
G – 0.3429 0.2000 
U – – 0.8857 
 (a) Levels of AtRNL ligation in reaction conditions described in Supplementary Figure 1 
are expressed as median percentage and range (in parentheses) from four independent 
reactions. (b) Mann-Whitney U-test was performed for statistical analysis, and P values 
are displayed, all greater than 0.05. (c) AtRNL ligation was performed with reduced 200 
nM AtRNL, instead of 1 µM, to compare the levels of ligation when the reactions were 
incomplete. Median percentages and ranges (in parentheses) from four independent 
Base Circular Dimer Circular dimer 
A 27% (23–31) 1.7% (1.5–2.3) 0.53% (0.45–0.74) 
G 27% (24–28) 1.9% (1.5–2.5) 0.54% (0.39–1.1) 
U 29% (24–30) 2.3% (1.3–2.7) 0.64% (0.48–1.2) 
C 29% (25–32) 1.8% (1.7–2.0) 0.53% (0.47–0.80) 
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reactions are displayed. d, Mann-Whitney U-test was performed for statistical analysis, and 
P values are displayed, all greater than 0.05. No 3′ base bias was observed for AtRNL 
ligation.  
 
Table A.4 Ribose-seq coverage for each library in this study 
Ribose-seq library 
Coverage (aligned reads/kb) 
Nuclear Mitochondrial 




rnh201 (KK-30) 0.149 8.42 
rnh1 rnh201 (KK-174) 0.149 9.92 
rnh1 rnh201 (KK-125) 0.239 13.2 










Coverage is expressed as aligned reads per kb and does not reflect the relative abundance 
of rNMPs among different strains.  
 















A 15.4% 25.6% 45.0% 45.8% 
C 44.0% 36.8% 22.4% 15.3% 
G 28.1% 19.0% 16.5% 5.8% 




A 23.2% 38.2% 43.3% 43.5% 
C 35.4% 25.6% 19.3% 10.0% 
G 22.7% 14.5% 13.5% 6.2% 




A 20.4% 35.7% 47.5% 47.8% 
C 39.2% 28.3% 19.6% 11.1% 
G 27.5% 24.1% 14.4% 7.2% 




A 17.1% 33.6% 44.9% 46.5% 
C 40.2% 27.0% 22.0% 11.8% 
G 27.7% 23.7% 15.0% 7.4% 




A 20.1% 35.4% 45.2% 44.3% 
C 36.8% 28.6% 19.4% 12.1% 
G 29.7% 20.9% 15.0% 5.9% 
U/T 13.4% 15.1% 20.4% 37.7% 
rnh1 
rnh201 
ung1        
(KK-164) 
A 24.3% 35.8% 44.3% 47.1% 
C 35.3% 30.2% 19.4% 13.2% 
G 26.5% 22.7% 15.3% 6.5% 





A 19.5% 38.9% 52.2% 47.2% 
C 40.3% 28.6% 18.2% 11.5% 
G 26.5% 21.5% 13.0% 6.6% 




A 14.9% 21.9% 42.5% 46.2% 
C 40.2% 43.1% 22.0% 16.3% 
G 23.6% 16.3% 16.4% 6.4% 




A 20.4% 30.0% 44.3% 45.3% 
C 37.1% 33.1% 19.4% 14.6% 
G 25.0% 16.7% 15.3% 6.1% 
U/T 17.5% 20.3% 21.0% 34.0% 
Absolute nucleotide frequencies of nuclear and mitochondrial rNMPs and the nucleotide 







Table A.6 Results of rNMP bypass by Phusion polymerase  
 a 
Base Bypass probability 
C 93% (93–93) 
U 93% (92–94) 
 b 
P value U 
C 0.6857 
(a) Bypass probabilities reaction conditions described in Supplementary Figure 4 are 
expressed as median percentage and range (in parentheses) from four independent 
reactions. (b) Mann-Whitney U-test was performed for statistical analysis, and P value is 
displayed.  
 
Table A.7 Results of DSB repair assay with rNMP-containing oligos  
 a 
Oligo WT rnh201 ung1 
LEU2.D 65% (55–75) 63% (55–65) 65% (55–70) 
LEU2.rG 30% (20–40) 90% (75–100) N/A 
LEU2.dU 5.0% (0–10) N/A 55% (45–60) 
LEU2.rU 33% (25–45) 55% (45–65) 33% (30–40) 
 b 
Oligo rnh201 ung1 
LEU2.D 0.5357 1.0000 
LEU2.rG 0.0286 N/A 
LEU2.dU N/A 0.0294 
LEU2.rU 0.0421 1.0000 
(a) Data shown in Figure 2.4 are presented here as median percentages of StuI-cut Leu+ 
transformants from four independent transformations and ranges in parentheses. For each 
transformation, 20 Leu+ transformants were selected for analysis. b, Mann-Whitney U-test 
was implemented for statistical analysis against the WT, and P values are displayed. N/A, 
not applicable because data are not available for comparison.  
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Table A.8 List of hotspots of rNMP incorporation within S. cerevisiae mitochondrial 
DNA, rDNA repeat, and Ty1 
Position Strand Gene Base 








































W COB A 30 136 17 24 34 2 20 10 22 
Chr XIIa 
453,839 
C RDN25 G 97 45 18 30 22 1 25 12 10 
Chr IVb 
650,383 
Cb Ty1 A 15 42 10 11 19 46 20 19 110 
Chr M 
14,688 
W COX1 A 7 49 5 10 14 33 12 8 38 
Chr M 
14,739 
W COX1 A 8 46 7 14 12 0 5 0 13 
Chr M 
19,157 
W COX1 A 15 73 4 5 22 28 5 7 27 
Hotspots of of rNMP incorporation were determined by finding positions of rNMPs within 
the locus of interest with ribose-seq signal greater than the mean plus three standard 
deviations for each library from rnh201∆ (KK-100), rnh201∆ (KK-100, EconoTaq), 
rnh201∆ (KK-30), rnh1∆ rnh201∆ (KK-174), and rnh1∆ rnh201∆ (KK-125) cells (in 
bold). Ribose-seq signal counts found in all other libraries are also shown. 
aThere are two rDNA repeats on Chr XII in the reference genome (sacCer2). Only the first 
repeat unit is shown as an example. 
bBecause of the presence of multiple copies of Ty1 in the genome, YDRCTy1-1 on Chr IV 
is shown as an example. 
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Figure A.1 Mechanism of alkaline cleavage of ribonucleotides in DNA. The 
ribonucleoside embedded in double-stranded DNA is in red. During alkaline treatment, 
DNA strands are denatured, and cleavage occurs at the rNMP site, generating a 2′,3′-cyclic 
phosphate end and an opposite 5′-hydroxyl end. The 2′,3′-cyclic phosphate is in 
equilibrium with 2′-phosphate and 3′-phosphate forms. Boxes in black indicate the 2′,3′-
cyclic phosphate and 2′-phosphate DNA termini, which are substrates of AtRNL.  
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Figure A.2 3’ bias for AtRNL ligation. Hot 5′-radiolabeled 30-nt DNA oligo with a 
single rNMP (either A, G, U, or C) in the 22nd position was mixed with cold equimolar 
30-nt DNA oligos with rNMPs of 3 other bases in the 22nd positions. 5′-radiolabel is 
indicated by ‘P’ in purple. The mixture was treated with 0.3M NaOH for 2 hr at 55 °C and 
neutralized. 100 nM of alkali-cleaved products (25 nM of each base) were then incubated 
with 1 µM AtRNL in appropriate buffer (see Methods) for 1 hr at 30 °C. The resulting 
products were treated with T5 exonuclease for 2 hr at 37 °C. Aliquots were withdrawn after 
appropriate steps and quenched. The products were analyzed by urea-PAGE. The circular 
22-mer migrates faster than the unligated, linear 22-mer. Only circular products were 
resistant to T5 exonuclease while all linear substrates/products were degraded. Median 
percentages of circular 22-mer formation from four independent reactions are displayed. 
See Supplementary Table 1 for more statistics. First left lane, ss DNA ladder. No 3′ base 
bias was observed for AtRNL ligation (see Table A.3). Self-ligation was preferred to 
dimerization with a shorter 22-nt substrate; however, with the shorter substrate, lower 
levels of linear dimers, which are not resistant to T5 exonuclease, and circular dimers were 
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observed. Increasing the length of the ss DNA substrate from 22 nt to 32 nt eliminated 
dimerization (Figure 1.1a).  
 
                        
Figure A.3 Ribose-seq library from genomic DNA of S. cerevisiae rnh201 (KK-100) 
cells. Appropriate PCR products were analyzed by PAGE. ‘P’ indicates primers-only. No 
amplification product was observed when either (a) AtRNL ligation step or (b) alkali 
treatment was omitted. Tpt1 denotes the step of 2’-phosphate removal at the ligation 
junction in Figure 1.1a. First left lane, ds DNA ladder.  
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Figure A.4 Bypass of a single rNMP by Phusion DNA polymerase. 5′-radiolabeled 30-
nt primer, ByPrim (Table A.2), was annealed to the 46-nt template oligo containing either 
rCMP (ByTemp.rC) or rUMP (ByTemp.rU) in the 8th position. 100 nM of annealed 
substrate was incubated with 0.2 units of Phusion High-Fidelity DNA Polymerase (NEB) 
and 2 mM dNTPs in appropriate buffer (see Methods) for 30 sec at 72 °C. The reactions 
were quenched and analyzed by urea-PAGE. Median bypass probabilities from four 
independent reactions are shown. See Supplementary Table 5 for more statistics. First left 
lane, ss DNA ladder. The primer extension assay showed no significant difference between 
bypass efficiency over rUMP and rCMP by Phusion DNA polymerase (Table A.6). 
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Figure A.5 Normalized frequency of nucleotides surrounding the rNMP sites. 
Normalized frequency of nucleotides relative to (a) nuclear and (b) mitochondrial mapped 
positions of sequences from ribose-seq library, PCR-amplified with EconoTaq DNA 
Polymerase (Lucigen), of genomic DNA from S. cerevisiae rnh201∆ (KK-100) cells. 
Position 0 corresponds to the rNMP. Negative and positive numbers (from -10 to -1 and 1 
to 10) correspond to upstream and downstream positions from the rNMP, respectively. 
Frequencies were normalized to either nuclear or mitochondrial genomic mononucleotide 
frequencies. Normalized frequency of nucleotides relative to (c) nuclear and (d) 
mitochondrial mapped positions of sequences from ribose-seq library of genomic DNA 
from S. cerevisiae rnh201∆ (KK-30) cells. Normalized frequency of nucleotides relative 
to (e) nuclear and (f) mitochondrial mapped positions of sequences from ribose-seq library 
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of genomic DNA from S. cerevisiae rnh1∆ rnh201∆ (KK-174) cells. Normalized frequency 
of nucleotides relative to (g) nuclear and (h) mitochondrial mapped positions of sequences 
from ribose-seq library of genomic DNA from S. cerevisiae rnh1∆ rnh201∆ (KK-125) 
cells. Normalized frequency of nucleotides relative to (i) nuclear and (j) mitochondrial 
mapped positions of sequences from ribose-seq library of genomic DNA from S. cerevisiae 
rnh1∆ rnh201∆ ung1∆ (KK-164) cells. Normalized frequency of nucleotides relative to (k) 
nuclear and (l) mitochondrial mapped positions of sequences from ribose-seq library of 
genomic DNA from S. cerevisiae pol2-M644G rnh201∆ (KK-170) cells. Normalized 
frequency of nucleotides relative to (m) nuclear and (n) mitochondrial mapped positions of 




Figure A.6 Zoom-out of normalized frequency of nucleotides surrounding the rNMP 
sites. Normalized frequency of nucleotides relative to (a) nuclear and (b) mitochondrial 
mapped positions of sequences from ribose-seq library, PCR-amplified with EconoTaq 
DNA Polymerase (Lucigen), of genomic DNA from S. cerevisiae rnh201∆ (KK-100) cells. 
Position 0 corresponds to the rNMP. Negative and positive numbers (from -100 to -1 and 
1 to 100) correspond to upstream and downstream positions from the rNMP, respectively. 
Frequencies were normalized to either nuclear or mitochondrial genomic mononucleotide 
frequencies. Normalized frequency of nucleotides relative to (c) nuclear and (d) 
mitochondrial mapped positions of sequences from ribose-seq library of genomic DNA 
from S. cerevisiae rnh201∆ (KK-30) cells. Normalized frequency of nucleotides relative 
to (e) nuclear and (f) mitochondrial mapped positions of sequences from ribose-seq library 
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of genomic DNA from S. cerevisiae rnh1∆ rnh201∆ (KK-174) cells. Normalized frequency 
of nucleotides relative to (g) nuclear and (h) mitochondrial mapped positions of sequences 
from ribose-seq library of genomic DNA from S. cerevisiae rnh1∆ rnh201∆ (KK-125) 
cells. Normalized frequency of nucleotides relative to (i) nuclear and (j) mitochondrial 
mapped positions of sequences from ribose-seq library of genomic DNA from S. cerevisiae 
rnh1∆ rnh201∆ ung1∆ (KK-164) cells. Normalized frequency of nucleotides relative to (k) 
nuclear and (l) mitochondrial mapped positions of sequences from ribose-seq library of 
genomic DNA from S. cerevisiae pol2-M644G rnh201∆ (KK-170) cells. Normalized 
frequency of nucleotides relative to (m) nuclear and (n) mitochondrial mapped positions 
of sequences from ribose-seq library of genomic DNA from S. cerevisiae pol2-4 rnh201∆ 
(KK-107) cells. Normalized frequency of nucleotides relative to (o) nuclear and (p) 
mitochondrial mapped positions of sequences from ribose-seq library of genomic DNA 
from S. cerevisiae pol3-5DV rnh201∆ (KK-120) cells. 
 
                                       
Figure A.7 Normalized frequency of nucleotides surrounding the rNMP sites on 
leading and lagging strands. Normalized frequency of nucleotides relative to mapped 
positions of sequences in (a) leading and (b) lagging strands from ribose-seq library of 
genomic DNA from S. cerevisiae rnh1∆ rnh201∆ (KK-174) cells. Position 0 corresponds 
to the rNMP. Negative and positive numbers (from -10 to -1 and 1 to 10) correspond to 
upstream and downstream positions from the rNMP, respectively. ARSs with Trep of no 
longer than 25 min were selected with flanking size of 10 kb. Frequencies were normalized 
to genomic mononucleotide frequencies of either leading or lagging strand of the selected 
ARSs and flanking size. Normalized frequency of nucleotides relative to mapped positions 
of sequences in (c) leading and (d) lagging strands from ribose-seq library of genomic 
DNA from S. cerevisiae pol3-5DV rnh201∆ (KK-120) cells.  
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APPENDIX B. Supplementary Information for Chapter 3 
Table B.1 List of single strand (ss) oligonucleotides used in this study 
Name Length 5’ label and sequence (5’-3’) 
ss_dG_40 40 32P-AGTGTGGATGCCGTGAAGAdGATCATCAAGGTTATCGCCTC 
ss_rG_40 40 32P-AGTGTGGATGCCGTGAAGArGATCATCAAGGTTATCGCCTC 
ss_dF_40 40 32P-AGTGTGGATGCCGTGAAGAdFATCATCAAGGTTATCGCCTC 
ss_rF_40 40 32P-AGTGTGGATGCCGTGAAGArFATCATCAAGGTTATCGCCTC 
ss_dG 25 IRDye700-GGATCCGGTAGTdGTTAGGCCTGAAC 
ss_rG 25 IRDye700-GGATCCGGTAGTrGTTAGGCCTGAAC 
ss_rOH 25 Cy5-GGATCCGGTAGTrOHTTAGGCCTGAAC 
ss_d8oxoG 25 IRDye700-GGATCCGGTAGTd8oxoGTTAGGCCTGAAC 
ss_r8oxoG 25 IRDye700-GGATCCGGTAGTr8oxoGTTAGGCCTGAAC 
ss_dF 26 IRDye800-AATTCACCGGTACCdFTCTAGAATTCG 
ss_dC_40 40 GAGGCGATAACCTTGATGATCTCTTCACGGCATCCACACT 
ss_dC 25 GTTCAGGCCTAACACTACCGGATCC 
ss_dA 25 GTTCAGGCCTAAAACTACCGGATCC 
ss_dC 26 CGAATTCTAGACGGTACCGGTGAATT 
Name, length, 5′ labeling and sequence of all single strand oligonucleotides used in this 
study are presented. All ss oligonucleotides were PAGE purified. Ribonucleotides are in 
red and bolded, and the corresponding deoxyribonucleotides are in blue and bolded. 32P, 
IRDye700 phosphoramidite, IRDye800 phosphoramidite and Cyanine 5 dyes are indicated 
at the 5’ end of each corresponding oligonucleotide. In the part colored in grey all single 
strand complementary oligonucleotides are listed with the nucleotide opposite to the 
ribonucleotide in bolded font. 
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Figure B.1 Structure of modified bases incorporated in DNA oligomer. Schematic 
representation of the (a) deoxy- and (b) ribo- tetrahydrofuran, (c) ribose 1’OH abasic site 




Figure B.2 Gel-quantification of RNase H2 recombination protein used in this study. 
Human recombinant RNase H2 protein was separated onto 10% SDS–PAGE gel followed 
by Coomassie staining. Bands corresponding to each protein were quantified and 
normalized on a standardization curve of Bovine Serum Albumin (BSA) protein. The 
molecular weight (Mw) expressed in kilodaltons (kDa) is shown on the right of each panel. 
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Subunit A, subunit B and subunit C corresponds to 299 aa (1 isoform, 33,395 kDa), 213 aa 
(2 isoform, 35,139 kDa), and 164 aa (1,784 kDa).  
 
                  
Figure B.3 Western blot analysis on nuclear HeLa cell extracts and its enzymatic 
activity on different substrates. (a) HeLa cells were transfected with specific siRNAs 
directed versus RNase H2 and APE1 proteins and compared to the Scramble control. 
Nuclear cell extracts were separated onto 12% SDS–PAGE, and Western blot analysis was 
performed by using an anti-APE1 antibody and an anti-RNase H2 antibody. Lamin A was 
used as loading control. Expression levels for each condition was normalized to the 
Scramble and indicated under each corresponding lane. The molecular weight (Mw) 
expressed in kilodaltons (kDa) is shown on the right of each panel. (b) Representative 
denaturing polyacrylamide gel of oligonucleotides (0.25 µM) incision by nuclear HeLa cell 
extracts (NCE). In order to discriminate the activity of RNase H2, 500 ng of NCE, in which 
RNase H2 expression was previously knocked down through specific siRNA (indicated as 
siRNase H2), were tested in comparison to control cells (Scramble) at different time points, 
expressed in minutes. rG- containing oligonucleotide was used as positive control. Time 
points, expressed in minutes, are shown on the top of the figure. Enzymatic reaction was 
performed at 37°C in RNase H2-buffer. S indicates the substrate position, while P indicates 
the product position. 
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Figure B.4 Gel-quantification of APE1 WT and mutant recombinant proteins used in 
this study. Human recombinant APE1 WT (a) and mutants APE1 N∆33 and APE1 E96A 
proteins (b) were separated onto 10% SDS–PAGE gel followed by Coomassie staining. 
Bands corresponding to each protein were quantified and normalized on a standardization 
curve of Bovine Serum Albumin (BSA) protein. The molecular weight (Mw) expressed in 
kilodaltons (kDa) is shown on the right of each panel. (c) Representative denaturing 
polyacrylamide gel of oligonucleotides (2.5 pmol) incision by different APE1 mutants 
N∆33 and E96A (0.288 nM), in comparison to wild type APE1 (WT). The reaction was 
performed in APE1-buffer for different time points, expressed in minutes and shown on 
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the top of the figure, at 37°C. ds_dF:dC oligonucleotide was used as positive control. S 
indicates the substrate position while P indicates the product position. (d) Representative 
denaturing polyacrylamide gel of oligonucleotides (0.25 µM) incision by nuclear HeLa cell 
extracts (NCE). In order to discriminate the activity of APE1, 10 ng of NCE, in which 
APE1 expression was previously knocked down through specific siRNA (indicated as 
siAPE1), were tested in comparison to control cells (Scramble) at different time points, 
expressed in minutes and shown on the top of the figure. dF- containing oligonucleotide 
was used as positive control. Enzymatic reaction was performed at 37°C in APE1-buffer. 






Figure B.5 Human OGG1 binds r8oxoG- containing oligonucleotide. (a) MALDI-TOF 
mass spectrum of the modified 25-mer oligodeoxyribonucleotide that contains a r8oxoG 
residue (calculated mass: 8528.9; measured mass: 8527.2). Here the classical spectrum for 
a pure oligonucleotide showing an unique fragment with two states of charge: Peak [M-
H]- : 8526.2 and Peak [M-2H]2- : 4262.8 is reported for the oligonucleotide synthesized 
and used in all the experiments. (b) Reversed-phase chromatography of the labeled 
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modified oligonucleotide (Gradient of 0 to 35% of CH3CN in TEAA 10mM in 45min – 
detection 254nm). (c) Human recombinant OGG1 protein was separated onto 10% SDS–
PAGE gel followed by Coomassie staining. Bands corresponding to each protein were 
quantified and normalized on a standardization curve of Bovine Serum Albumin (BSA) 
protein. The molecular weight (Mw) expressed in kilodaltons (kDa) is shown on the right 
of each panel. (d) Graph depicting dose response of OGG1 lyase activity on ds_d8oxoG:dC 
positive control oligonucleotide is shown. Data are expressed as mean + SD of three 
independent technical replicas. (e) Representative native EMSA polyacrylamide gel of 
OGG1 binding on ds_r8oxoG:dC oligonucleotide (25 nM) is shown. ds_dG:dC and 
ds_rG:dC are used as negative controls whereas ds_d8oxoG:dC as used as positive control. 
The ‘Bound’ arrow denotes the retarded complex between OGG1 and the probe whereas 
the ‘Free’ arrow denotes the unbound substrate. Amounts of OGG1 protein, expressed in 
pico moles, are shown on the top of the figure. Reactions were performed as explained in 





Figure B.6 Evaluation of the apparent molecular weight of the cleavage products by 
APE1. (a) Representative denaturing polyacrylamide gel of ds_rG:dC and ds_r8oxoG:dC 
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oligonucleotides (25 nM) incision by APE1 (50 fmol) in APE1 buffer for 30 minutes at 
37°C. At the right of the bottom panel, a longer product of about 12 nucleotides is indicated 
by an asterisk whereas a smaller one of 11 nucleotides is indicated by a double asterisk. 
On the right side, a schematic representation of the cleavage products, showing the position 
of the ribonucleotide (red box with R) embedded in the DNA oligonucleotide and the APE1 
cleavage on it, producing a longer product of about 12 nucleotides and a smaller one of 11 
nucleotides. (b) Representative denaturing polyacrylamide gel of alkaline hydrolysis on 
ds_rG:dC and ds_r8oxoG:dC oligonucleotides (25 nM) upon treatment with 0.3 M NaOH 
for 2 hours at 55°C. On the left of the panel, marker shows the size of the products. (c) 
APE1 enzymatic activity on single strand (ss) versus double strand (ds) dF- and r8oxoG-
containing oligonucleotides. 2 fmol and 50 fmol of APE1 protein were incubated with dF-
containing oligonucleotide and r8oxoG-containing oligonucleotides for 10 and 30 minutes, 
respectively (top). APE1 enzymatic activity on single strand (ss) versus double strand (ds) 
dF- and rOH-containing oligonucleotides. 2 fmol of APE1 protein were incubated with 
oligonucleotides for 10 minutes (bottom).  Reactions were prepared in APE1 buffer in a 10 
µl of final volume at 37°C. S indicates the substrate position while P indicates the product 
position. (d) Representative denaturing polyacrylamide gel of APE1 mutants (5 nM), 
including E96A and NΔ33, on the ds_r8oxoG:dC oligonucleotide (25 nM). S indicates the 
substrate position, while P indicates the product position. Moreover, at the right of the 
panel, a longer product of about 12 nucleotides is indicated by an asterisk whereas a smaller 
one of 11 nucleotides is indicated by a double asterisk. (e) Representative denaturing 
polyacrylamide gel of APE1 (5 nM) incision in the presence of Compound #3 inhibitor. S 
indicates the substrate position, while P indicates the product position. Moreover, at the 
right of the panel, a longer product of about 12 nucleotides is indicated by an asterisk 






Figure B.7APE1 is part of the protein complex recognizing r8oxoG from cell extracts, 
as evaluated through supershift EMSA analysis. (a) HeLa cells were transfected with 
siRNAs directed versus RNase H2 and APE1 proteins and compared to the Scramble 
control. Whole cell extracts were separated onto 12% SDS–PAGE, and Western blot 
analysis was performed by using an anti-APE1 antibody and an anti-RNase H2 antibody. 
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Tubulin was used as loading control. The molecular weight (MW) expressed in kilodaltons 
(kDa) is shown on the right of each panel. (b) Representative native EMSA polyacrylamide 
gel on ds_r8oxoG:dC oligonucleotide incubated with 2.5 µg of whole cell extracts from 
untreated HeLa cells (lane 2) and HeLa cells transfected with control siRNA (lane 3), 
silenced for APE1 (lane 4), RNase H2 (lane 5) and APE1/RNase H2 (lane 6) for 30 minutes 
at 37°C. Lane 1 corresponds to r8oxoG-containing oligonucleotide alone without any cell 
extract. On the right side of the gel, an arrow denotes the retarded complex between cell 
extract and the probe (left). Histogram shows the difference of binding between each 
condition (right). (c) Representative native polyacrylamide gel of ds_r8oxoG:dC 
oligonucleotide incubated at 37°C for 30 minutes with the indicated amounts of whole cell 
extracts (WCE) without or with a pre-incubation with the specific monoclonal antibody 
recognizing APE1 protein, at 4°C for 1 hour, before gel separation. Bound complex to the 
oligonucleotide is indicated by an arrow named ‘Bound’, whereas the supershifted 
complex, obtained after incubation with the specific antibody, is indicated by an arrow 
named ‘Supershifted’. (d) Representative native polyacrylamide gel of ds_r8oxoG:dC 
oligonucleotide incubated at 37°C for 30 minutes with the indicated amounts of whole cell 
extracts (WCE) without or with a pre-incubation with increasing amounts of the specific 
monoclonal antibody recognizing APE1 protein, at 4°C for 1 hour, before gel separation. 
Bound complex to the oligonucleotide is indicated by an arrow named ‘Bound’, whereas 
the supershifted complex, obtained after incubation with the specific antibody, is indicated 
by an arrow named ‘Supershifted’. (e) Western blot analysis performed on total cell 
extracts (Input) (left) and on immunoprecipitated material (IP) (right) from HeLa cells 
previously transfected with FLAG-tagged APE1 expressing plasmids. Silencing of RNase 
H2 was performed to demonstrate the specificity of the recognized band by the anti-RNAse 
H2 antibody used. Whole cell extracts were immunoprecipitated with a with α-FLAG resin. 
Co-immunoprecipitation with NPM1 was used as positive control as already described 








Figure B.8 APE1 possesses NIR activity on r8oxoG-containing oligonucleotide under 
specific experimental conditions. Comparison of the reaction conditions used in this 
study with that by Sassa et al. Representative denaturing polyacrylamide gel of 
ds_r8oxoG:dC oligonucleotide incision by APE1 under different buffer conditions. On top 
of the panel MgCl2 and KCl concentrations (mM) are indicated for each experimental 
condition. The presence of EDTA is indicated where is the case. Lane 2 reproduces buffer 
conditions from Sassa et al. [154]. S indicates the substrate position while P indicates the 




APPENDIX C. Supplementary information for Chapter 5 
Table C.1 All strains used in this study 
Strain Relevant genotype Source 
E134 (KK-44) 
MATα ade5-1 lys2-14A trp1-289 his7-2 leu2-3,112 
ura3-52 
Koh et al., 2015 [70] 
KK-100 KK-44 rnh201Δ::hygMX4 Koh et al., 2015 [70] 
KK-172 KK-44 rnh1Δ::kanMX4 this study 
SB-286 KK-44 rnh202-FF346,347AA this study 
BY4742 (KK-2) MATα his3Δ1 leu2Δ0 lys2Δ0 ura3 Δ0 
Storici et al., 2001 
[183] 
SB-305 KK-2 rnh201Δ::hygMX4 this study 
SB-285 KK-2 rnh202-FF346,347AA this study 
SB-311 KK-2 rnh201-P45D Y219A this study 
YFP17 (SB-288) 
Δho Δhml::ADE1 mataΔ::hisG Δhmr::ADE1 ade1 
leu2-3,1122 lys5 trp1::hisG ura3-52 
ade3::GAL::HO 
Keskin et al., 2015 
[184] 
SB-293 SB-293 rnh201Δ::hygMX4 this study 
DG2204 (HK-692) 
MATa LYS+ trp1 ADE+ LEU+ ura3 his3-Δ200 
hisG Gal+ Spo+ Tyless 
Garfinkel et al., 2005 
[185] 
HK-705 HK-692 rnh201Δ::hygMX4 this study 
JZ105 (KK-154) 
Mat1M Δmat2,3::LEU2 ade6-210 leu1-32 ura4-
D18 his2 
Vengrova et al., 2004 
[42] 
HK-983 KK-154 rnh201Δ::kanMX4 this study 






Table C.2 List of strains used and the corresponding restriction enzymes used for 
fragmentation of genomic DNA.  
Strain FS # Enzymes used 
E134 (KK-44) FS 93 DraI, EcoRV, SspI (DES) 
   
 FS 95 DES 
 FS 115 RsaI, HaeIII (RH) 
KK-100 FS117 DraI, EcoRV, SspI, AluI (DESA) 
 FS 118 DESA 
 FS 141 DESA 
 FS 156 DESA 
   
BY4742 (KK-2) FS 106 DES 
   
SB-305 FS 138 DESA 
   
SB-285 FS 150 DES 
   
SB-311 FS 153 DES 
   
YFP17 (SB-288) FS 107 DES 
   
SB-293 FS 140 RH 
   
DG2204 (HK-692) FS 129 DESA 
   
HK-705 FS 130 DESA 
   
JZ105 (KK-154) FS 94 DES 
   
HK-983 FS 97 DES 
Ribose-seq libraries were constructed by fragmentation of genomic DNA using restriction 
endonucleases. Three sets of enzymes were used: (i) RsaI, HaeIII (RH), (ii) DraI, EcoRV, 
SspI (DES), and (iii) DraI, EcoRV, SspI and AluI (DESA). The library names and the 
corresponding enzymes used for their construction are indicated. The enzymes were 
purchased from New England Biolabs.  
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Table C.3 List of oligonucleotides used in this study 









RNH P45D.60 60 
5’AATGGGTATCGATGAAGCTGGCAGAGGGGACGTATTAGG
GCCAATGGTCTACGCAGTAG 
RNH Y219A.60 60 
5’GGGATCCCGATGAGATCCTGGGTTCTGGAGCCCCCTCCGA
CCCGAAGACAGTCGCATGGC 
Adaptor.L1 * 65 
5’ P-NNC CGN NNN NNA GAT CGG AAG AGC GTC GTG TAG 
GGA AAG AGT GTT GAT GAT AGA TCC GTG TCG CAA CT 
Adaptor.L2 * 65 
5’ P-NNT GAN NNN NNA GAT CGG AAG AGC GTC GTG TAG 
GGA AAG AGT GTT GAT GAT AGA TCC GTG TCG CAA CT 
Adaptor.S * 25 5’ P-GTT GCG ACA CGG ATC TAT CAA CAC T -Am 
PCR.1 54 
5’ GTG ACT GGA GTT CAG ACG TGT GCT CTT CCG ATC TTG 
ATA GAT CCG TGT CGC AAC 
PCR.2 20 5’ ACA CTC TTT CCC TAC ACG AC 
PCR.701 53 
5’ CAA GCA GAA GAC GGC ATA CGA GAT CGA GTA ATG 
TGA CTG GAG TTC AGA CGT GT 
PCR.702 53 
5’ CAA GCA GAA GAC GGC ATA CGA GAT TCT CCG GAG 
TGA CTG GAG TTC AGA CGT GT 
PCR.501 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT ATA 
GCC TAC ACT CTT TCC CTA CAC GAC 
PCR.502 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACA TAG 
AGG CAC ACT CTT TCC CTA CAC GAC 
PCR.503 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACC CTA 
TCC TAC ACT CTT TCC CTA CAC GAC 
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PCR.504 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACG GCT 
CTG AAC ACT CTT TCC CTA CAC GAC 
PCR.505 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACA GGC 
GAA GAC ACT CTT TCC CTA CAC GAC 
PCR.506 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACT AAT 
CTT AAC ACT CTT TCC CTA CAC GAC 
PCR.507 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACC AGG 
ACG TAC ACT CTT TCC CTA CAC GAC 
PCR.508 57 
5’ AAT GAT ACG GCG ACC ACC GAG ATC TAC ACG TAC 
TGA CAC ACT CTT TCC CTA CAC GAC 
Name, length, and sequence of oligonucleotides used in this study are described. The bold 
and underlined letters in oligonucleotides (202.PIP.F, 202.PIP.R, RNH P45D.60, and RNH 
Y219A.60) indicate the specific mutations that were introduced in RNH202 or RNH201 
region. All bold letters in the PCR primers indicate the specific sequence of index used in 
sequencing. ‘P and Am’ indicate end modifications of phosphate and amino groups 
respectively. All oligonucleotides were desalted, except for those marked in *, which were 
HPLC purified. 202.PIP.F, 202.PIP.R, RNH P45D.60, and RNH Y219A.60 were 






Figure C.1 Identity and sequence context of rNMP incorporation in S. cerevisiae 
rnh201 genome. Shown here are normalized nucleotide plots relative to mapped 
positions of sequences from ribose-seq library of rnh201 cells (KK-100). Four 
independent libraries were prepared from rnh201 cells (KK-100), FS117 (row 1), FS118 
(row 2), FS141 (row 3), and FS156 (row 4). All these libraries were prepared by using 






Figure C.2 rNMP composition in S. cerevisiae rnh201 cells. The observed rNMP 
frequencies from Figure C.1 were divided by the expected proportion of bases shown in 
Table C.4 for four independent libraries of S. cerevisiae rnh201 (KK-100) genome. 
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